activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	119275	CHEMBL769154	Inhibition of Protein kinase PRAK at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	18.0	CHEMBL3094	Homo sapiens	Inhibition	%	18.0
	119275	CHEMBL769154	Inhibition of Protein kinase PRAK at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	18.0	CHEMBL3094	Homo sapiens	Inhibition	%	18.0
	133234	CHEMBL769154	Inhibition of Protein kinase PRAK at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	1.0	CHEMBL3094	Homo sapiens	Inhibition	%	1.0
	138059	CHEMBL769154	Inhibition of Protein kinase PRAK at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccccc3)c(Br)cc12)C1CC1		CHEMBL259270	=	Inhibition	%	21.0	CHEMBL3094	Homo sapiens	Inhibition	%	21.0
	144077	CHEMBL769154	Inhibition of Protein kinase PRAK at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)ccc12)C1CC1		CHEMBL405145	=	Inhibition	%		CHEMBL3094	Homo sapiens	Inhibition	%	
	177489	CHEMBL762712	Inhibition of PRAK, MAPK5	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	59.0	CHEMBL3094	Homo sapiens	Activity	%	59.0
	178802	CHEMBL762712	Inhibition of PRAK, MAPK5	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	Activity	%	82.0	CHEMBL3094	Homo sapiens	Activity	%	82.0
	182549	CHEMBL762712	Inhibition of PRAK, MAPK5	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	Activity	%	57.0	CHEMBL3094	Homo sapiens	Activity	%	57.0
	554904	CHEMBL842204	Inhibition of PRAK (p38 regulated/activated kinase) in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Inhibition	%	13.0	CHEMBL3094	Homo sapiens	Inhibition	%	13.0
	559748	CHEMBL842205	inhibition of PRAK (p38 regulated/activated kinase) in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL288143	=	Inhibition	%	21.0	CHEMBL3094	Homo sapiens	Inhibition	%	21.0
	572991	CHEMBL842205	inhibition of PRAK (p38 regulated/activated kinase) in presence of 10 uM ATP	B	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL259744	=	Inhibition	%	7.0	CHEMBL3094	Homo sapiens	Inhibition	%	7.0
	586382	CHEMBL842204	Inhibition of PRAK (p38 regulated/activated kinase) in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL258701	=	Inhibition	%	22.0	CHEMBL3094	Homo sapiens	Inhibition	%	22.0
	590220	CHEMBL842206	Inhibition of PRAK (p38 regulated/activated kinase) in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3F)cc12		CHEMBL407373	=	Inhibition	%	5.0	CHEMBL3094	Homo sapiens	Inhibition	%	5.0
	616538	CHEMBL769155	Inhibition of Protein kinase PRAK at 100 nM	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	Control	%	86.0	CHEMBL3094	Homo sapiens	Control	%	86.0
	616577	CHEMBL769156	Inhibition of Protein kinase PRAK at 500 nM	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	Control	%	50.0	CHEMBL3094	Homo sapiens	Control	%	50.0
	915734	CHEMBL769152	Inhibition of human Protein kinase PRAK at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340776	=	Activity	%	88.0	CHEMBL3094	Homo sapiens	Activity	%	88.0
	931195	CHEMBL769152	Inhibition of human Protein kinase PRAK at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCOCCn1cc2c2cccnc21		CHEMBL337642	=	Activity	%	102.0	CHEMBL3094	Homo sapiens	Activity	%	102.0
	989306	CHEMBL769158	Inhibition of p38-regulated activated kinase (Protein kinase PRAK)	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	IC50	nM	50000.0	CHEMBL3094	Homo sapiens	IC50	uM	50.0
	1011312	CHEMBL732638	Inhibition of p38-regulated activated kinase (PRAK)	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	IC50	nM	1900.0	CHEMBL3094	Homo sapiens	IC50	uM	1.9
	1034890	CHEMBL769315	Inhibition of Protein kinase PRAK at 10 uM	B	COc1ccc(C2=C(Nc3cccc(Cl)c3)C(=O)NC2=O)cc1		CHEMBL158208	=	Inhibition	%	11.0	CHEMBL3094	Homo sapiens	Inhibition	%	11.0
	1036285	CHEMBL769315	Inhibition of Protein kinase PRAK at 10 uM	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Inhibition	%	0.0	CHEMBL3094	Homo sapiens	Inhibition	%	0.0
	1048351	CHEMBL769315	Inhibition of Protein kinase PRAK at 10 uM	B	COc1ccccc1C1=C(N2CCc3ccccc32)C(=O)NC1=O		CHEMBL160585	=	Inhibition	%	15.0	CHEMBL3094	Homo sapiens	Inhibition	%	15.0
	1055597	CHEMBL769315	Inhibition of Protein kinase PRAK at 10 uM	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160586	=	Inhibition	%	0.0	CHEMBL3094	Homo sapiens	Inhibition	%	0.0
	1058283	CHEMBL769315	Inhibition of Protein kinase PRAK at 10 uM	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156379	=	Inhibition	%	7.0	CHEMBL3094	Homo sapiens	Inhibition	%	7.0
	1173965	CHEMBL769157	Inhibition of Protein kinase PRAK	B	CCN(CC)C/C=C/c1nc(O)c2c(ccc3nc(Nc4c(Cl)cccc4Cl)n(C)c32)c1C		CHEMBL281957	>	IC50	nM	1000.0	CHEMBL3094	Homo sapiens	IC50	uM	1.0
	1441911	CHEMBL830719	Inhibition of Protein kinase PRAK at 10 uM with 100 uM ATP	B	O=C(Nc1ncnc2oc(-c3cccnc3)cc12)C1CCCC1		CHEMBL182419	=	Inhibition	%	7.0	CHEMBL3094	Homo sapiens	Inhibition	%	7.0
	1489986	CHEMBL828417	Inhibition of protein kinase PRAK	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F		CHEMBL1788116	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	1498766	CHEMBL877328	Inhibition of p38-regulated/activated kinase (PRAK)	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cc3)nc2n(C2CCCC2)c1=O		CHEMBL365847	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
Not Active	1658708	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12		CHEMBL188678		Activity			CHEMBL3094	Homo sapiens	Activity		
	1665739	CHEMBL860237	Inhibition of PRAK at 10 uM	B	CN1C(=O)C(C(=O)Nc2nncs2)c2cc3occc3cc21		CHEMBL200906	=	Inhibition	%	28.0	CHEMBL3094	Homo sapiens	Inhibition	%	28.0
	1666384	CHEMBL865776	Inhibition of PRAK activity at 10 uM	B	Oc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)ccc1Cl		CHEMBL373011	=	Inhibition	%	19.0	CHEMBL3094	Homo sapiens	Inhibition	%	19.0
	1666385	CHEMBL865776	Inhibition of PRAK activity at 10 uM	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1		CHEMBL477989	=	Inhibition	%	18.0	CHEMBL3094	Homo sapiens	Inhibition	%	18.0
	1671492	CHEMBL869956	Inhibition of PRAK at 10 uM	B	Cc1c(Nc2ccc(Br)cc2F)c(C(=O)NOCCO)cn(C)c1=O		CHEMBL199860	=	Inhibition	%	16.0	CHEMBL3094	Homo sapiens	Inhibition	%	16.0
	1671521	CHEMBL869956	Inhibition of PRAK at 10 uM	B	CCONC(=O)c1cn(C)c(=O)c(F)c1Nc1ccc(Br)cc1F		CHEMBL201426	=	Inhibition	%	18.0	CHEMBL3094	Homo sapiens	Inhibition	%	18.0
	1671545	CHEMBL869956	Inhibition of PRAK at 10 uM	B	CONC(=O)c1cn(C)c(=O)c(C)c1Nc1ccc(Br)cc1F		CHEMBL426840	=	Inhibition	%	9.0	CHEMBL3094	Homo sapiens	Inhibition	%	9.0
	1671637	CHEMBL869956	Inhibition of PRAK at 10 uM	B	CCONC(=O)c1cn(C)c(=O)c(C)c1Nc1ccc(Br)cc1F		CHEMBL203138	=	Inhibition	%	18.0	CHEMBL3094	Homo sapiens	Inhibition	%	18.0
Not Determined	1728731	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccco3)ccc12		CHEMBL196964		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Determined	1728774	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc(F)cc3)ccc12		CHEMBL197439		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Determined	1728817	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccsc3)ccc12		CHEMBL196764		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Determined	1728860	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3oc3ccccc34)ccc12		CHEMBL196759		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Determined	1728903	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cc4ccccc4s3)ccc12		CHEMBL381025		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Determined	1728956	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3Sc3ccccc3S4)ccc12		CHEMBL199216		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Determined	1728999	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)ccc12		CHEMBL436767		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Determined	1729042	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4ccccc34)ccc12		CHEMBL199050		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Determined	1729085	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(/C=C/c3ccc(Cl)cc3)ccc12		CHEMBL199051		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Determined	1729128	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4[nH]ccc4c3)ccc12		CHEMBL369969		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Determined	1729171	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4ncccc4c3)ccc12		CHEMBL198740		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Determined	1729214	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3Oc3ccccc3S4)ccc12		CHEMBL197239		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Determined	1729257	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	Nc1cc(C(=O)O)cc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c1		CHEMBL370108		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Determined	1729300	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3sc3ccccc34)ccc12		CHEMBL198801		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Determined	1729346	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	O=C1c2ccccc2C(=O)N1Cc1cccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c1		CHEMBL197219		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Determined	1729389	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	O=C1c2ccccc2C(=O)N1Cc1ccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)cc1		CHEMBL197227		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Determined	1729432	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccs3)ccc12		CHEMBL371968		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Determined	1729475	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4ccccc4c3)ccc12		CHEMBL200299		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Determined	1729518	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3csc4ccccc34)ccc12		CHEMBL199416		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Determined	1729561	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc(OCc4ccccc4)cc3)ccc12		CHEMBL382501		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Determined	1729619	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	Cc1ccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c2ccccc12		CHEMBL200275		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Determined	1729662	CHEMBL860400	Inhibitory activity against PRAK at 10 uM	B	COC(=O)/C=C/c1ccccc1-c1ccc2c(=O)cc(N3CCOCC3)oc2c1		CHEMBL199424		Activity			CHEMBL3094	Homo sapiens	Activity		
	1734098	CHEMBL862829	Residual activity at human PRAK at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	95.0	CHEMBL3094	Homo sapiens	Activity	%	95.0
	1735022	CHEMBL854497	Activity against PRAK at 10 uM in the presence of 100 uM ATP relative to control	B	COc1cc(/C=C2\C(=O)NN(c3ccc(Cl)c(Cl)c3)C2=O)ccc1O		CHEMBL380093	=	Activity	%	71.0	CHEMBL3094	Homo sapiens	Activity	%	71.0
	1735041	CHEMBL854497	Activity against PRAK at 10 uM in the presence of 100 uM ATP relative to control	B	COc1cccc(NC(=O)Nc2nnc(-c3ccncc3)s2)c1		CHEMBL377430	=	Activity	%	69.0	CHEMBL3094	Homo sapiens	Activity	%	69.0
	1751571	CHEMBL869140	Inhibition of PRAK	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3Cl)cn12		CHEMBL215652	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	1751572	CHEMBL869140	Inhibition of PRAK	B	CC(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12		CHEMBL213423	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	1751573	CHEMBL869140	Inhibition of PRAK	B	CCNc1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL213451	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	1751574	CHEMBL869140	Inhibition of PRAK	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3F)cn12		CHEMBL212382	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	1751575	CHEMBL869140	Inhibition of PRAK	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12		CHEMBL212968	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	1751576	CHEMBL869140	Inhibition of PRAK	B	CC(C)c1nnc2ccc(-c3c[nH]nc3-c3cc(F)ccc3F)cn12		CHEMBL214198	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	1751655	CHEMBL869140	Inhibition of PRAK	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccccc3)cn12		CHEMBL379929	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	1769441	CHEMBL910946	Inhibition of PRAK	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL3094	Homo sapiens	IC50	uM	1.0
	1790028	CHEMBL854696	Percentage activity of human PRAK in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	74.0	CHEMBL3094	Homo sapiens	Activity	%	74.0
	1790340	CHEMBL873777	Percent residual activity, relative to control, of PRAK at 1uM concentration of inhibitor in presence of 20uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	97.0	CHEMBL3094	Homo sapiens	Activity	%	97.0
	1790394	CHEMBL873777	Percent residual activity, relative to control, of PRAK at 1uM concentration of inhibitor in presence of 20uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL279185	=	Activity	%	89.0	CHEMBL3094	Homo sapiens	Activity	%	89.0
	1837920	CHEMBL920458	Inhibition of PRAK at 10 uM relative to control	B	CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1		CHEMBL376505	=	Inhibition	%	77.0	CHEMBL3094	Homo sapiens	Inhibition	%	77.0
	1837959	CHEMBL920458	Inhibition of PRAK at 10 uM relative to control	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Inhibition	%	87.0	CHEMBL3094	Homo sapiens	Inhibition	%	87.0
	1881812	CHEMBL904791	Inhibition of MK5	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	IC50	nM	500.0	CHEMBL3094	Homo sapiens	IC50	uM	0.5
	1881819	CHEMBL904791	Inhibition of MK5	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4)c3)cc21		CHEMBL388566	=	IC50	nM	140.0	CHEMBL3094	Homo sapiens	IC50	uM	0.14
	1881826	CHEMBL904791	Inhibition of MK5	B	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	=	IC50	nM	81.0	CHEMBL3094	Homo sapiens	IC50	uM	0.081
	1881836	CHEMBL904791	Inhibition of MK5	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	IC50	nM	210.0	CHEMBL3094	Homo sapiens	IC50	uM	0.21
	1981768	CHEMBL899285	Inhibition of PRAK assessed as residual activity at 0.01 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	88.0	CHEMBL3094	Homo sapiens	Activity	%	88.0
	1981769	CHEMBL899286	Inhibition of PRAK assessed as residual activity at 1 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	96.0	CHEMBL3094	Homo sapiens	Activity	%	96.0
	2025188	CHEMBL887016	Inhibition of human PRAK at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	96.0	CHEMBL3094	Homo sapiens	Inhibition	%	96.0
	2025456	CHEMBL887016	Inhibition of human PRAK at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	88.0	CHEMBL3094	Homo sapiens	Inhibition	%	88.0
	2025457	CHEMBL887016	Inhibition of human PRAK at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	102.0	CHEMBL3094	Homo sapiens	Inhibition	%	102.0
	2025458	CHEMBL887016	Inhibition of human PRAK at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	101.0	CHEMBL3094	Homo sapiens	Inhibition	%	101.0
	2036350	CHEMBL922896	Inhibition of PRAK	B	COc1ccc2[nH]c3c(c2c1)CCNC3C(=O)O		CHEMBL395157	=	IC50	nM	19000.0	CHEMBL3094	Homo sapiens	IC50	uM	19.0
	2036403	CHEMBL922896	Inhibition of PRAK	B	COc1ccc2[nH]c3c(c2c1)C1CCN(C1)C3C(=O)O		CHEMBL392876	=	IC50	nM	24000.0	CHEMBL3094	Homo sapiens	IC50	uM	24.0
	2036406	CHEMBL922896	Inhibition of PRAK	B	COc1ccc2[nH]c3c(c2c1)C1CCCN(C1)C3C(=O)O		CHEMBL394124	=	IC50	nM	25000.0	CHEMBL3094	Homo sapiens	IC50	uM	25.0
	2051666	CHEMBL941802	Inhibition of PRAK	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	1525.0	CHEMBL3094	Homo sapiens	Ki	uM	1.525
	2081804	CHEMBL928828	Inhibition of MAPKAP-K5 at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL3094	Homo sapiens	Inhibition	%	20.0
	2099518	CHEMBL948232	Inhibition of PRAK at 10 uM	B	CN(C)CCCOc1cc2c(cc1O)c1c3c(c(-c4ccccc4Cl)cc1n2C)C(=O)NC3=O		CHEMBL410261	=	Inhibition	%	137.0	CHEMBL3094	Homo sapiens	Inhibition	%	137.0
	2099586	CHEMBL948232	Inhibition of PRAK at 10 uM	B	Cn1c2cc(C(=O)NCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL272267	=	Inhibition	%	116.0	CHEMBL3094	Homo sapiens	Inhibition	%	116.0
	2099587	CHEMBL948232	Inhibition of PRAK at 10 uM	B	Cn1c2cc(SCCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL404335	=	Inhibition	%	99.0	CHEMBL3094	Homo sapiens	Inhibition	%	99.0
	2099588	CHEMBL948232	Inhibition of PRAK at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)c(OCCCN3CCOCC3)cc2n1CCO		CHEMBL271715	=	Inhibition	%	111.0	CHEMBL3094	Homo sapiens	Inhibition	%	111.0
	2099589	CHEMBL948232	Inhibition of PRAK at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)c(OCCCN3CCCC3)cc2n1CCO		CHEMBL270021	=	Inhibition	%	104.0	CHEMBL3094	Homo sapiens	Inhibition	%	104.0
	2099590	CHEMBL948232	Inhibition of PRAK at 10 uM	B	Cn1c2cc(OCCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O	Outside typical range	CHEMBL255427	=	Inhibition	%	248.0	CHEMBL3094	Homo sapiens	Inhibition	%	248.0
	2101325	CHEMBL949033	Inhibition of PRAK at 10 uM	B	CC(C)(C)CN1CCC(NC(=O)c2csc(NC(=O)c3ccc4cc5n(c4c3)C3(CCC3)CNC5=O)n2)CC1		CHEMBL257834	=	Inhibition	%	98.0	CHEMBL3094	Homo sapiens	Inhibition	%	98.0
	2147367	CHEMBL922152	Activity of human PRAK kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	110.0	CHEMBL3094	Homo sapiens	Activity	%	110.0
Not Evaluated	2149611	CHEMBL931308	Inhibition of human MAPKAPK5	B	NC(=O)c1c(NC(=O)C2CC2)sc2c1CCCC2		CHEMBL379367		Activity			CHEMBL3094	Homo sapiens	Activity		
	2153710	CHEMBL928277	Inhibition of PRAK at 20 uM	B	CN(C)CCOc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL409525	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	Inhibition	%	50.0
	2153745	CHEMBL928277	Inhibition of PRAK at 20 uM	B	c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1		CHEMBL260015	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	Inhibition	%	50.0
Not Active	2170335	CHEMBL927894	Activity at PRAK at 3 uM	B	COc1c(NC(=O)c2ccc(C)c(N3C=C(C(=O)NCC(C)(C)CN(C)C)NN3)c2)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL254992		Activity			CHEMBL3094	Homo sapiens	Activity		
	2239715	CHEMBL996944	Inhibition of PRAK at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCc1nnn[nH]1		CHEMBL471329	=	Inhibition	%	66.0	CHEMBL3094	Homo sapiens	INH	%	66.0
	2239743	CHEMBL996944	Inhibition of PRAK at 10 uM	B	CS(=O)(=O)NC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL460940	=	Inhibition	%	55.0	CHEMBL3094	Homo sapiens	INH	%	55.0
	2239771	CHEMBL996944	Inhibition of PRAK at 10 uM	B	CN(C)CCNC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL462011	=	Inhibition	%	98.0	CHEMBL3094	Homo sapiens	INH	%	98.0
	2239799	CHEMBL996944	Inhibition of PRAK at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL508541	=	Inhibition	%	102.0	CHEMBL3094	Homo sapiens	INH	%	102.0
	2239827	CHEMBL996944	Inhibition of PRAK at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4)cc21)C(=O)NC3=O		CHEMBL455192	=	Inhibition	%	76.0	CHEMBL3094	Homo sapiens	INH	%	76.0
	2239855	CHEMBL996944	Inhibition of PRAK at 10 uM	B	O=C1NC(=O)c2c1c(-c1c(Cl)cccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL471163	=	Inhibition	%	21.0	CHEMBL3094	Homo sapiens	INH	%	21.0
	2239882	CHEMBL996944	Inhibition of PRAK at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL411662	=	Inhibition	%	58.0	CHEMBL3094	Homo sapiens	INH	%	58.0
	2239910	CHEMBL996944	Inhibition of PRAK at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Inhibition	%	6.0	CHEMBL3094	Homo sapiens	INH	%	6.0
	2248289	CHEMBL1012719	Inhibition of PRAK at 5 uM	B	O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1		CHEMBL183906	=	Inhibition	%	-3.0	CHEMBL3094	Homo sapiens	INH	%	-3.0
	2248290	CHEMBL1012719	Inhibition of PRAK at 5 uM	B	CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1		CHEMBL84558	=	Inhibition	%	4.0	CHEMBL3094	Homo sapiens	INH	%	4.0
	2279736	CHEMBL958301	Inhibition of PRAK at 10 uM	B	CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1		CHEMBL493937	>	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
Not Active	2298978	CHEMBL1020732	Inhibition of human PRAK at 10 umol/L	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C(=O)N(C)C)cc1)c1ccccc1		CHEMBL525203		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Active	2302155	CHEMBL950824	Inhibition of PRAK at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
	2356977	CHEMBL958273	Inhibition of PRAK at 1 uM relative to control	B	Cc1ccn(-c2ccc(-c3ncco3)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL525893	>	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	2357013	CHEMBL958273	Inhibition of PRAK at 1 uM relative to control	B	Cc1ccn(-c2cccc(C(F)(F)F)c2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL504805	>	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	2470259	CHEMBL987178	Inhibition of MAPKAPK5 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL3094	Homo sapiens	INH	%	10.0
	2526381	CHEMBL981415	Binding affinity to PRAK2	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	8.0	CHEMBL3094	Homo sapiens	Kd	nM	8.0
Not Active	2527092	CHEMBL984164	Inhibition of PRAK at => 3 ug/mL	B	COc1c(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL451523		Activity			CHEMBL3094	Homo sapiens	Activity		
	2562285	CHEMBL984698	Inhibition of human PRAK expressed in insect Sf9 cells at 10 uM	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1		CHEMBL477989	=	Inhibition	%	18.0	CHEMBL3094	Homo sapiens	INH	%	18.0
	2562307	CHEMBL984698	Inhibition of human PRAK expressed in insect Sf9 cells at 10 uM	B	O/N=C1\CCc2cc(-c3cc(CN4CCOCC4)oc3-c3ccncc3)ccc21		CHEMBL476732	=	Inhibition	%	11.0	CHEMBL3094	Homo sapiens	INH	%	11.0
	2584886	CHEMBL955796	Inhibition of MK5	B	O=c1[nH]cnc2[nH]c(-c3ccnc(/C=C/c4ccc(CN5CCOCC5)cc4)c3)cc12		CHEMBL461139	=	IC50	nM	24.0	CHEMBL3094	Homo sapiens	IC50	uM	0.024
	2584914	CHEMBL955796	Inhibition of MK5	B	CN(C)CCOc1ccc(/C=C/c2cc(-c3cc4c(=O)[nH]cnc4[nH]3)ccn2)cc1		CHEMBL461140	=	IC50	nM	28.0	CHEMBL3094	Homo sapiens	IC50	uM	0.028
	2613333	CHEMBL1016938	Inhibition of PRAK	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	nM	10000.0
	2635915	CHEMBL1004127	Inhibition of PRAK at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	=	Residual_activity	%	75.0	CHEMBL3094	Homo sapiens	Residual_activity	%	75.0
	2635983	CHEMBL1004127	Inhibition of PRAK at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	=	Residual_activity	%	75.0	CHEMBL3094	Homo sapiens	Residual_activity	%	75.0
	2636051	CHEMBL1004127	Inhibition of PRAK at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	=	Residual_activity	%	75.0	CHEMBL3094	Homo sapiens	Residual_activity	%	75.0
	2721702	CHEMBL1055104	Inhibition of PRAK at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	2897165	CHEMBL1061121	Percent residual PRAK activity in the presence of 10uM inhibitor	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Activity	%	76.0	CHEMBL3094	Homo sapiens	Activity	%	76.0
	2897166	CHEMBL1061121	Percent residual PRAK activity in the presence of 10uM inhibitor	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Activity	%	93.0	CHEMBL3094	Homo sapiens	Activity	%	93.0
	2897167	CHEMBL1061121	Percent residual PRAK activity in the presence of 10uM inhibitor	B	Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL289277	=	Activity	%	81.0	CHEMBL3094	Homo sapiens	Activity	%	81.0
	2900342	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900343	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900344	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900345	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900346	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900347	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900348	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900349	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900350	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900351	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900352	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900353	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900354	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900355	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900356	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900357	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900358	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900359	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900360	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900361	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900362	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900363	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900364	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900365	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900366	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900367	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900368	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900369	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900370	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900371	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900372	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900373	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900374	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900375	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900376	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900377	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900378	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2900379	CHEMBL1061904	Binding constant for MAPKAPK5 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	2908113	CHEMBL1061100	Percentage PRAK activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	97.0	CHEMBL3094	Homo sapiens	Activity	%	97.0
	2908114	CHEMBL1061100	Percentage PRAK activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	107.0	CHEMBL3094	Homo sapiens	Activity	%	107.0
	2908115	CHEMBL1061100	Percentage PRAK activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	83.0	CHEMBL3094	Homo sapiens	Activity	%	83.0
	2908116	CHEMBL1063665	Percentage PRAK activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	89.0	CHEMBL3094	Homo sapiens	Activity	%	89.0
	2908117	CHEMBL1063665	Percentage PRAK activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	83.0	CHEMBL3094	Homo sapiens	Activity	%	83.0
	2908118	CHEMBL1063665	Percentage PRAK activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	107.0	CHEMBL3094	Homo sapiens	Activity	%	107.0
	2908119	CHEMBL1063665	Percentage PRAK activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	91.0	CHEMBL3094	Homo sapiens	Activity	%	91.0
	2908120	CHEMBL1063665	Percentage PRAK activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	80.0	CHEMBL3094	Homo sapiens	Activity	%	80.0
	2908121	CHEMBL1063665	Percentage PRAK activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	76.0	CHEMBL3094	Homo sapiens	Activity	%	76.0
	2908122	CHEMBL1063665	Percentage PRAK activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	82.0	CHEMBL3094	Homo sapiens	Activity	%	82.0
	2908123	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	82.0	CHEMBL3094	Homo sapiens	Activity	%	82.0
	2908124	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	97.0	CHEMBL3094	Homo sapiens	Activity	%	97.0
	2908125	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	67.0	CHEMBL3094	Homo sapiens	Activity	%	67.0
	2908126	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	66.0	CHEMBL3094	Homo sapiens	Activity	%	66.0
	2908127	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	77.0	CHEMBL3094	Homo sapiens	Activity	%	77.0
	2908128	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	91.0	CHEMBL3094	Homo sapiens	Activity	%	91.0
	2908129	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	83.0	CHEMBL3094	Homo sapiens	Activity	%	83.0
	2908130	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	67.0	CHEMBL3094	Homo sapiens	Activity	%	67.0
Antagonist	2908131	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	36.0	CHEMBL3094	Homo sapiens	Activity	%	36.0
	2908132	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	96.0	CHEMBL3094	Homo sapiens	Activity	%	96.0
	2908133	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	81.0	CHEMBL3094	Homo sapiens	Activity	%	81.0
	2908134	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	63.0	CHEMBL3094	Homo sapiens	Activity	%	63.0
	2908135	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	88.0	CHEMBL3094	Homo sapiens	Activity	%	88.0
	2908136	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	78.0	CHEMBL3094	Homo sapiens	Activity	%	78.0
	2908137	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	61.0	CHEMBL3094	Homo sapiens	Activity	%	61.0
	2908138	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	76.0	CHEMBL3094	Homo sapiens	Activity	%	76.0
	2908139	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	62.0	CHEMBL3094	Homo sapiens	Activity	%	62.0
	2908140	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	61.0	CHEMBL3094	Homo sapiens	Activity	%	61.0
	2908141	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	84.0	CHEMBL3094	Homo sapiens	Activity	%	84.0
	2908142	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	82.0	CHEMBL3094	Homo sapiens	Activity	%	82.0
	2908143	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	85.0	CHEMBL3094	Homo sapiens	Activity	%	85.0
	2908144	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	81.0	CHEMBL3094	Homo sapiens	Activity	%	81.0
	2908145	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	92.0	CHEMBL3094	Homo sapiens	Activity	%	92.0
	2908146	CHEMBL1063666	Percentage PRAK activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	79.0	CHEMBL3094	Homo sapiens	Activity	%	79.0
	2908147	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	94.0	CHEMBL3094	Homo sapiens	Activity	%	94.0
	2908148	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	76.0	CHEMBL3094	Homo sapiens	Activity	%	76.0
	2908149	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	93.0	CHEMBL3094	Homo sapiens	Activity	%	93.0
	2908150	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	82.0	CHEMBL3094	Homo sapiens	Activity	%	82.0
	2908151	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	86.0	CHEMBL3094	Homo sapiens	Activity	%	86.0
	2908152	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	86.0	CHEMBL3094	Homo sapiens	Activity	%	86.0
	2908153	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	96.0	CHEMBL3094	Homo sapiens	Activity	%	96.0
	2908154	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	96.0	CHEMBL3094	Homo sapiens	Activity	%	96.0
	2908155	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	84.0	CHEMBL3094	Homo sapiens	Activity	%	84.0
	2908156	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	69.0	CHEMBL3094	Homo sapiens	Activity	%	69.0
	2908157	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	83.0	CHEMBL3094	Homo sapiens	Activity	%	83.0
	2908158	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	76.0	CHEMBL3094	Homo sapiens	Activity	%	76.0
	2908159	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	80.0	CHEMBL3094	Homo sapiens	Activity	%	80.0
	2908160	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	79.0	CHEMBL3094	Homo sapiens	Activity	%	79.0
	2908161	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	58.0	CHEMBL3094	Homo sapiens	Activity	%	58.0
	2908162	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	97.0	CHEMBL3094	Homo sapiens	Activity	%	97.0
	2908163	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	90.0	CHEMBL3094	Homo sapiens	Activity	%	90.0
	2908164	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	85.0	CHEMBL3094	Homo sapiens	Activity	%	85.0
	2908165	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	84.0	CHEMBL3094	Homo sapiens	Activity	%	84.0
	2908166	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	74.0	CHEMBL3094	Homo sapiens	Activity	%	74.0
	2908167	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	97.0	CHEMBL3094	Homo sapiens	Activity	%	97.0
	2908168	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	89.0	CHEMBL3094	Homo sapiens	Activity	%	89.0
	2908169	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	96.0	CHEMBL3094	Homo sapiens	Activity	%	96.0
	2908170	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	96.0	CHEMBL3094	Homo sapiens	Activity	%	96.0
	2908171	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	89.0	CHEMBL3094	Homo sapiens	Activity	%	89.0
	2908172	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	92.0	CHEMBL3094	Homo sapiens	Activity	%	92.0
	2908173	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	90.0	CHEMBL3094	Homo sapiens	Activity	%	90.0
	2908174	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	91.0	CHEMBL3094	Homo sapiens	Activity	%	91.0
	2908175	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	68.0	CHEMBL3094	Homo sapiens	Activity	%	68.0
	2908176	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	83.0	CHEMBL3094	Homo sapiens	Activity	%	83.0
	2908177	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	94.0	CHEMBL3094	Homo sapiens	Activity	%	94.0
	2908178	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	85.0	CHEMBL3094	Homo sapiens	Activity	%	85.0
	2908179	CHEMBL1061101	Percentage PRAK activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	101.0	CHEMBL3094	Homo sapiens	Activity	%	101.0
	2908180	CHEMBL1063769	Percentage PRAK activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	82.0	CHEMBL3094	Homo sapiens	Activity	%	82.0
	2908181	CHEMBL1063769	Percentage PRAK activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	81.0	CHEMBL3094	Homo sapiens	Activity	%	81.0
	2908182	CHEMBL1061102	Percentage PRAK activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	90.0	CHEMBL3094	Homo sapiens	Activity	%	90.0
	2908183	CHEMBL1063667	Percentage PRAK activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	97.0	CHEMBL3094	Homo sapiens	Activity	%	97.0
	2921278	CHEMBL1049121	Inhibition of MAPKAPK5 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	64.0	CHEMBL3094	Homo sapiens	Activity	%	64.0
	2924777	CHEMBL1056867	Inhibition of PRAK assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	114.0	CHEMBL3094	Homo sapiens	Activity	%	114.0
	2924778	CHEMBL1056867	Inhibition of PRAK assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	97.0	CHEMBL3094	Homo sapiens	Activity	%	97.0
	2924779	CHEMBL1056867	Inhibition of PRAK assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	114.0	CHEMBL3094	Homo sapiens	Activity	%	114.0
	2924780	CHEMBL1056867	Inhibition of PRAK assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	72.0	CHEMBL3094	Homo sapiens	Activity	%	72.0
	2926214	CHEMBL1050226	Inhibition of PRAK assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	87.0	CHEMBL3094	Homo sapiens	Activity	%	87.0
	2928400	CHEMBL1060298	Inhibition of PRAK assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	81.0	CHEMBL3094	Homo sapiens	Activity	%	81.0
Not Active	2938598	CHEMBL1040611	Inhibition of PRAK at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
	2999007	CHEMBL1041979	Inhibition of PRAK assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	88.0	CHEMBL3094	Homo sapiens	Activity	%	88.0
	2999797	CHEMBL1041979	Inhibition of PRAK assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	98.0	CHEMBL3094	Homo sapiens	Activity	%	98.0
	2999873	CHEMBL1049875	Inhibition of PRAK assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	83.0	CHEMBL3094	Homo sapiens	Activity	%	83.0
	2999949	CHEMBL1049875	Inhibition of PRAK assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	101.0	CHEMBL3094	Homo sapiens	Activity	%	101.0
Not Active	3005112	CHEMBL1047301	Inhibition of PRAK at 10 uM	B	CCCc1cc(N2CCC(N)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL578601		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Active	3006192	CHEMBL1047301	Inhibition of PRAK at 10 uM	B	CCCc1cc(N2CCNCC2)nc2sc(C(N)=O)c(N)c12		CHEMBL568922		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Active	3006193	CHEMBL1047301	Inhibition of PRAK at 10 uM	B	CCCc1cc(N2CCC(O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL576887		Activity			CHEMBL3094	Homo sapiens	Activity		
Not Active	3006194	CHEMBL1047301	Inhibition of PRAK at 10 uM	B	CCCc1cc(N2CCCC(O)C2)nc2sc(C(N)=O)c(N)c12		CHEMBL576989		Activity			CHEMBL3094	Homo sapiens	Activity		
	3052651	CHEMBL1041138	Residual activity of MAPKAPK5 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	90.0	CHEMBL3094	Homo sapiens	Residual activity	%	90.0
	3053960	CHEMBL1050291	Residual activity of MAPKAPK5 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	134.0	CHEMBL3094	Homo sapiens	Residual activity	%	134.0
	3054212	CHEMBL1040680	Residual activity of MAPKAPK5 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	124.0	CHEMBL3094	Homo sapiens	Residual activity	%	124.0
	3055499	CHEMBL1041138	Residual activity of MAPKAPK5 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	107.0	CHEMBL3094	Homo sapiens	Residual activity	%	107.0
	3056804	CHEMBL1050291	Residual activity of MAPKAPK5 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	143.0	CHEMBL3094	Homo sapiens	Residual activity	%	143.0
	3057056	CHEMBL1040680	Residual activity of MAPKAPK5 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	97.0	CHEMBL3094	Homo sapiens	Residual activity	%	97.0
	3058376	CHEMBL1041138	Residual activity of MAPKAPK5 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	90.0	CHEMBL3094	Homo sapiens	Residual activity	%	90.0
	3058628	CHEMBL1050291	Residual activity of MAPKAPK5 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	109.0	CHEMBL3094	Homo sapiens	Residual activity	%	109.0
	3072974	CHEMBL1040680	Residual activity of MAPKAPK5 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	95.0	CHEMBL3094	Homo sapiens	Residual activity	%	95.0
	3094745	CHEMBL1068407	Inhibition of PRAK at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2scc3c2OCCO3)cnc1N		CHEMBL599171	=	Inhibition	%	-4.0	CHEMBL3094	Homo sapiens	INH	%	-4.0
	3094767	CHEMBL1068407	Inhibition of PRAK at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2ccsc2)cnc1N		CHEMBL610226	=	Inhibition	%	2.0	CHEMBL3094	Homo sapiens	INH	%	2.0
	3094818	CHEMBL1068407	Inhibition of PRAK at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3cccc4c3OCO4)cnc2N)cc1		CHEMBL590335	=	Inhibition	%	34.0	CHEMBL3094	Homo sapiens	INH	%	34.0
	3094829	CHEMBL1068407	Inhibition of PRAK at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3scc4c3OCCO4)cnc2N)cc1		CHEMBL602931	=	Inhibition	%	65.0	CHEMBL3094	Homo sapiens	INH	%	65.0
	3130781	CHEMBL1065112	Inhibition of PRAK at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	3131780	CHEMBL1068812	Inhibition of PRAK at 3 uM relative to control	B	NC(=O)c1ccc(NC(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1		CHEMBL600852	>	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	3213959	CHEMBL1116707	Inhibition of MAPKAPK5 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	-3.0	CHEMBL3094	Homo sapiens	INH	%	-3.0
	3224880	CHEMBL1100958	Inhibition of PRAK at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	3226259	CHEMBL1100958	Inhibition of PRAK at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	3260048	CHEMBL1104343	Inhibition of PRAK at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	84.0	CHEMBL3094	Homo sapiens	Activity	%	84.0
Not Determined	3261170	CHEMBL1112581	Inhibition of PRAK at 10 uM	B	O=C1OC(c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL579387		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Not Determined	3261171	CHEMBL1112581	Inhibition of PRAK at 10 uM	B	Cc1cccc(C2=N/C(=C\c3cccnc3)C(=O)O2)c1		CHEMBL1091786		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Not Determined	3261172	CHEMBL1112581	Inhibition of PRAK at 10 uM	B	O=C1OC(c2ccc(Cl)cc2)=N/C1=C\c1cccnc1		CHEMBL1091787		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
	3261173	CHEMBL1112581	Inhibition of PRAK at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286	=	Inhibition	%	5.0	CHEMBL3094	Homo sapiens	INH	%	5.0
Not Determined	3261174	CHEMBL1112581	Inhibition of PRAK at 10 uM	B	O=C1OC(c2ccc(F)c(F)c2)=N/C1=C\c1cccnc1		CHEMBL1091764		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
	3261175	CHEMBL1112581	Inhibition of PRAK at 10 uM	B	Cc1cc(C2=N/C(=C\c3cccnc3)C(=O)O2)ccc1Br		CHEMBL1091766	=	Inhibition	%	10.0	CHEMBL3094	Homo sapiens	INH	%	10.0
	3261425	CHEMBL1104343	Inhibition of PRAK at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	89.0	CHEMBL3094	Homo sapiens	Activity	%	89.0
Not Active	3272524	CHEMBL1108319	Inhibition of PRAK	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Not Active	3272525	CHEMBL1108319	Inhibition of PRAK	B	COc1ccccc1/C=C1/C(=O)Nc2ccccc21		CHEMBL444673		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Not Active	3272526	CHEMBL1108319	Inhibition of PRAK	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1F		CHEMBL1088391		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Not Active	3272527	CHEMBL1108319	Inhibition of PRAK	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1[N+](=O)[O-]		CHEMBL1088392		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Not Active	3272528	CHEMBL1108319	Inhibition of PRAK	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1S(=O)(=O)O		CHEMBL1088529		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Not Active	3272529	CHEMBL1108319	Inhibition of PRAK	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc2c(c1)OCO2		CHEMBL1086669		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Not Active	3272530	CHEMBL1108319	Inhibition of PRAK	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1cc(F)cc(F)c1		CHEMBL1086670		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Not Active	3272531	CHEMBL1108319	Inhibition of PRAK	B	NC(=O)Cc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL1086795		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Not Active	3272532	CHEMBL1108319	Inhibition of PRAK	B	COc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1OC		CHEMBL1086796		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Not Active	3272533	CHEMBL1108319	Inhibition of PRAK	B	COc1cc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc(OC)c1OC		CHEMBL383871		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
	3272534	CHEMBL1108319	Inhibition of PRAK	B	COc1cc(OC)c(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1		CHEMBL1086939	<	Inhibition	%	20.0	CHEMBL3094	Homo sapiens	INH	%	20.0
Not Active	3272535	CHEMBL1108319	Inhibition of PRAK	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
	3306928	CHEMBL1118052	Inhibition of PRAK at 3 uM	B	O=C(Nc1cc2cc[nH]c(=O)c2cc1Cl)C(NC1CC1)c1ccccc1		CHEMBL1084106	=	Inhibition	%	63.0	CHEMBL3094	Homo sapiens	INH	%	63.0
	3332015	CHEMBL1166065	Inhibition of MAPKAPK5 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	3333430	CHEMBL1166065	Inhibition of MAPKAPK5 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	3334835	CHEMBL1166065	Inhibition of MAPKAPK5 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	3336255	CHEMBL1166065	Inhibition of MAPKAPK5 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	3341797	CHEMBL1166065	Inhibition of MAPKAPK5 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	3343244	CHEMBL1166065	Inhibition of MAPKAPK5 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	3354430	CHEMBL1173994	Inhibition of PRAK1 at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4cc[nH]n4)cn23)cc1		CHEMBL1170750	=	Inhibition	%	3.0	CHEMBL3094	Homo sapiens	INH	%	3.0
	3354431	CHEMBL1173994	Inhibition of PRAK1 at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4cn[nH]c4)cn23)cc1		CHEMBL1172464	=	Inhibition	%	5.0	CHEMBL3094	Homo sapiens	INH	%	5.0
	3354432	CHEMBL1173994	Inhibition of PRAK1 at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4ccncc4)cn23)cc1		CHEMBL1170317	=	Inhibition	%	5.0	CHEMBL3094	Homo sapiens	INH	%	5.0
	3354433	CHEMBL1173994	Inhibition of PRAK1 at 10 uM by mobility shift assay	B	c1n[nH]cc1-c1cnc2ncc(-c3cn[nH]c3)n2c1		CHEMBL1171532	=	Inhibition	%	6.0	CHEMBL3094	Homo sapiens	INH	%	6.0
	3354434	CHEMBL1173994	Inhibition of PRAK1 at 10 uM by mobility shift assay	B	Cn1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)cn1		CHEMBL1171533	=	Inhibition	%	5.0	CHEMBL3094	Homo sapiens	INH	%	5.0
	3354435	CHEMBL1173994	Inhibition of PRAK1 at 10 uM by mobility shift assay	B	c1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)n[nH]1		CHEMBL1171534	=	Inhibition	%	7.0	CHEMBL3094	Homo sapiens	INH	%	7.0
	3354436	CHEMBL1173994	Inhibition of PRAK1 at 10 uM by mobility shift assay	B	OCc1cccc(-c2cnc3ncc(-c4cn[nH]c4)cn23)c1		CHEMBL1171699	=	Inhibition	%	3.0	CHEMBL3094	Homo sapiens	INH	%	3.0
	3354437	CHEMBL1173994	Inhibition of PRAK1 at 10 uM by mobility shift assay	B	c1ccc2c(-c3cnc4cnc(-c5cn[nH]c5)cn34)c[nH]c2c1		CHEMBL1170126	=	Inhibition	%	35.0	CHEMBL3094	Homo sapiens	INH	%	35.0
	3354438	CHEMBL1173994	Inhibition of PRAK1 at 10 uM by mobility shift assay	B	NCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170747	=	Inhibition	%	7.0	CHEMBL3094	Homo sapiens	INH	%	7.0
	3354439	CHEMBL1173994	Inhibition of PRAK1 at 10 uM by mobility shift assay	B	OCc1cccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)c1		CHEMBL1170748	=	Inhibition	%	4.0	CHEMBL3094	Homo sapiens	INH	%	4.0
	3354440	CHEMBL1173994	Inhibition of PRAK1 at 10 uM by mobility shift assay	B	OCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170749	=	Inhibition	%	10.0	CHEMBL3094	Homo sapiens	INH	%	10.0
	3354937	CHEMBL1173994	Inhibition of PRAK1 at 10 uM by mobility shift assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	40.0	CHEMBL3094	Homo sapiens	INH	%	40.0
	3358656	CHEMBL1174898	Inhibition of MAPKAPK5 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	95.0	CHEMBL3094	Homo sapiens	INH	%	95.0
	3359098	CHEMBL1174898	Inhibition of MAPKAPK5 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	98.0	CHEMBL3094	Homo sapiens	INH	%	98.0
	3443449	CHEMBL1244215	Inhibition of MAPKAPK5 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	3.0	CHEMBL3094	Homo sapiens	INH	%	3.0
	3443666	CHEMBL1244215	Inhibition of MAPKAPK5 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	3.0	CHEMBL3094	Homo sapiens	INH	%	3.0
	3444821	CHEMBL1244215	Inhibition of MAPKAPK5 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	5.0	CHEMBL3094	Homo sapiens	INH	%	5.0
	3445187	CHEMBL1244499	Binding affinity to MAPKAPK5	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	930.0	CHEMBL3094	Homo sapiens	Kd	nM	930.0
	3445445	CHEMBL1244215	Inhibition of MAPKAPK5 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	3.0	CHEMBL3094	Homo sapiens	INH	%	3.0
	3445662	CHEMBL1244215	Inhibition of MAPKAPK5 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	7.0	CHEMBL3094	Homo sapiens	INH	%	7.0
	3445865	CHEMBL1244215	Inhibition of MAPKAPK5 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	7.0	CHEMBL3094	Homo sapiens	INH	%	7.0
	3446055	CHEMBL1244215	Inhibition of MAPKAPK5 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	4.0	CHEMBL3094	Homo sapiens	INH	%	4.0
	3446540	CHEMBL1249576	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 1 uM	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Inhibition	%	98.0	CHEMBL3094	Homo sapiens	INH	%	98.0
	3446569	CHEMBL1249576	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 1 uM	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Inhibition	%	96.0	CHEMBL3094	Homo sapiens	INH	%	96.0
	3446593	CHEMBL1249576	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 1 uM	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Inhibition	%	74.0	CHEMBL3094	Homo sapiens	INH	%	74.0
	3446618	CHEMBL1247640	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 20 uM	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Inhibition	%	51.0	CHEMBL3094	Homo sapiens	INH	%	51.0
	3446645	CHEMBL1249552	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 50 uM	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Inhibition	%	68.0	CHEMBL3094	Homo sapiens	INH	%	68.0
	3446673	CHEMBL1249576	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 1 uM	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Inhibition	%	85.0	CHEMBL3094	Homo sapiens	INH	%	85.0
	3446699	CHEMBL1247616	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Inhibition	%	88.0	CHEMBL3094	Homo sapiens	INH	%	88.0
	3446723	CHEMBL1247616	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Inhibition	%	112.0	CHEMBL3094	Homo sapiens	INH	%	112.0
	3446747	CHEMBL1249552	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 50 uM	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Inhibition	%	108.0	CHEMBL3094	Homo sapiens	INH	%	108.0
	3446772	CHEMBL1247616	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 10 uM	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Inhibition	%	71.0	CHEMBL3094	Homo sapiens	INH	%	71.0
	3446785	CHEMBL1249805	Inhibition of His-tagged human PRAK expressed in Sf9 cells	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	IC50	nM	50000.0	CHEMBL3094	Homo sapiens	IC50	uM	50.0
	3446804	CHEMBL1247616	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 10 uM	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Inhibition	%	93.0	CHEMBL3094	Homo sapiens	INH	%	93.0
	3446831	CHEMBL1247616	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 10 uM	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Inhibition	%	36.0	CHEMBL3094	Homo sapiens	INH	%	36.0
	3446843	CHEMBL1249805	Inhibition of His-tagged human PRAK expressed in Sf9 cells	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	IC50	nM	1900.0	CHEMBL3094	Homo sapiens	IC50	uM	1.9
	3446858	CHEMBL1247640	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 20 uM	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Inhibition	%	6.0	CHEMBL3094	Homo sapiens	INH	%	6.0
	3446889	CHEMBL1247640	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 20 uM	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Inhibition	%	91.0	CHEMBL3094	Homo sapiens	INH	%	91.0
	3447266	CHEMBL1247616	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 10 uM	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Inhibition	%	104.0	CHEMBL3094	Homo sapiens	INH	%	104.0
	3447299	CHEMBL1247616	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 10 uM	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	81.0	CHEMBL3094	Homo sapiens	INH	%	81.0
	3447329	CHEMBL1249576	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 1 uM	B	NCCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL270875	=	Inhibition	%	89.0	CHEMBL3094	Homo sapiens	INH	%	89.0
	3447353	CHEMBL1249576	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 1 uM	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Inhibition	%	96.0	CHEMBL3094	Homo sapiens	INH	%	96.0
	3447377	CHEMBL1249576	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 1 uM	B	CN1C(=O)C(c2c[nH]c3ccccc23)=C(c2c[nH]c3ccccc23)C1=O		CHEMBL291725	=	Inhibition	%	85.0	CHEMBL3094	Homo sapiens	INH	%	85.0
	3447401	CHEMBL1249576	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 1 uM	B	Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL269264	=	Inhibition	%	102.0	CHEMBL3094	Homo sapiens	INH	%	102.0
	3447425	CHEMBL1249576	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 1 uM	B	Cn1cc(C2=C(c3c4n(c5ccccc35)CCC(CN)C4)C(=O)NC2=O)c2ccccc21		CHEMBL421565	=	Inhibition	%	101.0	CHEMBL3094	Homo sapiens	INH	%	101.0
	3447449	CHEMBL1249576	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 1 uM	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Inhibition	%	76.0	CHEMBL3094	Homo sapiens	INH	%	76.0
	3447473	CHEMBL1247616	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 10 uM	B	O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL16958	=	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	3447497	CHEMBL1247616	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 10 uM	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Inhibition	%	58.0	CHEMBL3094	Homo sapiens	INH	%	58.0
	3447523	CHEMBL1249576	Inhibition of His-tagged human PRAK expressed in Sf9 cells at 1 uM	B	CC[C@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@@H]4O		CHEMBL1242366	=	Inhibition	%	77.0	CHEMBL3094	Homo sapiens	INH	%	77.0
	3448491	CHEMBL1244499	Binding affinity to MAPKAPK5	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	3448775	CHEMBL1244499	Binding affinity to MAPKAPK5	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	3449724	CHEMBL1244499	Binding affinity to MAPKAPK5	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	3450128	CHEMBL1244499	Binding affinity to MAPKAPK5	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	3450357	CHEMBL1244499	Binding affinity to MAPKAPK5	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	3451047	CHEMBL1244499	Binding affinity to MAPKAPK5	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	uM	10.0
	3463283	CHEMBL1252486	Inhibition of MAPKAPK5 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	10.0	CHEMBL3094	Homo sapiens	INH	%	10.0
	3463827	CHEMBL1252486	Inhibition of MAPKAPK5 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	4.0	CHEMBL3094	Homo sapiens	INH	%	4.0
	3464046	CHEMBL1252486	Inhibition of MAPKAPK5 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	1.0	CHEMBL3094	Homo sapiens	INH	%	1.0
	3523913	CHEMBL1273648	Inhibition of MAPK5	B	CC(C)c1n[nH]c(Cl)c1-c1ccnc(Nc2ccc(N3CCC(N(C)C)CC3)cn2)n1		CHEMBL1272116	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	3523914	CHEMBL1273648	Inhibition of MAPK5	B	CC(C)c1n[nH]c(C(F)(F)F)c1-c1ccnc(Nc2ccc(N3CCC(N(C)C)CC3)cn2)n1		CHEMBL1272171	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	3525171	CHEMBL1274100	Inhibition of PRAK at 1 uM	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL496862	=	Inhibition	%	87.0	CHEMBL3094	Homo sapiens	INH	%	87.0
	3525201	CHEMBL1274100	Inhibition of PRAK at 1 uM	B	O=C1Nc2ccccc2/C1=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL500435	=	Inhibition	%	38.0	CHEMBL3094	Homo sapiens	INH	%	38.0
	3525231	CHEMBL1274100	Inhibition of PRAK at 1 uM	B	CN(C)C(=O)c1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL1272078	=	Inhibition	%	59.0	CHEMBL3094	Homo sapiens	INH	%	59.0
	3525261	CHEMBL1274100	Inhibition of PRAK at 1 uM	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL1272128	=	Inhibition	%	67.0	CHEMBL3094	Homo sapiens	INH	%	67.0
	3525291	CHEMBL1274100	Inhibition of PRAK at 1 uM	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL1272289	=	Inhibition	%	96.0	CHEMBL3094	Homo sapiens	INH	%	96.0
	3525321	CHEMBL1274100	Inhibition of PRAK at 1 uM	B	CCNCc1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)CC)ccc32)c2ccccc2)cc1		CHEMBL1271471	=	Inhibition	%	70.0	CHEMBL3094	Homo sapiens	INH	%	70.0
Not Active	3599528	CHEMBL1291144	Displacement of radiolabeled PARK substrate peptide from MAPKAPK5 at 1 to 3 uM	B	Oc1ccc2c(c1)CCN(CCCCc1ccccc1)CC2O		CHEMBL1289626		Activity			CHEMBL3094	Homo sapiens	Activity		
	5121163	CHEMBL1648693	Inhibition of human PRAK at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	119.0	CHEMBL3094	Homo sapiens	INH	%	119.0
	5132603	CHEMBL1648762	Inhibition of PRAK assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	88.0	CHEMBL3094	Homo sapiens	Activity	%	88.0
	5133746	CHEMBL1648762	Inhibition of PRAK assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	100.0	CHEMBL3094	Homo sapiens	Activity	%	100.0
	5133925	CHEMBL1648762	Inhibition of PRAK assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	100.0	CHEMBL3094	Homo sapiens	Activity	%	100.0
	5152425	CHEMBL1656377	Inhibition of MK5 by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	=	IC50	nM	640.0	CHEMBL3094	Homo sapiens	IC50	nM	640.0
Not Determined	5152437	CHEMBL1656377	Inhibition of MK5 by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651521		IC50			CHEMBL3094	Homo sapiens	IC50		
Not Determined	5152449	CHEMBL1656377	Inhibition of MK5 by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1651522		IC50			CHEMBL3094	Homo sapiens	IC50		
	5152461	CHEMBL1656377	Inhibition of MK5 by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCCCCC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651523	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	nM	10000.0
	5191381	CHEMBL1664047	Inhibition of PRAK at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	19.0	CHEMBL3094	Homo sapiens	INH	%	19.0
	5191382	CHEMBL1664047	Inhibition of PRAK at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	81.0	CHEMBL3094	Homo sapiens	INH	%	81.0
	6167670	CHEMBL1769211	Inhibition of PRAK	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)n1		CHEMBL1765781	>	Ki	nM	1000.0	CHEMBL3094	Homo sapiens	Ki	uM	1.0
	6175002	CHEMBL1767719	Inhibition of human recombinant PRAK at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2[nH]nc(C(C)C)c2n1		CHEMBL1738742	=	Inhibition	%	30.0	CHEMBL3094	Homo sapiens	INH	%	30.0
	6175019	CHEMBL1767719	Inhibition of human recombinant PRAK at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Inhibition	%	28.0	CHEMBL3094	Homo sapiens	INH	%	28.0
	6202205	CHEMBL1780658	Inhibition of MK5 at 1 uM	B	O=C1NCC2(CCCNC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21		CHEMBL1779369	>=	Inhibition	%	95.0	CHEMBL3094	Homo sapiens	INH	%	95.0
	6202206	CHEMBL1780658	Inhibition of MK5 at 1 uM	B	COc1cncc(-c2nccc(-c3cc4c([nH]3)C3(CCCNC3)CNC4=O)n2)c1		CHEMBL1779370	>=	Inhibition	%	95.0	CHEMBL3094	Homo sapiens	INH	%	95.0
	6220058	CHEMBL1786802	Inhibition of MK5 at 1 uM	B	CCCc1cnc(N)c(CNC(=S)Nc2ccc3[nH]c(=O)oc3c2)n1		CHEMBL1783710	>	Inhibition	%	70.0	CHEMBL3094	Homo sapiens	INH	%	70.0
	6273857	CHEMBL1806148	Inhibition of PRAK assessed as residual enzyme activity at 10 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Activity	%	97.0	CHEMBL3094	Homo sapiens	Activity	%	97.0
	6314175	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(=O)[nH]1		CHEMBL1813604	=	Inhibition	%	8.0	CHEMBL3094	Homo sapiens	INH	%	8.0
	6314176	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccnc3)[nH]c(=O)c12		CHEMBL1813606	=	Inhibition	%	12.0	CHEMBL3094	Homo sapiens	INH	%	12.0
	6314177	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccccn3)[nH]c(=O)c12		CHEMBL1813607	=	Inhibition	%	18.0	CHEMBL3094	Homo sapiens	INH	%	18.0
	6314178	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccncc3)[nH]c(=O)c12		CHEMBL1813608	=	Inhibition	%	13.0	CHEMBL3094	Homo sapiens	INH	%	13.0
	6314179	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)c1		CHEMBL1813609	=	Inhibition	%	10.0	CHEMBL3094	Homo sapiens	INH	%	10.0
	6314180	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)cc1		CHEMBL1813610	=	Inhibition	%	7.0	CHEMBL3094	Homo sapiens	INH	%	7.0
	6314181	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4[nH]nc(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813611	=	Inhibition	%	11.0	CHEMBL3094	Homo sapiens	INH	%	11.0
	6314182	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccs3)[nH]c(=O)c12		CHEMBL1813612	=	Inhibition	%	12.0	CHEMBL3094	Homo sapiens	INH	%	12.0
	6314183	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2[nH]nc(N)c2c(=O)[nH]1		CHEMBL1813613	=	Inhibition	%	1.0	CHEMBL3094	Homo sapiens	INH	%	1.0
	6314184	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccc(N4CCOCC4)cc3)[nH]c(=O)c12		CHEMBL1813614	=	Inhibition	%	11.0	CHEMBL3094	Homo sapiens	INH	%	11.0
	6314185	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(CC3CCNCC3)[nH]c(=O)c12		CHEMBL1813615	=	Inhibition	%	3.0	CHEMBL3094	Homo sapiens	INH	%	3.0
	6314186	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2c3c([nH]c(=O)c12)CCCC3		CHEMBL1813617	=	Inhibition	%	0.0	CHEMBL3094	Homo sapiens	INH	%	0.0
	6314187	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCCCC2)n1		CHEMBL1813618	=	Inhibition	%	10.0	CHEMBL3094	Homo sapiens	INH	%	10.0
	6314188	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCOCC2)n1		CHEMBL1813619	=	Inhibition	%	5.0	CHEMBL3094	Homo sapiens	INH	%	5.0
	6314189	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(=O)[nH]1		CHEMBL1813620	=	Inhibition	%	5.0	CHEMBL3094	Homo sapiens	INH	%	5.0
	6314190	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccc3)cc21		CHEMBL1813621	=	Inhibition	%	11.0	CHEMBL3094	Homo sapiens	INH	%	11.0
	6314191	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccn3)cc21		CHEMBL1813622	=	Inhibition	%	9.0	CHEMBL3094	Homo sapiens	INH	%	9.0
	6314192	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)cc1		CHEMBL1813623	=	Inhibition	%	16.0	CHEMBL3094	Homo sapiens	INH	%	16.0
	6314193	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)c1		CHEMBL1813624	=	Inhibition	%	6.0	CHEMBL3094	Homo sapiens	INH	%	6.0
	6314194	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4c(c(N)nn4C)c(=O)[nH]3)cc2)CC1		CHEMBL1813625	=	Inhibition	%	26.0	CHEMBL3094	Homo sapiens	INH	%	26.0
	6314195	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	COC(=O)CCc1c(C)[nH]c(=O)c2c(N)nn(C)c12		CHEMBL1813627	=	Inhibition	%	2.0	CHEMBL3094	Homo sapiens	INH	%	2.0
	6314196	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2c(C)[nH]c(=O)c3c(N)nn(C)c23)cc1		CHEMBL1813628	=	Inhibition	%	13.0	CHEMBL3094	Homo sapiens	INH	%	13.0
	6314197	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NC(=O)Nc3ccccc3)nn2C)c(=O)[nH]1		CHEMBL1813630	=	Inhibition	%	4.0	CHEMBL3094	Homo sapiens	INH	%	4.0
	6314198	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccccc3)[nH]c(=O)c12		CHEMBL1813777	=	Inhibition	%	3.0	CHEMBL3094	Homo sapiens	INH	%	3.0
	6314199	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NS(C)(=O)=O)nn2C)c(=O)[nH]1		CHEMBL1813778	=	Inhibition	%	0.0	CHEMBL3094	Homo sapiens	INH	%	0.0
	6314200	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(S(=O)(=O)Nc2nn(C)c3cc(C)[nH]c(=O)c23)c(OC)c1		CHEMBL1813779	=	Inhibition	%	1.0	CHEMBL3094	Homo sapiens	INH	%	1.0
	6314201	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccc(N4CCN(C)CC4)cc3)[nH]c(=O)c12		CHEMBL1813780	=	Inhibition	%	6.0	CHEMBL3094	Homo sapiens	INH	%	6.0
	6314202	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCCCC2)n1		CHEMBL1813781	=	Inhibition	%	17.0	CHEMBL3094	Homo sapiens	INH	%	17.0
	6314203	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCOCC2)n1		CHEMBL1813782	=	Inhibition	%	5.0	CHEMBL3094	Homo sapiens	INH	%	5.0
	6314204	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CC[C@H](O)C2)n1		CHEMBL1813784	=	Inhibition	%	1.0	CHEMBL3094	Homo sapiens	INH	%	1.0
	6314205	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2c1c(N)nn2C		CHEMBL1813785	=	Inhibition	%	5.0	CHEMBL3094	Homo sapiens	INH	%	5.0
	6314206	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(-c2ccccc2)cc2c1c(N)nn2C		CHEMBL1813786	=	Inhibition	%	1.0	CHEMBL3094	Homo sapiens	INH	%	1.0
	6314207	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2nn(-c3ccccc3)c(N)c12		CHEMBL1813787	=	Inhibition	%	2.0	CHEMBL3094	Homo sapiens	INH	%	2.0
	6314208	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813788	=	Inhibition	%	5.0	CHEMBL3094	Homo sapiens	INH	%	5.0
	6315094	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813789	=	Inhibition	%	2.0	CHEMBL3094	Homo sapiens	INH	%	2.0
	6315095	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813790	=	Inhibition	%	22.0	CHEMBL3094	Homo sapiens	INH	%	22.0
	6315096	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccn3)cc2nn1-c1ccccc1		CHEMBL1813791	=	Inhibition	%	2.0	CHEMBL3094	Homo sapiens	INH	%	2.0
	6315097	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	COc1ccccc1-c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813792	=	Inhibition	%	6.0	CHEMBL3094	Homo sapiens	INH	%	6.0
	6315098	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3nn(-c4ccccc4)c(N)c3c(=O)[nH]2)cc1		CHEMBL1813793	=	Inhibition	%	12.0	CHEMBL3094	Homo sapiens	INH	%	12.0
	6315099	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4nn(-c5ccccc5)c(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813795	=	Inhibition	%	4.0	CHEMBL3094	Homo sapiens	INH	%	4.0
	6315100	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccn1		CHEMBL1813796	=	Inhibition	%	-1.0	CHEMBL3094	Homo sapiens	INH	%	-1.0
	6315101	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(N2CCCCC2)n1		CHEMBL1813797	=	Inhibition	%	10.0	CHEMBL3094	Homo sapiens	INH	%	10.0
	6315102	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cc1[nH]c(=O)c2c(N)n(-c3ccccc3)nc2c1-c1ccccc1		CHEMBL1813798	=	Inhibition	%	6.0	CHEMBL3094	Homo sapiens	INH	%	6.0
	6315103	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cn1nc2c3c(nc(-c4ccccc4)cc31)NCC(=O)N2		CHEMBL1813799	=	Inhibition	%	3.0	CHEMBL3094	Homo sapiens	INH	%	3.0
	6315104	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2cnc(-c3ccccc3)cc21		CHEMBL1813800	=	Inhibition	%	5.0	CHEMBL3094	Homo sapiens	INH	%	5.0
	6315105	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(cn1)c(N)nn2C		CHEMBL1813801	=	Inhibition	%	9.0	CHEMBL3094	Homo sapiens	INH	%	9.0
	6315106	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Nc1c2cnc(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813802	=	Inhibition	%	2.0	CHEMBL3094	Homo sapiens	INH	%	2.0
	6315107	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2cn1		CHEMBL1813803	=	Inhibition	%	13.0	CHEMBL3094	Homo sapiens	INH	%	13.0
	6315108	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]ncc2c(=O)[nH]1		CHEMBL1813804	=	Inhibition	%	1.0	CHEMBL3094	Homo sapiens	INH	%	1.0
	6315109	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(N)nc(N)c2c(=O)[nH]1		CHEMBL1813805	=	Inhibition	%	3.0	CHEMBL3094	Homo sapiens	INH	%	3.0
	6315110	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(-c3ccccc3)nc(N)c2c(=O)[nH]1		CHEMBL1813806	=	Inhibition	%	5.0	CHEMBL3094	Homo sapiens	INH	%	5.0
	6315111	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	Cc1nc(N)c2c(=O)[nH]c(C)cc2n1		CHEMBL1813807	=	Inhibition	%	1.0	CHEMBL3094	Homo sapiens	INH	%	1.0
	6315112	CHEMBL1815693	Inhibition of PRAK1 at 30 uM by microfluidic mobility shift assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	37.0	CHEMBL3094	Homo sapiens	INH	%	37.0
	6339934	CHEMBL1826617	Activity of MAPKAPK5 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	76.0	CHEMBL3094	Homo sapiens	Activity	%	76.0
	6352270	CHEMBL1826247	Inhibition of PRAK assessed as residual activity at 10 uM by radioactivity assay in presence of 20 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	43.0	CHEMBL3094	Homo sapiens	Activity	%	43.0
	6386363	CHEMBL1839852	Inhibition of recombinant MK5	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	7567318	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7567777	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7568274	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7568706	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	2800.0	CHEMBL3094	Homo sapiens	Kd	nM	2800.0
	7569291	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7569751	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7569781	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7570244	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7570671	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7571267	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7571758	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7572221	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7572637	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7573263	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7573739	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7574208	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7574616	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7574784	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7575245	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7575716	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7576181	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7576589	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7576758	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7577217	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7577695	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	1200.0	CHEMBL3094	Homo sapiens	Kd	nM	1200.0
	7578165	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7578570	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7578766	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7579140	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7579590	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7580064	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7581124	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7581509	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7581954	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7582425	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7582447	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7582847	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7583470	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7583867	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7584312	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7584803	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7585207	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7585800	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7586208	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7586683	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7587137	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7587761	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7588191	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7588662	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7589113	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7589708	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	930.0	CHEMBL3094	Homo sapiens	Kd	nM	930.0
	7590175	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7590649	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7591100	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7591257	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7591679	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7592151	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7592624	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7593077	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7593224	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7593659	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7594131	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7594604	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7595056	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7595192	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7595636	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7596110	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7596581	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7597164	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7597617	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7598090	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL3094	Homo sapiens	Kd	nM	10000.0
	7598560	CHEMBL1908620	Binding constant for MAPKAPK5 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	270.0	CHEMBL3094	Homo sapiens	Kd	nM	270.0
	7922718	CHEMBL1919213	Inhibition of human recombinant MAPKAPK5 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	3.0	CHEMBL3094	Homo sapiens	INH	%	3.0
	7939954	CHEMBL1919623	Inhibition of human PRAK	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	7961053	CHEMBL1932889	Inhibition of MAPKAPK5	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL3094	Homo sapiens	IC50	uM	30.0
	7961054	CHEMBL1932889	Inhibition of MAPKAPK5	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL3094	Homo sapiens	IC50	uM	30.0
	7969788	CHEMBL1930360	Inhibition of PRAK assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	97.0	CHEMBL3094	Homo sapiens	Activity	%	97.0
	7971379	CHEMBL1929904	Inhibition of PRAK at 10 uM	B	NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL1929247	=	Inhibition	%	4.0	CHEMBL3094	Homo sapiens	INH	%	4.0
	7989275	CHEMBL1936687	Inhibition of human PRAK at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)C(C)(C)CNC4=O)nc1C(=O)NC1CCCC1		CHEMBL1933142	>=	Inhibition	%	80.0	CHEMBL3094	Homo sapiens	INH	%	80.0
	7989276	CHEMBL1936687	Inhibition of human PRAK at 3 uM	B	Cc1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)on1		CHEMBL1933143	>=	Inhibition	%	80.0	CHEMBL3094	Homo sapiens	INH	%	80.0
	7989277	CHEMBL1936687	Inhibition of human PRAK at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)cn1		CHEMBL1933148	>=	Inhibition	%	80.0	CHEMBL3094	Homo sapiens	INH	%	80.0
	7989278	CHEMBL1936687	Inhibition of human PRAK at 3 uM	B	Cn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL1933279	<	Inhibition	%	80.0	CHEMBL3094	Homo sapiens	INH	%	80.0
	8013114	CHEMBL1948133	Inhibition of MK5 using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	=	IC50	nM	1700.0	CHEMBL3094	Homo sapiens	IC50	uM	1.7
	8058756	CHEMBL1960722	Inhibition of MAPKAPK5	B	c1cn2c(-c3cn[nH]c3)cnc(Nc3ccc(N4CCOCC4)cc3)c2n1		CHEMBL1956561	=	IC50	nM	829.0	CHEMBL3094	Homo sapiens	IC50	nM	829.0
	8058757	CHEMBL1960722	Inhibition of MAPKAPK5	B	CN(c1ccc(N2CCOCC2)cc1)c1ncc(-c2cn[nH]c2)n2ccnc12		CHEMBL1956562	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	nM	10000.0
	8058758	CHEMBL1960722	Inhibition of MAPKAPK5	B	c1cn2c(-c3c[nH]nn3)cnc(Nc3ccc(N4CCOCC4)cc3)c2n1		CHEMBL1956563	=	IC50	nM	1490.0	CHEMBL3094	Homo sapiens	IC50	nM	1490.0
	8058759	CHEMBL1960722	Inhibition of MAPKAPK5	B	NC(=O)c1ccc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)cc1		CHEMBL1956564	=	IC50	nM	1370.0	CHEMBL3094	Homo sapiens	IC50	nM	1370.0
	8058760	CHEMBL1960722	Inhibition of MAPKAPK5	B	NS(=O)(=O)c1ccc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)cc1		CHEMBL1956565	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	nM	10000.0
	8058761	CHEMBL1960722	Inhibition of MAPKAPK5	B	NC(=O)c1ccc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)cc1F		CHEMBL1956566	=	IC50	nM	2390.0	CHEMBL3094	Homo sapiens	IC50	nM	2390.0
	8058762	CHEMBL1960722	Inhibition of MAPKAPK5	B	O=c1cc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)cc[nH]1		CHEMBL1956567	=	IC50	nM	390.0	CHEMBL3094	Homo sapiens	IC50	nM	390.0
	8058763	CHEMBL1960722	Inhibition of MAPKAPK5	B	CCOc1cc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)ccn1		CHEMBL1956568	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	nM	10000.0
	8058764	CHEMBL1960722	Inhibition of MAPKAPK5	B	CN(C)c1cc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)ccn1		CHEMBL1956569	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	nM	10000.0
	8058765	CHEMBL1960722	Inhibition of MAPKAPK5	B	NC(=O)c1ccc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)s1		CHEMBL1956570	=	IC50	nM	1420.0	CHEMBL3094	Homo sapiens	IC50	nM	1420.0
	8058766	CHEMBL1960722	Inhibition of MAPKAPK5	B	NC(=O)c1cnc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)s1		CHEMBL1956571	=	IC50	nM	2820.0	CHEMBL3094	Homo sapiens	IC50	nM	2820.0
	8058767	CHEMBL1960722	Inhibition of MAPKAPK5	B	NC(=O)c1ncc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)s1		CHEMBL1956572	=	IC50	nM	3200.0	CHEMBL3094	Homo sapiens	IC50	nM	3200.0
	8058768	CHEMBL1960722	Inhibition of MAPKAPK5	B	NC(=O)c1cc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)cs1		CHEMBL1956573	=	IC50	nM	437.0	CHEMBL3094	Homo sapiens	IC50	nM	437.0
	8058769	CHEMBL1960722	Inhibition of MAPKAPK5	B	O=C1NCc2cc(-c3cnc(Nc4ccc(N5CCOCC5)cc4)c4nccn34)ccc21		CHEMBL1956574	=	IC50	nM	239.0	CHEMBL3094	Homo sapiens	IC50	nM	239.0
	8058770	CHEMBL1960722	Inhibition of MAPKAPK5	B	c1cn2c(-c3ccc4[nH]ccc4c3)cnc(Nc3ccc(N4CCOCC4)cc3)c2n1		CHEMBL1956575	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	nM	10000.0
	8058771	CHEMBL1960722	Inhibition of MAPKAPK5	B	NC(=O)c1coc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)c1		CHEMBL1956684	=	IC50	nM	148.0	CHEMBL3094	Homo sapiens	IC50	nM	148.0
	8058772	CHEMBL1960722	Inhibition of MAPKAPK5	B	NC(=O)c1cc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)co1		CHEMBL1956685	=	IC50	nM	88.0	CHEMBL3094	Homo sapiens	IC50	nM	88.0
	8058773	CHEMBL1960722	Inhibition of MAPKAPK5	B	CN1CCN(c2ccc(Nc3ncc(-c4cc[nH]c(=O)c4)n4ccnc34)cc2)CC1		CHEMBL1956686	=	IC50	nM	290.0	CHEMBL3094	Homo sapiens	IC50	nM	290.0
	8058774	CHEMBL1960722	Inhibition of MAPKAPK5	B	c1nc2c(Nc3ccc(N4CCOCC4)cc3)ncc(-c3cn[nH]c3)n2n1		CHEMBL1956687	=	IC50	nM	816.0	CHEMBL3094	Homo sapiens	IC50	nM	816.0
	8058775	CHEMBL1960722	Inhibition of MAPKAPK5	B	O=C1NCc2cc(-c3cnc(Nc4ccc(N5CCOCC5)cc4)c4ncnn34)ccc21		CHEMBL1956682	=	IC50	nM	195.0	CHEMBL3094	Homo sapiens	IC50	nM	195.0
	8058776	CHEMBL1960722	Inhibition of MAPKAPK5	B	CN1CCN(c2ccc(Nc3ncc(-c4cc[nH]c(=O)c4)n4ncnc34)cc2)CC1		CHEMBL1956683	=	IC50	nM	3730.0	CHEMBL3094	Homo sapiens	IC50	nM	3730.0
	8058777	CHEMBL1960721	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of TNF-alpha-induced MMP1 expression incubated for 30 mins prior to TNFalpha-challenge measured after 48 hrs by ELISA	B	c1cn2c(-c3cn[nH]c3)cnc(Nc3ccc(N4CCOCC4)cc3)c2n1		CHEMBL1956561	=	IC50	nM	2823.0	CHEMBL3094	Homo sapiens	IC50	nM	2823.0
	8058778	CHEMBL1960721	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of TNF-alpha-induced MMP1 expression incubated for 30 mins prior to TNFalpha-challenge measured after 48 hrs by ELISA	B	c1cn2c(-c3c[nH]nn3)cnc(Nc3ccc(N4CCOCC4)cc3)c2n1		CHEMBL1956563	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	nM	10000.0
	8058779	CHEMBL1960721	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of TNF-alpha-induced MMP1 expression incubated for 30 mins prior to TNFalpha-challenge measured after 48 hrs by ELISA	B	NC(=O)c1ccc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)cc1		CHEMBL1956564	=	IC50	nM	914.0	CHEMBL3094	Homo sapiens	IC50	nM	914.0
	8058780	CHEMBL1960721	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of TNF-alpha-induced MMP1 expression incubated for 30 mins prior to TNFalpha-challenge measured after 48 hrs by ELISA	B	NS(=O)(=O)c1ccc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)cc1		CHEMBL1956565	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	nM	10000.0
	8058781	CHEMBL1960721	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of TNF-alpha-induced MMP1 expression incubated for 30 mins prior to TNFalpha-challenge measured after 48 hrs by ELISA	B	NC(=O)c1ccc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)cc1F		CHEMBL1956566	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	nM	10000.0
	8058782	CHEMBL1960721	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of TNF-alpha-induced MMP1 expression incubated for 30 mins prior to TNFalpha-challenge measured after 48 hrs by ELISA	B	O=c1cc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)cc[nH]1		CHEMBL1956567	=	IC50	nM	871.0	CHEMBL3094	Homo sapiens	IC50	nM	871.0
	8058783	CHEMBL1960721	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of TNF-alpha-induced MMP1 expression incubated for 30 mins prior to TNFalpha-challenge measured after 48 hrs by ELISA	B	NC(=O)c1ccc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)s1		CHEMBL1956570	=	IC50	nM	392.0	CHEMBL3094	Homo sapiens	IC50	nM	392.0
	8058784	CHEMBL1960721	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of TNF-alpha-induced MMP1 expression incubated for 30 mins prior to TNFalpha-challenge measured after 48 hrs by ELISA	B	NC(=O)c1cnc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)s1		CHEMBL1956571	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	nM	10000.0
	8058785	CHEMBL1960721	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of TNF-alpha-induced MMP1 expression incubated for 30 mins prior to TNFalpha-challenge measured after 48 hrs by ELISA	B	NC(=O)c1ncc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)s1		CHEMBL1956572	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	nM	10000.0
	8058786	CHEMBL1960721	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of TNF-alpha-induced MMP1 expression incubated for 30 mins prior to TNFalpha-challenge measured after 48 hrs by ELISA	B	NC(=O)c1cc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)cs1		CHEMBL1956573	=	IC50	nM	327.0	CHEMBL3094	Homo sapiens	IC50	nM	327.0
	8058787	CHEMBL1960721	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of TNF-alpha-induced MMP1 expression incubated for 30 mins prior to TNFalpha-challenge measured after 48 hrs by ELISA	B	O=C1NCc2cc(-c3cnc(Nc4ccc(N5CCOCC5)cc4)c4nccn34)ccc21		CHEMBL1956574	=	IC50	nM	676.0	CHEMBL3094	Homo sapiens	IC50	nM	676.0
	8058788	CHEMBL1960721	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of TNF-alpha-induced MMP1 expression incubated for 30 mins prior to TNFalpha-challenge measured after 48 hrs by ELISA	B	NC(=O)c1coc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)c1		CHEMBL1956684	=	IC50	nM	227.0	CHEMBL3094	Homo sapiens	IC50	nM	227.0
	8058789	CHEMBL1960721	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of TNF-alpha-induced MMP1 expression incubated for 30 mins prior to TNFalpha-challenge measured after 48 hrs by ELISA	B	NC(=O)c1cc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)co1		CHEMBL1956685	=	IC50	nM	702.0	CHEMBL3094	Homo sapiens	IC50	nM	702.0
	8058790	CHEMBL1960721	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of TNF-alpha-induced MMP1 expression incubated for 30 mins prior to TNFalpha-challenge measured after 48 hrs by ELISA	B	CN1CCN(c2ccc(Nc3ncc(-c4cc[nH]c(=O)c4)n4ccnc34)cc2)CC1		CHEMBL1956686	=	IC50	nM	871.0	CHEMBL3094	Homo sapiens	IC50	nM	871.0
	8058791	CHEMBL1960721	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of TNF-alpha-induced MMP1 expression incubated for 30 mins prior to TNFalpha-challenge measured after 48 hrs by ELISA	B	c1nc2c(Nc3ccc(N4CCOCC4)cc3)ncc(-c3cn[nH]c3)n2n1		CHEMBL1956687	=	IC50	nM	2608.0	CHEMBL3094	Homo sapiens	IC50	nM	2608.0
	8058792	CHEMBL1960721	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of TNF-alpha-induced MMP1 expression incubated for 30 mins prior to TNFalpha-challenge measured after 48 hrs by ELISA	B	O=C1NCc2cc(-c3cnc(Nc4ccc(N5CCOCC5)cc4)c4ncnn34)ccc21		CHEMBL1956682	=	IC50	nM	445.0	CHEMBL3094	Homo sapiens	IC50	nM	445.0
Active	8058793	CHEMBL1960720	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of MMP13 expression	B	c1cn2c(-c3cn[nH]c3)cnc(Nc3ccc(N4CCOCC4)cc3)c2n1		CHEMBL1956561		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Active	8058794	CHEMBL1960720	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of MMP13 expression	B	CN(c1ccc(N2CCOCC2)cc1)c1ncc(-c2cn[nH]c2)n2ccnc12		CHEMBL1956562		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Active	8058795	CHEMBL1960720	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of MMP13 expression	B	c1cn2c(-c3c[nH]nn3)cnc(Nc3ccc(N4CCOCC4)cc3)c2n1		CHEMBL1956563		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Active	8058796	CHEMBL1960720	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of MMP13 expression	B	NC(=O)c1ccc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)cc1		CHEMBL1956564		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Active	8058797	CHEMBL1960720	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of MMP13 expression	B	NS(=O)(=O)c1ccc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)cc1		CHEMBL1956565		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Active	8058798	CHEMBL1960720	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of MMP13 expression	B	NC(=O)c1ccc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)cc1F		CHEMBL1956566		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Active	8058799	CHEMBL1960720	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of MMP13 expression	B	O=c1cc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)cc[nH]1		CHEMBL1956567		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Active	8058800	CHEMBL1960720	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of MMP13 expression	B	CCOc1cc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)ccn1		CHEMBL1956568		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Active	8058801	CHEMBL1960720	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of MMP13 expression	B	CN(C)c1cc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)ccn1		CHEMBL1956569		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Active	8058802	CHEMBL1960720	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of MMP13 expression	B	NC(=O)c1ccc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)s1		CHEMBL1956570		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Active	8058803	CHEMBL1960720	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of MMP13 expression	B	NC(=O)c1cnc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)s1		CHEMBL1956571		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Active	8058804	CHEMBL1960720	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of MMP13 expression	B	NC(=O)c1ncc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)s1		CHEMBL1956572		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Active	8058805	CHEMBL1960720	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of MMP13 expression	B	NC(=O)c1cc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)cs1		CHEMBL1956573		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Active	8058806	CHEMBL1960720	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of MMP13 expression	B	O=C1NCc2cc(-c3cnc(Nc4ccc(N5CCOCC5)cc4)c4nccn34)ccc21		CHEMBL1956574		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Active	8058807	CHEMBL1960720	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of MMP13 expression	B	c1cn2c(-c3ccc4[nH]ccc4c3)cnc(Nc3ccc(N4CCOCC4)cc3)c2n1		CHEMBL1956575		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Active	8058808	CHEMBL1960720	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of MMP13 expression	B	NC(=O)c1coc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)c1		CHEMBL1956684		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
Active	8058809	CHEMBL1960720	Inhibition of MAPKAPK5 in synovial fibroblast from rheumatoid arthritis patient assessed as inhibition of MMP13 expression	B	NC(=O)c1cc(-c2cnc(Nc3ccc(N4CCOCC4)cc3)c3nccn23)co1		CHEMBL1956685		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
	8061280	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.17	CHEMBL3094	Homo sapiens	Inhibition	%	-0.17
	8061457	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-1.84	CHEMBL3094	Homo sapiens	Inhibition	%	-1.84
	8061788	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.42	CHEMBL3094	Homo sapiens	Inhibition	%	1.42
	8061979	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	0.25	CHEMBL3094	Homo sapiens	Inhibition	%	0.25
	8062319	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.23	CHEMBL3094	Homo sapiens	Inhibition	%	1.23
	8062481	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	3.66	CHEMBL3094	Homo sapiens	Inhibition	%	3.66
	8062705	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	1.63	CHEMBL3094	Homo sapiens	Inhibition	%	1.63
	8062803	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-0.69	CHEMBL3094	Homo sapiens	Inhibition	%	-0.69
	8063027	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.43	CHEMBL3094	Homo sapiens	Inhibition	%	-0.43
	8063159	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-1.34	CHEMBL3094	Homo sapiens	Inhibition	%	-1.34
	8063326	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.42	CHEMBL3094	Homo sapiens	Inhibition	%	1.42
	8063550	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.91	CHEMBL3094	Homo sapiens	Inhibition	%	1.91
	8063658	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	0.77	CHEMBL3094	Homo sapiens	Inhibition	%	0.77
	8063840	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	1.48	CHEMBL3094	Homo sapiens	Inhibition	%	1.48
	8064064	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	0.49	CHEMBL3094	Homo sapiens	Inhibition	%	0.49
	8064179	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	0.93	CHEMBL3094	Homo sapiens	Inhibition	%	0.93
	8064613	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-2.16	CHEMBL3094	Homo sapiens	Inhibition	%	-2.16
	8064751	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-0.17	CHEMBL3094	Homo sapiens	Inhibition	%	-0.17
	8065141	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.05	CHEMBL3094	Homo sapiens	Inhibition	%	1.05
	8065257	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.22	CHEMBL3094	Homo sapiens	Inhibition	%	1.22
	8065481	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.32	CHEMBL3094	Homo sapiens	Inhibition	%	1.32
	8065656	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	-0.29	CHEMBL3094	Homo sapiens	Inhibition	%	-0.29
	8065771	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.33	CHEMBL3094	Homo sapiens	Inhibition	%	0.33
	8065995	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	-1.26	CHEMBL3094	Homo sapiens	Inhibition	%	-1.26
	8066205	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.45	CHEMBL3094	Homo sapiens	Inhibition	%	-0.45
	8066341	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-1.05	CHEMBL3094	Homo sapiens	Inhibition	%	-1.05
	8066565	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	0.14	CHEMBL3094	Homo sapiens	Inhibition	%	0.14
	8066731	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.54	CHEMBL3094	Homo sapiens	Inhibition	%	2.54
	8067079	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.31	CHEMBL3094	Homo sapiens	Inhibition	%	1.31
	8067254	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.38	CHEMBL3094	Homo sapiens	Inhibition	%	0.38
	8067599	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.01	CHEMBL3094	Homo sapiens	Inhibition	%	0.01
	8067809	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-1.56	CHEMBL3094	Homo sapiens	Inhibition	%	-1.56
	8068168	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	1.55	CHEMBL3094	Homo sapiens	Inhibition	%	1.55
	8068332	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.22	CHEMBL3094	Homo sapiens	Inhibition	%	1.22
	8068681	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.52	CHEMBL3094	Homo sapiens	Inhibition	%	0.52
	8068855	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	-0.4	CHEMBL3094	Homo sapiens	Inhibition	%	-0.4
	8069204	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-0.42	CHEMBL3094	Homo sapiens	Inhibition	%	-0.42
	8069499	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	0.32	CHEMBL3094	Homo sapiens	Inhibition	%	0.32
	8069660	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.58	CHEMBL3094	Homo sapiens	Inhibition	%	2.58
	8069884	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.54	CHEMBL3094	Homo sapiens	Inhibition	%	1.54
	8070010	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-0.3	CHEMBL3094	Homo sapiens	Inhibition	%	-0.3
	8070182	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.94	CHEMBL3094	Homo sapiens	Inhibition	%	0.94
	8070406	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	-0.4	CHEMBL3094	Homo sapiens	Inhibition	%	-0.4
	8070531	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.04	CHEMBL3094	Homo sapiens	Inhibition	%	0.04
	8070829	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	0.45	CHEMBL3094	Homo sapiens	Inhibition	%	0.45
	8071210	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.85	CHEMBL3094	Homo sapiens	Inhibition	%	2.85
	8071336	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.08	CHEMBL3094	Homo sapiens	Inhibition	%	0.08
	8071733	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	0.87	CHEMBL3094	Homo sapiens	Inhibition	%	0.87
	8071858	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.19	CHEMBL3094	Homo sapiens	Inhibition	%	-0.19
	8072082	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.07	CHEMBL3094	Homo sapiens	Inhibition	%	0.07
	8072172	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.26	CHEMBL3094	Homo sapiens	Inhibition	%	-0.26
	8072553	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.73	CHEMBL3094	Homo sapiens	Inhibition	%	1.73
	8072678	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.05	CHEMBL3094	Homo sapiens	Inhibition	%	0.05
	8072902	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.07	CHEMBL3094	Homo sapiens	Inhibition	%	0.07
	8073069	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	0.07	CHEMBL3094	Homo sapiens	Inhibition	%	0.07
	8073418	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.36	CHEMBL3094	Homo sapiens	Inhibition	%	-0.36
	8073537	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.02	CHEMBL3094	Homo sapiens	Inhibition	%	0.02
	8073761	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-2.03	CHEMBL3094	Homo sapiens	Inhibition	%	-2.03
	8073770	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-2.14	CHEMBL3094	Homo sapiens	Inhibition	%	-2.14
	8073994	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.65	CHEMBL3094	Homo sapiens	Inhibition	%	-0.65
	8074146	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.59	CHEMBL3094	Homo sapiens	Inhibition	%	2.59
	8074500	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.04	CHEMBL3094	Homo sapiens	Inhibition	%	0.04
	8074657	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.43	CHEMBL3094	Homo sapiens	Inhibition	%	0.43
	8075008	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.21	CHEMBL3094	Homo sapiens	Inhibition	%	0.21
	8075343	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.65	CHEMBL3094	Homo sapiens	Inhibition	%	-0.65
	8075580	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-1.46	CHEMBL3094	Homo sapiens	Inhibition	%	-1.46
	8075721	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.73	CHEMBL3094	Homo sapiens	Inhibition	%	1.73
	8076087	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.11	CHEMBL3094	Homo sapiens	Inhibition	%	-0.11
	8076235	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	-0.72	CHEMBL3094	Homo sapiens	Inhibition	%	-0.72
	8076459	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.21	CHEMBL3094	Homo sapiens	Inhibition	%	0.21
	8076593	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.62	CHEMBL3094	Homo sapiens	Inhibition	%	-0.62
	8076919	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-1.42	CHEMBL3094	Homo sapiens	Inhibition	%	-1.42
	8077166	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-0.85	CHEMBL3094	Homo sapiens	Inhibition	%	-0.85
	8077294	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.67	CHEMBL3094	Homo sapiens	Inhibition	%	2.67
	8077518	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.95	CHEMBL3094	Homo sapiens	Inhibition	%	0.95
	8077669	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.07	CHEMBL3094	Homo sapiens	Inhibition	%	-0.07
	8078036	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	-0.58	CHEMBL3094	Homo sapiens	Inhibition	%	-0.58
	8078175	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-1.43	CHEMBL3094	Homo sapiens	Inhibition	%	-1.43
	8078501	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.32	CHEMBL3094	Homo sapiens	Inhibition	%	-0.32
	8078751	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-1.11	CHEMBL3094	Homo sapiens	Inhibition	%	-1.11
	8079091	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.82	CHEMBL3094	Homo sapiens	Inhibition	%	0.82
	8079249	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.57	CHEMBL3094	Homo sapiens	Inhibition	%	-0.57
	8079615	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.41	CHEMBL3094	Homo sapiens	Inhibition	%	0.41
	8079754	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-1.22	CHEMBL3094	Homo sapiens	Inhibition	%	-1.22
	8079978	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	6.44	CHEMBL3094	Homo sapiens	Inhibition	%	6.44
	8080083	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-1.28	CHEMBL3094	Homo sapiens	Inhibition	%	-1.28
	8080335	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-0.6	CHEMBL3094	Homo sapiens	Inhibition	%	-0.6
	8080674	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.99	CHEMBL3094	Homo sapiens	Inhibition	%	0.99
	8080838	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.59	CHEMBL3094	Homo sapiens	Inhibition	%	-0.59
	8081062	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.67	CHEMBL3094	Homo sapiens	Inhibition	%	-1.67
	8081197	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-0.19	CHEMBL3094	Homo sapiens	Inhibition	%	-0.19
	8081565	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	40.9	CHEMBL3094	Homo sapiens	Inhibition	%	40.9
	8081668	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-0.23	CHEMBL3094	Homo sapiens	Inhibition	%	-0.23
	8081892	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-0.79	CHEMBL3094	Homo sapiens	Inhibition	%	-0.79
	8081920	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	1.18	CHEMBL3094	Homo sapiens	Inhibition	%	1.18
	8082144	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-0.83	CHEMBL3094	Homo sapiens	Inhibition	%	-0.83
	8082257	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.13	CHEMBL3094	Homo sapiens	Inhibition	%	1.13
	8082654	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.48	CHEMBL3094	Homo sapiens	Inhibition	%	-1.48
	8082777	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.63	CHEMBL3094	Homo sapiens	Inhibition	%	0.63
	8083001	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	-0.21	CHEMBL3094	Homo sapiens	Inhibition	%	-0.21
	8083157	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	1.4	CHEMBL3094	Homo sapiens	Inhibition	%	1.4
	8083480	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.1	CHEMBL3094	Homo sapiens	Inhibition	%	0.1
	8083734	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.13	CHEMBL3094	Homo sapiens	Inhibition	%	-1.13
	8083844	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.0	CHEMBL3094	Homo sapiens	Inhibition	%	1.0
	8084068	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.6	CHEMBL3094	Homo sapiens	Inhibition	%	1.6
	8084253	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	1.52	CHEMBL3094	Homo sapiens	Inhibition	%	1.52
	8084595	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.61	CHEMBL3094	Homo sapiens	Inhibition	%	0.61
	8084756	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	4.54	CHEMBL3094	Homo sapiens	Inhibition	%	4.54
	8085078	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-1.16	CHEMBL3094	Homo sapiens	Inhibition	%	-1.16
	8085334	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-1.78	CHEMBL3094	Homo sapiens	Inhibition	%	-1.78
	8085666	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.06	CHEMBL3094	Homo sapiens	Inhibition	%	1.06
	8085855	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	8.94	CHEMBL3094	Homo sapiens	Inhibition	%	8.94
	8086194	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.28	CHEMBL3094	Homo sapiens	Inhibition	%	0.28
	8086356	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	1.61	CHEMBL3094	Homo sapiens	Inhibition	%	1.61
	8086679	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.36	CHEMBL3094	Homo sapiens	Inhibition	%	0.36
	8086890	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.11	CHEMBL3094	Homo sapiens	Inhibition	%	1.11
	8087114	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.46	CHEMBL3094	Homo sapiens	Inhibition	%	1.46
	8087272	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.96	CHEMBL3094	Homo sapiens	Inhibition	%	0.96
	8087610	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	2.09	CHEMBL3094	Homo sapiens	Inhibition	%	2.09
	8087748	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	0.84	CHEMBL3094	Homo sapiens	Inhibition	%	0.84
	8088114	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.41	CHEMBL3094	Homo sapiens	Inhibition	%	2.41
	8088262	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.73	CHEMBL3094	Homo sapiens	Inhibition	%	0.73
	8088486	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	3.19	CHEMBL3094	Homo sapiens	Inhibition	%	3.19
	8088614	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	1.26	CHEMBL3094	Homo sapiens	Inhibition	%	1.26
	8088931	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	-0.74	CHEMBL3094	Homo sapiens	Inhibition	%	-0.74
	8089059	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.3	CHEMBL3094	Homo sapiens	Inhibition	%	-0.3
	8089283	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.07	CHEMBL3094	Homo sapiens	Inhibition	%	-0.07
	8089431	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	0.48	CHEMBL3094	Homo sapiens	Inhibition	%	0.48
	8089775	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.46	CHEMBL3094	Homo sapiens	Inhibition	%	0.46
	8089955	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.16	CHEMBL3094	Homo sapiens	Inhibition	%	0.16
	8090344	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.03	CHEMBL3094	Homo sapiens	Inhibition	%	1.03
	8090511	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	0.74	CHEMBL3094	Homo sapiens	Inhibition	%	0.74
	8090874	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	0.88	CHEMBL3094	Homo sapiens	Inhibition	%	0.88
	8091079	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.45	CHEMBL3094	Homo sapiens	Inhibition	%	1.45
	8091440	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	1.79	CHEMBL3094	Homo sapiens	Inhibition	%	1.79
	8091595	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.76	CHEMBL3094	Homo sapiens	Inhibition	%	0.76
	8091935	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	1.9	CHEMBL3094	Homo sapiens	Inhibition	%	1.9
	8092072	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	0.89	CHEMBL3094	Homo sapiens	Inhibition	%	0.89
	8092296	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.1	CHEMBL3094	Homo sapiens	Inhibition	%	1.1
	8092447	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.2	CHEMBL3094	Homo sapiens	Inhibition	%	2.2
	8092819	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.51	CHEMBL3094	Homo sapiens	Inhibition	%	0.51
	8092948	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	1.22	CHEMBL3094	Homo sapiens	Inhibition	%	1.22
	8093260	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	-0.21	CHEMBL3094	Homo sapiens	Inhibition	%	-0.21
	8093624	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-0.92	CHEMBL3094	Homo sapiens	Inhibition	%	-0.92
	8093763	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	2.48	CHEMBL3094	Homo sapiens	Inhibition	%	2.48
	8094107	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	-0.58	CHEMBL3094	Homo sapiens	Inhibition	%	-0.58
	8094287	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.41	CHEMBL3094	Homo sapiens	Inhibition	%	0.41
	8094511	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.28	CHEMBL3094	Homo sapiens	Inhibition	%	0.28
	8094686	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	1.95	CHEMBL3094	Homo sapiens	Inhibition	%	1.95
	8094842	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	0.74	CHEMBL3094	Homo sapiens	Inhibition	%	0.74
	8095206	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-0.8	CHEMBL3094	Homo sapiens	Inhibition	%	-0.8
	8095409	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.42	CHEMBL3094	Homo sapiens	Inhibition	%	1.42
	8095774	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	5.7	CHEMBL3094	Homo sapiens	Inhibition	%	5.7
	8095922	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.57	CHEMBL3094	Homo sapiens	Inhibition	%	0.57
	8096146	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.85	CHEMBL3094	Homo sapiens	Inhibition	%	0.85
	8096263	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	2.24	CHEMBL3094	Homo sapiens	Inhibition	%	2.24
	8096626	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.67	CHEMBL3094	Homo sapiens	Inhibition	%	0.67
	8096782	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	1.6	CHEMBL3094	Homo sapiens	Inhibition	%	1.6
	8097153	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.8	CHEMBL3094	Homo sapiens	Inhibition	%	0.8
	8097460	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	-1.07	CHEMBL3094	Homo sapiens	Inhibition	%	-1.07
	8097834	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-1.02	CHEMBL3094	Homo sapiens	Inhibition	%	-1.02
	8097967	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.42	CHEMBL3094	Homo sapiens	Inhibition	%	0.42
	8098191	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.0	CHEMBL3094	Homo sapiens	Inhibition	%	1.0
	8098311	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.16	CHEMBL3094	Homo sapiens	Inhibition	%	0.16
	8098715	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.38	CHEMBL3094	Homo sapiens	Inhibition	%	0.38
	8098900	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	16.03	CHEMBL3094	Homo sapiens	Inhibition	%	16.03
	8099044	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.41	CHEMBL3094	Homo sapiens	Inhibition	%	1.41
	8099268	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.21	CHEMBL3094	Homo sapiens	Inhibition	%	1.21
	8099410	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.07	CHEMBL3094	Homo sapiens	Inhibition	%	1.07
	8099604	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.61	CHEMBL3094	Homo sapiens	Inhibition	%	0.61
	8099828	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.5	CHEMBL3094	Homo sapiens	Inhibition	%	-0.5
	8099975	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	1.88	CHEMBL3094	Homo sapiens	Inhibition	%	1.88
	8100345	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	1.08	CHEMBL3094	Homo sapiens	Inhibition	%	1.08
	8100461	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	2.15	CHEMBL3094	Homo sapiens	Inhibition	%	2.15
	8100685	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	1.34	CHEMBL3094	Homo sapiens	Inhibition	%	1.34
	8100825	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.37	CHEMBL3094	Homo sapiens	Inhibition	%	0.37
	8100985	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	1.23	CHEMBL3094	Homo sapiens	Inhibition	%	1.23
	8101209	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	1.1	CHEMBL3094	Homo sapiens	Inhibition	%	1.1
	8101351	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.54	CHEMBL3094	Homo sapiens	Inhibition	%	-0.54
	8101536	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	1.58	CHEMBL3094	Homo sapiens	Inhibition	%	1.58
	8101760	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	1.26	CHEMBL3094	Homo sapiens	Inhibition	%	1.26
	8101789	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	0.16	CHEMBL3094	Homo sapiens	Inhibition	%	0.16
	8102013	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	-1.66	CHEMBL3094	Homo sapiens	Inhibition	%	-1.66
	8102168	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-1.41	CHEMBL3094	Homo sapiens	Inhibition	%	-1.41
	8102523	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.51	CHEMBL3094	Homo sapiens	Inhibition	%	0.51
	8102643	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.81	CHEMBL3094	Homo sapiens	Inhibition	%	-0.81
	8102867	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.44	CHEMBL3094	Homo sapiens	Inhibition	%	-0.44
	8103045	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.36	CHEMBL3094	Homo sapiens	Inhibition	%	0.36
	8103241	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	0.68	CHEMBL3094	Homo sapiens	Inhibition	%	0.68
	8103603	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.33	CHEMBL3094	Homo sapiens	Inhibition	%	0.33
	8103753	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	0.82	CHEMBL3094	Homo sapiens	Inhibition	%	0.82
	8104162	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.18	CHEMBL3094	Homo sapiens	Inhibition	%	0.18
	8104310	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	2.22	CHEMBL3094	Homo sapiens	Inhibition	%	2.22
	8104680	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	3.26	CHEMBL3094	Homo sapiens	Inhibition	%	3.26
	8105018	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	1.48	CHEMBL3094	Homo sapiens	Inhibition	%	1.48
	8105158	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.49	CHEMBL3094	Homo sapiens	Inhibition	%	0.49
	8105548	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	1.31	CHEMBL3094	Homo sapiens	Inhibition	%	1.31
	8105686	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.01	CHEMBL3094	Homo sapiens	Inhibition	%	0.01
	8105966	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.16	CHEMBL3094	Homo sapiens	Inhibition	%	0.16
	8106355	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.44	CHEMBL3094	Homo sapiens	Inhibition	%	0.44
	8106511	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-1.0	CHEMBL3094	Homo sapiens	Inhibition	%	-1.0
	8106864	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.24	CHEMBL3094	Homo sapiens	Inhibition	%	0.24
	8107209	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.98	CHEMBL3094	Homo sapiens	Inhibition	%	-0.98
	8107381	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.86	CHEMBL3094	Homo sapiens	Inhibition	%	0.86
	8107582	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.6	CHEMBL3094	Homo sapiens	Inhibition	%	1.6
	8107806	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	1.69	CHEMBL3094	Homo sapiens	Inhibition	%	1.69
	8107941	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	-0.56	CHEMBL3094	Homo sapiens	Inhibition	%	-0.56
	8108099	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	1.17	CHEMBL3094	Homo sapiens	Inhibition	%	1.17
	8108323	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	1.03	CHEMBL3094	Homo sapiens	Inhibition	%	1.03
	8108498	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.5	CHEMBL3094	Homo sapiens	Inhibition	%	-0.5
	8108645	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	1.77	CHEMBL3094	Homo sapiens	Inhibition	%	1.77
	8108869	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	2.11	CHEMBL3094	Homo sapiens	Inhibition	%	2.11
	8109011	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.61	CHEMBL3094	Homo sapiens	Inhibition	%	0.61
	8109349	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	1.27	CHEMBL3094	Homo sapiens	Inhibition	%	1.27
	8109479	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.27	CHEMBL3094	Homo sapiens	Inhibition	%	0.27
	8109703	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.4	CHEMBL3094	Homo sapiens	Inhibition	%	-0.4
	8109874	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	1.54	CHEMBL3094	Homo sapiens	Inhibition	%	1.54
	8110006	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	1.24	CHEMBL3094	Homo sapiens	Inhibition	%	1.24
	8110230	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.34	CHEMBL3094	Homo sapiens	Inhibition	%	2.34
	8110285	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	-0.79	CHEMBL3094	Homo sapiens	Inhibition	%	-0.79
	8110509	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.69	CHEMBL3094	Homo sapiens	Inhibition	%	0.69
	8110675	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-0.97	CHEMBL3094	Homo sapiens	Inhibition	%	-0.97
	8110833	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-1.32	CHEMBL3094	Homo sapiens	Inhibition	%	-1.32
	8111057	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	1.09	CHEMBL3094	Homo sapiens	Inhibition	%	1.09
	8111180	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.32	CHEMBL3094	Homo sapiens	Inhibition	%	0.32
	8111531	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.11	CHEMBL3094	Homo sapiens	Inhibition	%	0.11
	8111697	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.76	CHEMBL3094	Homo sapiens	Inhibition	%	0.76
	8112126	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	0.97	CHEMBL3094	Homo sapiens	Inhibition	%	0.97
	8112263	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.18	CHEMBL3094	Homo sapiens	Inhibition	%	-0.18
	8112655	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	1.73	CHEMBL3094	Homo sapiens	Inhibition	%	1.73
	8112827	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.44	CHEMBL3094	Homo sapiens	Inhibition	%	0.44
	8113203	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.21	CHEMBL3094	Homo sapiens	Inhibition	%	1.21
	8113339	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.15	CHEMBL3094	Homo sapiens	Inhibition	%	0.15
	8113563	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.46	CHEMBL3094	Homo sapiens	Inhibition	%	0.46
	8113687	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	1.32	CHEMBL3094	Homo sapiens	Inhibition	%	1.32
	8114027	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.44	CHEMBL3094	Homo sapiens	Inhibition	%	-0.44
	8114203	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	1.34	CHEMBL3094	Homo sapiens	Inhibition	%	1.34
	8114559	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	0.95	CHEMBL3094	Homo sapiens	Inhibition	%	0.95
	8114835	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	-0.72	CHEMBL3094	Homo sapiens	Inhibition	%	-0.72
	8115001	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	-0.03	CHEMBL3094	Homo sapiens	Inhibition	%	-0.03
	8115390	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.35	CHEMBL3094	Homo sapiens	Inhibition	%	0.35
	8115510	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.96	CHEMBL3094	Homo sapiens	Inhibition	%	0.96
	8115734	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	0.35	CHEMBL3094	Homo sapiens	Inhibition	%	0.35
	8115867	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.32	CHEMBL3094	Homo sapiens	Inhibition	%	0.32
	8116026	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.02	CHEMBL3094	Homo sapiens	Inhibition	%	-0.02
	8116250	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.16	CHEMBL3094	Homo sapiens	Inhibition	%	-0.16
	8116453	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	0.79	CHEMBL3094	Homo sapiens	Inhibition	%	0.79
	8116587	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.64	CHEMBL3094	Homo sapiens	Inhibition	%	-0.64
	8116811	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.46	CHEMBL3094	Homo sapiens	Inhibition	%	0.46
	8116983	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	1.77	CHEMBL3094	Homo sapiens	Inhibition	%	1.77
	8117154	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.78	CHEMBL3094	Homo sapiens	Inhibition	%	0.78
	8117378	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.36	CHEMBL3094	Homo sapiens	Inhibition	%	0.36
	8117536	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.03	CHEMBL3094	Homo sapiens	Inhibition	%	1.03
	8117890	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.34	CHEMBL3094	Homo sapiens	Inhibition	%	0.34
	8118028	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.47	CHEMBL3094	Homo sapiens	Inhibition	%	1.47
	8118368	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.35	CHEMBL3094	Homo sapiens	Inhibition	%	1.35
	8118540	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	1.44	CHEMBL3094	Homo sapiens	Inhibition	%	1.44
	8118764	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.07	CHEMBL3094	Homo sapiens	Inhibition	%	2.07
	8118900	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	1.47	CHEMBL3094	Homo sapiens	Inhibition	%	1.47
	8119171	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.4	CHEMBL3094	Homo sapiens	Inhibition	%	0.4
	8119330	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	-1.65	CHEMBL3094	Homo sapiens	Inhibition	%	-1.65
	8119554	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	0.22	CHEMBL3094	Homo sapiens	Inhibition	%	0.22
	8119721	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	2.24	CHEMBL3094	Homo sapiens	Inhibition	%	2.24
	8120064	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.43	CHEMBL3094	Homo sapiens	Inhibition	%	1.43
	8120203	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.37	CHEMBL3094	Homo sapiens	Inhibition	%	0.37
	8120587	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.48	CHEMBL3094	Homo sapiens	Inhibition	%	-0.48
	8120788	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.22	CHEMBL3094	Homo sapiens	Inhibition	%	1.22
	8121140	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.35	CHEMBL3094	Homo sapiens	Inhibition	%	0.35
	8121312	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.58	CHEMBL3094	Homo sapiens	Inhibition	%	0.58
	8121703	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.28	CHEMBL3094	Homo sapiens	Inhibition	%	0.28
	8121866	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.15	CHEMBL3094	Homo sapiens	Inhibition	%	1.15
	8122211	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-0.81	CHEMBL3094	Homo sapiens	Inhibition	%	-0.81
	8122349	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.56	CHEMBL3094	Homo sapiens	Inhibition	%	1.56
	8122573	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	2.27	CHEMBL3094	Homo sapiens	Inhibition	%	2.27
	8122693	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.31	CHEMBL3094	Homo sapiens	Inhibition	%	2.31
	8123084	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.21	CHEMBL3094	Homo sapiens	Inhibition	%	2.21
	8123226	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	1.22	CHEMBL3094	Homo sapiens	Inhibition	%	1.22
	8123504	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.56	CHEMBL3094	Homo sapiens	Inhibition	%	1.56
	8123878	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	-0.53	CHEMBL3094	Homo sapiens	Inhibition	%	-0.53
	8124045	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	0.59	CHEMBL3094	Homo sapiens	Inhibition	%	0.59
	8124388	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	0.42	CHEMBL3094	Homo sapiens	Inhibition	%	0.42
	8124527	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.83	CHEMBL3094	Homo sapiens	Inhibition	%	0.83
	8124751	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.57	CHEMBL3094	Homo sapiens	Inhibition	%	0.57
	8124916	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.44	CHEMBL3094	Homo sapiens	Inhibition	%	-1.44
	8125117	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	1.38	CHEMBL3094	Homo sapiens	Inhibition	%	1.38
	8125471	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.13	CHEMBL3094	Homo sapiens	Inhibition	%	0.13
	8125639	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-0.05	CHEMBL3094	Homo sapiens	Inhibition	%	-0.05
	8125863	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.14	CHEMBL3094	Homo sapiens	Inhibition	%	1.14
	8126027	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.03	CHEMBL3094	Homo sapiens	Inhibition	%	0.03
	8126191	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	0.91	CHEMBL3094	Homo sapiens	Inhibition	%	0.91
	8126530	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-0.72	CHEMBL3094	Homo sapiens	Inhibition	%	-0.72
	8126890	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	7.16	CHEMBL3094	Homo sapiens	Inhibition	%	7.16
	8127012	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	1.12	CHEMBL3094	Homo sapiens	Inhibition	%	1.12
	8127403	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	2.11	CHEMBL3094	Homo sapiens	Inhibition	%	2.11
	8127545	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	2.23	CHEMBL3094	Homo sapiens	Inhibition	%	2.23
	8127769	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	1.67	CHEMBL3094	Homo sapiens	Inhibition	%	1.67
	8127833	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	-0.04	CHEMBL3094	Homo sapiens	Inhibition	%	-0.04
	8128057	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	-1.56	CHEMBL3094	Homo sapiens	Inhibition	%	-1.56
	8128209	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	0.59	CHEMBL3094	Homo sapiens	Inhibition	%	0.59
	8128376	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	2.56	CHEMBL3094	Homo sapiens	Inhibition	%	2.56
	8128600	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.27	CHEMBL3094	Homo sapiens	Inhibition	%	0.27
	8128719	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	3.44	CHEMBL3094	Homo sapiens	Inhibition	%	3.44
	8129080	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.55	CHEMBL3094	Homo sapiens	Inhibition	%	0.55
	8129251	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.29	CHEMBL3094	Homo sapiens	Inhibition	%	-0.29
	8129440	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	2.0	CHEMBL3094	Homo sapiens	Inhibition	%	2.0
	8129664	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	1.17	CHEMBL3094	Homo sapiens	Inhibition	%	1.17
	8129803	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.19	CHEMBL3094	Homo sapiens	Inhibition	%	-0.19
	8130188	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.15	CHEMBL3094	Homo sapiens	Inhibition	%	0.15
	8130360	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.34	CHEMBL3094	Homo sapiens	Inhibition	%	-0.34
	8130520	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	1.44	CHEMBL3094	Homo sapiens	Inhibition	%	1.44
	8130744	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	2.13	CHEMBL3094	Homo sapiens	Inhibition	%	2.13
	8130860	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.47	CHEMBL3094	Homo sapiens	Inhibition	%	1.47
	8131223	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	2.17	CHEMBL3094	Homo sapiens	Inhibition	%	2.17
	8131343	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	1.72	CHEMBL3094	Homo sapiens	Inhibition	%	1.72
	8131567	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	2.6	CHEMBL3094	Homo sapiens	Inhibition	%	2.6
	8131734	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	2.01	CHEMBL3094	Homo sapiens	Inhibition	%	2.01
	8132099	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	1.36	CHEMBL3094	Homo sapiens	Inhibition	%	1.36
	8132385	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.02	CHEMBL3094	Homo sapiens	Inhibition	%	0.02
	8132532	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	-0.52	CHEMBL3094	Homo sapiens	Inhibition	%	-0.52
	8132924	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.73	CHEMBL3094	Homo sapiens	Inhibition	%	1.73
	8133045	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.35	CHEMBL3094	Homo sapiens	Inhibition	%	0.35
	8133407	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.08	CHEMBL3094	Homo sapiens	Inhibition	%	1.08
	8133579	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.04	CHEMBL3094	Homo sapiens	Inhibition	%	-0.04
	8133983	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	1.29	CHEMBL3094	Homo sapiens	Inhibition	%	1.29
	8134131	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.43	CHEMBL3094	Homo sapiens	Inhibition	%	-0.43
	8134515	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.96	CHEMBL3094	Homo sapiens	Inhibition	%	0.96
	8134699	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-0.78	CHEMBL3094	Homo sapiens	Inhibition	%	-0.78
	8135083	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.22	CHEMBL3094	Homo sapiens	Inhibition	%	1.22
	8135198	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.7	CHEMBL3094	Homo sapiens	Inhibition	%	1.7
	8135422	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.1	CHEMBL3094	Homo sapiens	Inhibition	%	1.1
	8135563	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	2.36	CHEMBL3094	Homo sapiens	Inhibition	%	2.36
	8135908	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	2.88	CHEMBL3094	Homo sapiens	Inhibition	%	2.88
	8136076	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	0.99	CHEMBL3094	Homo sapiens	Inhibition	%	0.99
	8136444	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	2.12	CHEMBL3094	Homo sapiens	Inhibition	%	2.12
	8136734	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-1.14	CHEMBL3094	Homo sapiens	Inhibition	%	-1.14
	8136869	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.08	CHEMBL3094	Homo sapiens	Inhibition	%	0.08
	8137093	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	-1.02	CHEMBL3094	Homo sapiens	Inhibition	%	-1.02
	8137256	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	0.95	CHEMBL3094	Homo sapiens	Inhibition	%	0.95
	8137376	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.03	CHEMBL3094	Homo sapiens	Inhibition	%	0.03
	8137600	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.02	CHEMBL3094	Homo sapiens	Inhibition	%	-0.02
	8137748	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.15	CHEMBL3094	Homo sapiens	Inhibition	%	1.15
	8137914	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.42	CHEMBL3094	Homo sapiens	Inhibition	%	-0.42
	8138138	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.7	CHEMBL3094	Homo sapiens	Inhibition	%	-0.7
	8138317	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.44	CHEMBL3094	Homo sapiens	Inhibition	%	1.44
	8138465	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.51	CHEMBL3094	Homo sapiens	Inhibition	%	-0.51
	8138689	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.12	CHEMBL3094	Homo sapiens	Inhibition	%	-1.12
	8138847	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.83	CHEMBL3094	Homo sapiens	Inhibition	%	0.83
	8139032	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-0.07	CHEMBL3094	Homo sapiens	Inhibition	%	-0.07
	8139256	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.19	CHEMBL3094	Homo sapiens	Inhibition	%	1.19
	8139415	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.42	CHEMBL3094	Homo sapiens	Inhibition	%	1.42
	8139753	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.66	CHEMBL3094	Homo sapiens	Inhibition	%	1.66
	8139894	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.0	CHEMBL3094	Homo sapiens	Inhibition	%	2.0
	8140118	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.05	CHEMBL3094	Homo sapiens	Inhibition	%	2.05
	8140241	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.09	CHEMBL3094	Homo sapiens	Inhibition	%	3.09
	8140400	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.08	CHEMBL3094	Homo sapiens	Inhibition	%	1.08
	8140624	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	0.53	CHEMBL3094	Homo sapiens	Inhibition	%	0.53
	8140767	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	2.05	CHEMBL3094	Homo sapiens	Inhibition	%	2.05
	8141069	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.04	CHEMBL3094	Homo sapiens	Inhibition	%	0.04
	8141423	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.19	CHEMBL3094	Homo sapiens	Inhibition	%	-0.19
	8141583	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.6	CHEMBL3094	Homo sapiens	Inhibition	%	1.6
	8141926	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.41	CHEMBL3094	Homo sapiens	Inhibition	%	-0.41
	8142087	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.05	CHEMBL3094	Homo sapiens	Inhibition	%	0.05
	8142479	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.8	CHEMBL3094	Homo sapiens	Inhibition	%	-0.8
	8142655	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-0.14	CHEMBL3094	Homo sapiens	Inhibition	%	-0.14
	8143028	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.11	CHEMBL3094	Homo sapiens	Inhibition	%	-1.11
	8143183	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.7	CHEMBL3094	Homo sapiens	Inhibition	%	1.7
	8143594	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.78	CHEMBL3094	Homo sapiens	Inhibition	%	1.78
	8143753	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	1.8	CHEMBL3094	Homo sapiens	Inhibition	%	1.8
	8144091	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	1.32	CHEMBL3094	Homo sapiens	Inhibition	%	1.32
	8144454	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	1.26	CHEMBL3094	Homo sapiens	Inhibition	%	1.26
	8144584	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.69	CHEMBL3094	Homo sapiens	Inhibition	%	1.69
	8144961	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	0.97	CHEMBL3094	Homo sapiens	Inhibition	%	0.97
	8145098	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.07	CHEMBL3094	Homo sapiens	Inhibition	%	2.07
	8145322	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.09	CHEMBL3094	Homo sapiens	Inhibition	%	2.09
	8145411	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	-1.65	CHEMBL3094	Homo sapiens	Inhibition	%	-1.65
	8145759	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-1.25	CHEMBL3094	Homo sapiens	Inhibition	%	-1.25
	8145920	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	1.58	CHEMBL3094	Homo sapiens	Inhibition	%	1.58
	8146264	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.03	CHEMBL3094	Homo sapiens	Inhibition	%	0.03
	8146424	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-0.76	CHEMBL3094	Homo sapiens	Inhibition	%	-0.76
	8146648	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.1	CHEMBL3094	Homo sapiens	Inhibition	%	1.1
	8146815	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.08	CHEMBL3094	Homo sapiens	Inhibition	%	-1.08
	8146984	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.79	CHEMBL3094	Homo sapiens	Inhibition	%	0.79
	8147208	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.86	CHEMBL3094	Homo sapiens	Inhibition	%	0.86
	8147350	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.76	CHEMBL3094	Homo sapiens	Inhibition	%	0.76
	8147503	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.75	CHEMBL3094	Homo sapiens	Inhibition	%	0.75
	8147727	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.02	CHEMBL3094	Homo sapiens	Inhibition	%	1.02
	8147914	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	0.85	CHEMBL3094	Homo sapiens	Inhibition	%	0.85
	8148072	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	1.94	CHEMBL3094	Homo sapiens	Inhibition	%	1.94
	8148296	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	2.01	CHEMBL3094	Homo sapiens	Inhibition	%	2.01
	8148410	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.06	CHEMBL3094	Homo sapiens	Inhibition	%	2.06
	8148773	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	0.81	CHEMBL3094	Homo sapiens	Inhibition	%	0.81
	8148911	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.51	CHEMBL3094	Homo sapiens	Inhibition	%	3.51
	8149135	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.54	CHEMBL3094	Homo sapiens	Inhibition	%	2.54
	8149294	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.76	CHEMBL3094	Homo sapiens	Inhibition	%	0.76
	8149652	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	1.39	CHEMBL3094	Homo sapiens	Inhibition	%	1.39
	8149750	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.29	CHEMBL3094	Homo sapiens	Inhibition	%	0.29
	8149974	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	-1.1	CHEMBL3094	Homo sapiens	Inhibition	%	-1.1
	8150099	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-0.29	CHEMBL3094	Homo sapiens	Inhibition	%	-0.29
	8150259	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	1.46	CHEMBL3094	Homo sapiens	Inhibition	%	1.46
	8150483	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.27	CHEMBL3094	Homo sapiens	Inhibition	%	0.27
	8150603	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-0.97	CHEMBL3094	Homo sapiens	Inhibition	%	-0.97
	8150992	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.23	CHEMBL3094	Homo sapiens	Inhibition	%	1.23
	8151155	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.55	CHEMBL3094	Homo sapiens	Inhibition	%	-1.55
	8151556	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.66	CHEMBL3094	Homo sapiens	Inhibition	%	0.66
	8151694	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.4	CHEMBL3094	Homo sapiens	Inhibition	%	0.4
	8152072	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.07	CHEMBL3094	Homo sapiens	Inhibition	%	1.07
	8152260	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	2.43	CHEMBL3094	Homo sapiens	Inhibition	%	2.43
	8152642	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	1.68	CHEMBL3094	Homo sapiens	Inhibition	%	1.68
	8152756	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	1.5	CHEMBL3094	Homo sapiens	Inhibition	%	1.5
	8152980	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	1.32	CHEMBL3094	Homo sapiens	Inhibition	%	1.32
	8153119	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	0.79	CHEMBL3094	Homo sapiens	Inhibition	%	0.79
	8153480	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.77	CHEMBL3094	Homo sapiens	Inhibition	%	2.77
	8153637	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.23	CHEMBL3094	Homo sapiens	Inhibition	%	1.23
	8153994	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	1.58	CHEMBL3094	Homo sapiens	Inhibition	%	1.58
	8154315	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	0.58	CHEMBL3094	Homo sapiens	Inhibition	%	0.58
	8154441	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-0.75	CHEMBL3094	Homo sapiens	Inhibition	%	-0.75
	8154824	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.49	CHEMBL3094	Homo sapiens	Inhibition	%	1.49
	8154944	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.17	CHEMBL3094	Homo sapiens	Inhibition	%	-0.17
	8155168	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.41	CHEMBL3094	Homo sapiens	Inhibition	%	-0.41
	8155344	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.34	CHEMBL3094	Homo sapiens	Inhibition	%	0.34
	8155505	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.4	CHEMBL3094	Homo sapiens	Inhibition	%	-1.4
	8155729	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.57	CHEMBL3094	Homo sapiens	Inhibition	%	0.57
	8155907	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.12	CHEMBL3094	Homo sapiens	Inhibition	%	1.12
	8156045	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.3	CHEMBL3094	Homo sapiens	Inhibition	%	0.3
	8156269	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-0.41	CHEMBL3094	Homo sapiens	Inhibition	%	-0.41
	8156481	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	0.83	CHEMBL3094	Homo sapiens	Inhibition	%	0.83
	8156631	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.0	CHEMBL3094	Homo sapiens	Inhibition	%	2.0
	8156998	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.61	CHEMBL3094	Homo sapiens	Inhibition	%	1.61
	8157342	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	-0.66	CHEMBL3094	Homo sapiens	Inhibition	%	-0.66
	8157483	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	1.19	CHEMBL3094	Homo sapiens	Inhibition	%	1.19
	8157837	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	0.91	CHEMBL3094	Homo sapiens	Inhibition	%	0.91
	8157998	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-1.74	CHEMBL3094	Homo sapiens	Inhibition	%	-1.74
	8158222	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.1	CHEMBL3094	Homo sapiens	Inhibition	%	-0.1
	8158248	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.64	CHEMBL3094	Homo sapiens	Inhibition	%	2.64
	8158472	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	1.81	CHEMBL3094	Homo sapiens	Inhibition	%	1.81
	8158630	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	1.69	CHEMBL3094	Homo sapiens	Inhibition	%	1.69
	8158799	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	0.74	CHEMBL3094	Homo sapiens	Inhibition	%	0.74
	8159023	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	0.41	CHEMBL3094	Homo sapiens	Inhibition	%	0.41
	8159158	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	2.46	CHEMBL3094	Homo sapiens	Inhibition	%	2.46
	8159502	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.37	CHEMBL3094	Homo sapiens	Inhibition	%	1.37
	8159633	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	1.7	CHEMBL3094	Homo sapiens	Inhibition	%	1.7
	8159857	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	5.81	CHEMBL3094	Homo sapiens	Inhibition	%	5.81
	8159998	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.42	CHEMBL3094	Homo sapiens	Inhibition	%	0.42
	8160359	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.49	CHEMBL3094	Homo sapiens	Inhibition	%	2.49
	8160509	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.92	CHEMBL3094	Homo sapiens	Inhibition	%	-0.92
	8160803	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	0.27	CHEMBL3094	Homo sapiens	Inhibition	%	0.27
	8160953	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	1.83	CHEMBL3094	Homo sapiens	Inhibition	%	1.83
	8161177	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	3.14	CHEMBL3094	Homo sapiens	Inhibition	%	3.14
	8161320	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	1.78	CHEMBL3094	Homo sapiens	Inhibition	%	1.78
	8161669	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	0.71	CHEMBL3094	Homo sapiens	Inhibition	%	0.71
	8161807	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	2.92	CHEMBL3094	Homo sapiens	Inhibition	%	2.92
	8162031	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	1.15	CHEMBL3094	Homo sapiens	Inhibition	%	1.15
	8162161	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.14	CHEMBL3094	Homo sapiens	Inhibition	%	1.14
	8162545	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-1.41	CHEMBL3094	Homo sapiens	Inhibition	%	-1.41
	8162798	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	2.26	CHEMBL3094	Homo sapiens	Inhibition	%	2.26
	8162946	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	2.33	CHEMBL3094	Homo sapiens	Inhibition	%	2.33
	8163339	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	0.72	CHEMBL3094	Homo sapiens	Inhibition	%	0.72
	8163473	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	4.32	CHEMBL3094	Homo sapiens	Inhibition	%	4.32
	8163820	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.61	CHEMBL3094	Homo sapiens	Inhibition	%	1.61
	8164178	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	33.18	CHEMBL3094	Homo sapiens	Inhibition	%	33.18
	8164318	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.28	CHEMBL3094	Homo sapiens	Inhibition	%	0.28
	8164697	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	1.48	CHEMBL3094	Homo sapiens	Inhibition	%	1.48
	8164841	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.32	CHEMBL3094	Homo sapiens	Inhibition	%	-0.32
	8165135	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	0.95	CHEMBL3094	Homo sapiens	Inhibition	%	0.95
	8165500	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.09	CHEMBL3094	Homo sapiens	Inhibition	%	2.09
	8165643	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	2.58	CHEMBL3094	Homo sapiens	Inhibition	%	2.58
	8165867	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.61	CHEMBL3094	Homo sapiens	Inhibition	%	0.61
	8165993	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	0.06	CHEMBL3094	Homo sapiens	Inhibition	%	0.06
	8166355	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	2.81	CHEMBL3094	Homo sapiens	Inhibition	%	2.81
	8166485	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	1.55	CHEMBL3094	Homo sapiens	Inhibition	%	1.55
	8166810	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	-1.77	CHEMBL3094	Homo sapiens	Inhibition	%	-1.77
	8167122	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	0.82	CHEMBL3094	Homo sapiens	Inhibition	%	0.82
	8167263	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	13.95	CHEMBL3094	Homo sapiens	Inhibition	%	13.95
	8167487	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	1.65	CHEMBL3094	Homo sapiens	Inhibition	%	1.65
	8167651	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	0.28	CHEMBL3094	Homo sapiens	Inhibition	%	0.28
	8167784	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	2.78	CHEMBL3094	Homo sapiens	Inhibition	%	2.78
	8168008	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	4.45	CHEMBL3094	Homo sapiens	Inhibition	%	4.45
	8168132	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.17	CHEMBL3094	Homo sapiens	Inhibition	%	2.17
	8168497	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	1.47	CHEMBL3094	Homo sapiens	Inhibition	%	1.47
	8168633	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.93	CHEMBL3094	Homo sapiens	Inhibition	%	0.93
	8168857	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.5	CHEMBL3094	Homo sapiens	Inhibition	%	-0.5
	8169021	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	4.15	CHEMBL3094	Homo sapiens	Inhibition	%	4.15
	8169163	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	0.66	CHEMBL3094	Homo sapiens	Inhibition	%	0.66
	8169387	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	-1.55	CHEMBL3094	Homo sapiens	Inhibition	%	-1.55
	8169467	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	0.65	CHEMBL3094	Homo sapiens	Inhibition	%	0.65
	8169691	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	1.41	CHEMBL3094	Homo sapiens	Inhibition	%	1.41
	8169825	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.74	CHEMBL3094	Homo sapiens	Inhibition	%	2.74
	8170194	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.59	CHEMBL3094	Homo sapiens	Inhibition	%	0.59
	8170319	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	0.84	CHEMBL3094	Homo sapiens	Inhibition	%	0.84
	8170683	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	1.57	CHEMBL3094	Homo sapiens	Inhibition	%	1.57
	8170818	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	1.19	CHEMBL3094	Homo sapiens	Inhibition	%	1.19
	8171042	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	0.53	CHEMBL3094	Homo sapiens	Inhibition	%	0.53
	8171239	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	-0.04	CHEMBL3094	Homo sapiens	Inhibition	%	-0.04
	8171456	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	1.44	CHEMBL3094	Homo sapiens	Inhibition	%	1.44
	8171821	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	3.7	CHEMBL3094	Homo sapiens	Inhibition	%	3.7
	8171974	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.63	CHEMBL3094	Homo sapiens	Inhibition	%	0.63
	8172330	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	1.86	CHEMBL3094	Homo sapiens	Inhibition	%	1.86
	8172458	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	0.76	CHEMBL3094	Homo sapiens	Inhibition	%	0.76
	8172682	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.48	CHEMBL3094	Homo sapiens	Inhibition	%	0.48
	8172824	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	1.16	CHEMBL3094	Homo sapiens	Inhibition	%	1.16
	8173184	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.65	CHEMBL3094	Homo sapiens	Inhibition	%	0.65
	8173349	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	1.56	CHEMBL3094	Homo sapiens	Inhibition	%	1.56
	8173714	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	0.52	CHEMBL3094	Homo sapiens	Inhibition	%	0.52
	8174025	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	2.5	CHEMBL3094	Homo sapiens	Inhibition	%	2.5
	8174157	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	1.73	CHEMBL3094	Homo sapiens	Inhibition	%	1.73
	8174529	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.6	CHEMBL3094	Homo sapiens	Inhibition	%	0.6
	8174651	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	-0.06	CHEMBL3094	Homo sapiens	Inhibition	%	-0.06
	8174875	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	0.89	CHEMBL3094	Homo sapiens	Inhibition	%	0.89
	8175018	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	2.94	CHEMBL3094	Homo sapiens	Inhibition	%	2.94
	8175378	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	1.09	CHEMBL3094	Homo sapiens	Inhibition	%	1.09
	8175634	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	4.02	CHEMBL3094	Homo sapiens	Inhibition	%	4.02
	8175797	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	0.87	CHEMBL3094	Homo sapiens	Inhibition	%	0.87
	8176174	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	1.5	CHEMBL3094	Homo sapiens	Inhibition	%	1.5
	8176323	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.71	CHEMBL3094	Homo sapiens	Inhibition	%	0.71
	8176547	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	0.23	CHEMBL3094	Homo sapiens	Inhibition	%	0.23
	8176679	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	5.0	CHEMBL3094	Homo sapiens	Inhibition	%	5.0
	8177033	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.25	CHEMBL3094	Homo sapiens	Inhibition	%	1.25
	8177175	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	1.58	CHEMBL3094	Homo sapiens	Inhibition	%	1.58
	8177537	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	2.48	CHEMBL3094	Homo sapiens	Inhibition	%	2.48
	8177701	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	3.04	CHEMBL3094	Homo sapiens	Inhibition	%	3.04
	8177925	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	1.52	CHEMBL3094	Homo sapiens	Inhibition	%	1.52
	8178065	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	0.45	CHEMBL3094	Homo sapiens	Inhibition	%	0.45
	8178377	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	0.7	CHEMBL3094	Homo sapiens	Inhibition	%	0.7
	8178504	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.57	CHEMBL3094	Homo sapiens	Inhibition	%	2.57
	8178728	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	1.85	CHEMBL3094	Homo sapiens	Inhibition	%	1.85
	8178877	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-0.88	CHEMBL3094	Homo sapiens	Inhibition	%	-0.88
	8179224	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	0.04	CHEMBL3094	Homo sapiens	Inhibition	%	0.04
	8179368	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	1.84	CHEMBL3094	Homo sapiens	Inhibition	%	1.84
	8179729	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.4	CHEMBL3094	Homo sapiens	Inhibition	%	0.4
	8179986	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	1.41	CHEMBL3094	Homo sapiens	Inhibition	%	1.41
	8180140	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	1.23	CHEMBL3094	Homo sapiens	Inhibition	%	1.23
	8180364	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	0.74	CHEMBL3094	Homo sapiens	Inhibition	%	0.74
	8180520	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	1.55	CHEMBL3094	Homo sapiens	Inhibition	%	1.55
	8180892	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	0.46	CHEMBL3094	Homo sapiens	Inhibition	%	0.46
	8181025	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	2.48	CHEMBL3094	Homo sapiens	Inhibition	%	2.48
	8181380	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-0.26	CHEMBL3094	Homo sapiens	Inhibition	%	-0.26
	8181520	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	1.02	CHEMBL3094	Homo sapiens	Inhibition	%	1.02
	8181744	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	1.27	CHEMBL3094	Homo sapiens	Inhibition	%	1.27
	8181883	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	8.8	CHEMBL3094	Homo sapiens	Inhibition	%	8.8
	8182270	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	2.44	CHEMBL3094	Homo sapiens	Inhibition	%	2.44
	8182410	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.6	CHEMBL3094	Homo sapiens	Inhibition	%	0.6
	8182726	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	-0.94	CHEMBL3094	Homo sapiens	Inhibition	%	-0.94
	8183072	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	2.88	CHEMBL3094	Homo sapiens	Inhibition	%	2.88
	8183221	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	0.94	CHEMBL3094	Homo sapiens	Inhibition	%	0.94
	8183574	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	2.37	CHEMBL3094	Homo sapiens	Inhibition	%	2.37
	8183716	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	6.01	CHEMBL3094	Homo sapiens	Inhibition	%	6.01
	8183940	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	1.31	CHEMBL3094	Homo sapiens	Inhibition	%	1.31
	8184076	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.36	CHEMBL3094	Homo sapiens	Inhibition	%	0.36
	8184342	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.73	CHEMBL3094	Homo sapiens	Inhibition	%	3.73
	8184713	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	0.9	CHEMBL3094	Homo sapiens	Inhibition	%	0.9
	8184870	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	0.63	CHEMBL3094	Homo sapiens	Inhibition	%	0.63
	8185243	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.0	CHEMBL3094	Homo sapiens	Inhibition	%	0.0
	8185374	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	2.77	CHEMBL3094	Homo sapiens	Inhibition	%	2.77
	8185598	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	2.33	CHEMBL3094	Homo sapiens	Inhibition	%	2.33
	8185729	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	1.08	CHEMBL3094	Homo sapiens	Inhibition	%	1.08
	8186092	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	0.86	CHEMBL3094	Homo sapiens	Inhibition	%	0.86
	8186233	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	1.6	CHEMBL3094	Homo sapiens	Inhibition	%	1.6
	8186457	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	4.42	CHEMBL3094	Homo sapiens	Inhibition	%	4.42
	8186621	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	1.93	CHEMBL3094	Homo sapiens	Inhibition	%	1.93
	8186760	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	-0.23	CHEMBL3094	Homo sapiens	Inhibition	%	-0.23
	8186984	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	1.02	CHEMBL3094	Homo sapiens	Inhibition	%	1.02
	8187082	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.25	CHEMBL3094	Homo sapiens	Inhibition	%	0.25
	8187430	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	1.98	CHEMBL3094	Homo sapiens	Inhibition	%	1.98
	8187578	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	-0.22	CHEMBL3094	Homo sapiens	Inhibition	%	-0.22
	8187802	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.86	CHEMBL3094	Homo sapiens	Inhibition	%	0.86
	8187931	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	5.39	CHEMBL3094	Homo sapiens	Inhibition	%	5.39
	8188298	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	3.24	CHEMBL3094	Homo sapiens	Inhibition	%	3.24
	8188433	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	0.26	CHEMBL3094	Homo sapiens	Inhibition	%	0.26
	8188657	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	0.26	CHEMBL3094	Homo sapiens	Inhibition	%	0.26
	8188707	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.52	CHEMBL3094	Homo sapiens	Inhibition	%	1.52
	8188931	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.86	CHEMBL3094	Homo sapiens	Inhibition	%	3.86
	8189079	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.1	CHEMBL3094	Homo sapiens	Inhibition	%	0.1
	8189235	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	0.49	CHEMBL3094	Homo sapiens	Inhibition	%	0.49
	8189459	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	1.17	CHEMBL3094	Homo sapiens	Inhibition	%	1.17
	8189608	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.14	CHEMBL3094	Homo sapiens	Inhibition	%	0.14
	8189964	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	2.73	CHEMBL3094	Homo sapiens	Inhibition	%	2.73
	8190096	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	1.35	CHEMBL3094	Homo sapiens	Inhibition	%	1.35
	8190320	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	0.67	CHEMBL3094	Homo sapiens	Inhibition	%	0.67
	8190460	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	1.31	CHEMBL3094	Homo sapiens	Inhibition	%	1.31
	8190821	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.7	CHEMBL3094	Homo sapiens	Inhibition	%	1.7
	8190985	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	2.12	CHEMBL3094	Homo sapiens	Inhibition	%	2.12
	8191347	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	0.33	CHEMBL3094	Homo sapiens	Inhibition	%	0.33
	8191443	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	-0.19	CHEMBL3094	Homo sapiens	Inhibition	%	-0.19
	8191667	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.55	CHEMBL3094	Homo sapiens	Inhibition	%	0.55
	8191789	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	3.27	CHEMBL3094	Homo sapiens	Inhibition	%	3.27
	8192162	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	-0.1	CHEMBL3094	Homo sapiens	Inhibition	%	-0.1
	8192291	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.76	CHEMBL3094	Homo sapiens	Inhibition	%	2.76
	8192515	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	5.41	CHEMBL3094	Homo sapiens	Inhibition	%	5.41
	8192659	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	1.79	CHEMBL3094	Homo sapiens	Inhibition	%	1.79
	8193019	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.27	CHEMBL3094	Homo sapiens	Inhibition	%	-0.27
	8193291	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.11	CHEMBL3094	Homo sapiens	Inhibition	%	1.11
	8193436	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.02	CHEMBL3094	Homo sapiens	Inhibition	%	0.02
	8193817	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	1.53	CHEMBL3094	Homo sapiens	Inhibition	%	1.53
	8193966	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.99	CHEMBL3094	Homo sapiens	Inhibition	%	-0.99
	8194321	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	3.96	CHEMBL3094	Homo sapiens	Inhibition	%	3.96
	8194676	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.12	CHEMBL3094	Homo sapiens	Inhibition	%	1.12
	8194819	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	2.24	CHEMBL3094	Homo sapiens	Inhibition	%	2.24
	8195176	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	4.06	CHEMBL3094	Homo sapiens	Inhibition	%	4.06
	8195340	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	1.97	CHEMBL3094	Homo sapiens	Inhibition	%	1.97
	8195703	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	1.17	CHEMBL3094	Homo sapiens	Inhibition	%	1.17
	8196025	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.22	CHEMBL3094	Homo sapiens	Inhibition	%	0.22
	8196142	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.42	CHEMBL3094	Homo sapiens	Inhibition	%	1.42
	8196366	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.52	CHEMBL3094	Homo sapiens	Inhibition	%	1.52
	8196516	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	0.87	CHEMBL3094	Homo sapiens	Inhibition	%	0.87
	8196868	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	2.5	CHEMBL3094	Homo sapiens	Inhibition	%	2.5
	8197009	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.16	CHEMBL3094	Homo sapiens	Inhibition	%	3.16
	8197370	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.8	CHEMBL3094	Homo sapiens	Inhibition	%	-0.8
	8197645	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.54	CHEMBL3094	Homo sapiens	Inhibition	%	2.54
	8197785	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-0.46	CHEMBL3094	Homo sapiens	Inhibition	%	-0.46
	8198009	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.67	CHEMBL3094	Homo sapiens	Inhibition	%	0.67
	8198166	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	1.2	CHEMBL3094	Homo sapiens	Inhibition	%	1.2
	8198304	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.15	CHEMBL3094	Homo sapiens	Inhibition	%	-0.15
	8198528	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.19	CHEMBL3094	Homo sapiens	Inhibition	%	2.19
	8198658	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	2.36	CHEMBL3094	Homo sapiens	Inhibition	%	2.36
	8199013	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	0.55	CHEMBL3094	Homo sapiens	Inhibition	%	0.55
	8199161	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	1.83	CHEMBL3094	Homo sapiens	Inhibition	%	1.83
	8199385	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.12	CHEMBL3094	Homo sapiens	Inhibition	%	2.12
	8199519	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.08	CHEMBL3094	Homo sapiens	Inhibition	%	2.08
	8199682	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	8.16	CHEMBL3094	Homo sapiens	Inhibition	%	8.16
	8199906	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	0.68	CHEMBL3094	Homo sapiens	Inhibition	%	0.68
	8200044	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	-0.12	CHEMBL3094	Homo sapiens	Inhibition	%	-0.12
	8200372	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.57	CHEMBL3094	Homo sapiens	Inhibition	%	0.57
	8200711	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	1.2	CHEMBL3094	Homo sapiens	Inhibition	%	1.2
	8200861	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	-0.35	CHEMBL3094	Homo sapiens	Inhibition	%	-0.35
	8201215	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	5.17	CHEMBL3094	Homo sapiens	Inhibition	%	5.17
	8201350	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	0.82	CHEMBL3094	Homo sapiens	Inhibition	%	0.82
	8201574	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.86	CHEMBL3094	Homo sapiens	Inhibition	%	1.86
	8201707	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.74	CHEMBL3094	Homo sapiens	Inhibition	%	-0.74
	8201986	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.63	CHEMBL3094	Homo sapiens	Inhibition	%	1.63
	8202350	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.39	CHEMBL3094	Homo sapiens	Inhibition	%	-1.39
	8202517	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	0.34	CHEMBL3094	Homo sapiens	Inhibition	%	0.34
	8202866	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	4.27	CHEMBL3094	Homo sapiens	Inhibition	%	4.27
	8202996	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	2.24	CHEMBL3094	Homo sapiens	Inhibition	%	2.24
	8203220	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	2.98	CHEMBL3094	Homo sapiens	Inhibition	%	2.98
	8203351	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	1.9	CHEMBL3094	Homo sapiens	Inhibition	%	1.9
	8203721	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.09	CHEMBL3094	Homo sapiens	Inhibition	%	1.09
	8203855	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.3	CHEMBL3094	Homo sapiens	Inhibition	%	4.3
	8204245	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.6	CHEMBL3094	Homo sapiens	Inhibition	%	1.6
	8204382	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	1.2	CHEMBL3094	Homo sapiens	Inhibition	%	1.2
	8204606	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	0.39	CHEMBL3094	Homo sapiens	Inhibition	%	0.39
	8204711	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	-0.73	CHEMBL3094	Homo sapiens	Inhibition	%	-0.73
	8205050	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.2	CHEMBL3094	Homo sapiens	Inhibition	%	2.2
	8205199	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	1.08	CHEMBL3094	Homo sapiens	Inhibition	%	1.08
	8205423	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	0.41	CHEMBL3094	Homo sapiens	Inhibition	%	0.41
	8205559	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.15	CHEMBL3094	Homo sapiens	Inhibition	%	2.15
	8205922	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.21	CHEMBL3094	Homo sapiens	Inhibition	%	1.21
	8206054	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.31	CHEMBL3094	Homo sapiens	Inhibition	%	-0.31
	8206330	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.16	CHEMBL3094	Homo sapiens	Inhibition	%	2.16
	8206697	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.3	CHEMBL3094	Homo sapiens	Inhibition	%	-0.3
	8206877	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	0.98	CHEMBL3094	Homo sapiens	Inhibition	%	0.98
	8207227	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	2.21	CHEMBL3094	Homo sapiens	Inhibition	%	2.21
	8207581	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	2.42	CHEMBL3094	Homo sapiens	Inhibition	%	2.42
	8207713	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	1.08	CHEMBL3094	Homo sapiens	Inhibition	%	1.08
	8208082	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.07	CHEMBL3094	Homo sapiens	Inhibition	%	1.07
	8208214	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.14	CHEMBL3094	Homo sapiens	Inhibition	%	2.14
	8208438	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	4.32	CHEMBL3094	Homo sapiens	Inhibition	%	4.32
	8208604	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	0.65	CHEMBL3094	Homo sapiens	Inhibition	%	0.65
	8208961	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	0.67	CHEMBL3094	Homo sapiens	Inhibition	%	0.67
	8209066	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.06	CHEMBL3094	Homo sapiens	Inhibition	%	0.06
	8209290	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.29	CHEMBL3094	Homo sapiens	Inhibition	%	-0.29
	8209406	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.31	CHEMBL3094	Homo sapiens	Inhibition	%	1.31
	8209780	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	0.51	CHEMBL3094	Homo sapiens	Inhibition	%	0.51
	8209916	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.99	CHEMBL3094	Homo sapiens	Inhibition	%	3.99
	8210281	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.26	CHEMBL3094	Homo sapiens	Inhibition	%	1.26
	8210417	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.45	CHEMBL3094	Homo sapiens	Inhibition	%	-1.45
	8210641	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.83	CHEMBL3094	Homo sapiens	Inhibition	%	-0.83
	8210676	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.56	CHEMBL3094	Homo sapiens	Inhibition	%	1.56
	8210900	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.59	CHEMBL3094	Homo sapiens	Inhibition	%	2.59
	8211044	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	2.02	CHEMBL3094	Homo sapiens	Inhibition	%	2.02
	8211214	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	-0.25	CHEMBL3094	Homo sapiens	Inhibition	%	-0.25
	8211438	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.04	CHEMBL3094	Homo sapiens	Inhibition	%	1.04
	8211561	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	4.45	CHEMBL3094	Homo sapiens	Inhibition	%	4.45
	8211914	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	3.04	CHEMBL3094	Homo sapiens	Inhibition	%	3.04
	8212046	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	1.74	CHEMBL3094	Homo sapiens	Inhibition	%	1.74
	8212270	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	0.61	CHEMBL3094	Homo sapiens	Inhibition	%	0.61
	8212411	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.06	CHEMBL3094	Homo sapiens	Inhibition	%	1.06
	8212768	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.14	CHEMBL3094	Homo sapiens	Inhibition	%	2.14
	8212938	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	1.3	CHEMBL3094	Homo sapiens	Inhibition	%	1.3
	8213291	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-0.55	CHEMBL3094	Homo sapiens	Inhibition	%	-0.55
	8213619	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.91	CHEMBL3094	Homo sapiens	Inhibition	%	-0.91
	8213732	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.64	CHEMBL3094	Homo sapiens	Inhibition	%	1.64
	8213956	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.42	CHEMBL3094	Homo sapiens	Inhibition	%	1.42
	8214103	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	0.89	CHEMBL3094	Homo sapiens	Inhibition	%	0.89
	8214240	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	2.09	CHEMBL3094	Homo sapiens	Inhibition	%	2.09
	8214464	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	4.22	CHEMBL3094	Homo sapiens	Inhibition	%	4.22
	8214598	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	1.13	CHEMBL3094	Homo sapiens	Inhibition	%	1.13
	8214974	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-1.14	CHEMBL3094	Homo sapiens	Inhibition	%	-1.14
	8215225	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.45	CHEMBL3094	Homo sapiens	Inhibition	%	1.45
	8215378	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	-0.15	CHEMBL3094	Homo sapiens	Inhibition	%	-0.15
	8215766	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	0.93	CHEMBL3094	Homo sapiens	Inhibition	%	0.93
	8215885	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	2.43	CHEMBL3094	Homo sapiens	Inhibition	%	2.43
	8216109	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	4.77	CHEMBL3094	Homo sapiens	Inhibition	%	4.77
	8216228	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.65	CHEMBL3094	Homo sapiens	Inhibition	%	1.65
	8216588	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	1.7	CHEMBL3094	Homo sapiens	Inhibition	%	1.7
	8216726	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	5.12	CHEMBL3094	Homo sapiens	Inhibition	%	5.12
	8216950	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.06	CHEMBL3094	Homo sapiens	Inhibition	%	1.06
	8217084	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.28	CHEMBL3094	Homo sapiens	Inhibition	%	4.28
	8217258	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.66	CHEMBL3094	Homo sapiens	Inhibition	%	0.66
	8217482	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.94	CHEMBL3094	Homo sapiens	Inhibition	%	0.94
	8217613	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	0.7	CHEMBL3094	Homo sapiens	Inhibition	%	0.7
	8217938	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.59	CHEMBL3094	Homo sapiens	Inhibition	%	-0.59
	8218277	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.59	CHEMBL3094	Homo sapiens	Inhibition	%	1.59
	8218404	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	0.76	CHEMBL3094	Homo sapiens	Inhibition	%	0.76
	8218771	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	2.58	CHEMBL3094	Homo sapiens	Inhibition	%	2.58
	8218902	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	1.29	CHEMBL3094	Homo sapiens	Inhibition	%	1.29
	8219126	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	0.86	CHEMBL3094	Homo sapiens	Inhibition	%	0.86
	8219286	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-0.78	CHEMBL3094	Homo sapiens	Inhibition	%	-0.78
	8219536	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.08	CHEMBL3094	Homo sapiens	Inhibition	%	4.08
	8219697	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	0.93	CHEMBL3094	Homo sapiens	Inhibition	%	0.93
	8219921	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	0.22	CHEMBL3094	Homo sapiens	Inhibition	%	0.22
	8220090	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.35	CHEMBL3094	Homo sapiens	Inhibition	%	1.35
	8220443	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.31	CHEMBL3094	Homo sapiens	Inhibition	%	2.31
	8220557	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.02	CHEMBL3094	Homo sapiens	Inhibition	%	2.02
	8220781	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	1.37	CHEMBL3094	Homo sapiens	Inhibition	%	1.37
	8220919	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	2.07	CHEMBL3094	Homo sapiens	Inhibition	%	2.07
	8221279	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.15	CHEMBL3094	Homo sapiens	Inhibition	%	4.15
	8221412	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	1.35	CHEMBL3094	Homo sapiens	Inhibition	%	1.35
	8221801	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.07	CHEMBL3094	Homo sapiens	Inhibition	%	0.07
	8221932	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	-0.19	CHEMBL3094	Homo sapiens	Inhibition	%	-0.19
	8222254	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	1.84	CHEMBL3094	Homo sapiens	Inhibition	%	1.84
	8222612	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.46	CHEMBL3094	Homo sapiens	Inhibition	%	1.46
	8222730	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	0.52	CHEMBL3094	Homo sapiens	Inhibition	%	0.52
	8222954	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	0.34	CHEMBL3094	Homo sapiens	Inhibition	%	0.34
	8223098	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	4.28	CHEMBL3094	Homo sapiens	Inhibition	%	4.28
	8223451	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	0.98	CHEMBL3094	Homo sapiens	Inhibition	%	0.98
	8223612	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-0.2	CHEMBL3094	Homo sapiens	Inhibition	%	-0.2
	8223862	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	1.38	CHEMBL3094	Homo sapiens	Inhibition	%	1.38
	8224248	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	1.02	CHEMBL3094	Homo sapiens	Inhibition	%	1.02
	8224418	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	0.78	CHEMBL3094	Homo sapiens	Inhibition	%	0.78
	8224777	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	3.73	CHEMBL3094	Homo sapiens	Inhibition	%	3.73
	8225115	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.73	CHEMBL3094	Homo sapiens	Inhibition	%	2.73
	8225249	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	1.59	CHEMBL3094	Homo sapiens	Inhibition	%	1.59
	8225611	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.81	CHEMBL3094	Homo sapiens	Inhibition	%	0.81
	8225746	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.28	CHEMBL3094	Homo sapiens	Inhibition	%	2.28
	8225970	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.41	CHEMBL3094	Homo sapiens	Inhibition	%	1.41
	8226128	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.35	CHEMBL3094	Homo sapiens	Inhibition	%	0.35
	8226253	CHEMBL1961998	GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	0.74	CHEMBL3094	Homo sapiens	Inhibition	%	0.74
	8226477	CHEMBL1961999	GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	-0.01	CHEMBL3094	Homo sapiens	Inhibition	%	-0.01
inactive	9589939	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589940	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589941	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589942	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589943	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589944	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589945	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589946	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589947	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589948	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589949	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589950	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589951	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589952	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589953	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589954	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589955	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589956	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9589957	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	794.33	CHEMBL3094	Homo sapiens	pKi		6.1
active	9589958	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	=	Ki	nM	398.11	CHEMBL3094	Homo sapiens	pKi		6.4
inactive	9589959	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9589960	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	794.33	CHEMBL3094	Homo sapiens	pKi		6.1
inactive	9589961	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589962	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589963	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589964	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589965	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589966	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589967	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589968	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589969	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589970	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589971	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589972	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589973	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589974	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589975	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589976	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9589977	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	63.1	CHEMBL3094	Homo sapiens	pKi		7.2
inactive	9589978	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589979	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589980	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589981	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589982	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589983	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589984	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589985	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589986	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589987	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589988	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589989	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589990	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589991	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589992	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589993	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589994	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589995	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589996	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589997	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589998	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9589999	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590000	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9590001	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	=	Ki	nM	125.89	CHEMBL3094	Homo sapiens	pKi		6.9
inactive	9590002	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590003	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590004	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590005	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590006	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590007	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590008	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590009	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590010	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590011	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590012	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590013	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590014	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590015	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590016	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590017	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590018	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590019	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590020	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590021	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590022	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590023	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590024	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590025	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590026	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590027	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590028	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590029	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590030	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590031	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590032	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590033	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590034	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590035	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590036	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590037	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590038	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590039	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590040	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590041	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590042	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590043	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590044	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590045	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590046	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590047	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590048	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590049	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590050	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9590051	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	=	Ki	nM	1258.93	CHEMBL3094	Homo sapiens	pKi		5.9
inactive	9590052	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590053	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590054	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590055	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590056	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590057	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590058	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590059	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590060	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590061	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590062	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590063	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9590064	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	398.11	CHEMBL3094	Homo sapiens	pKi		6.4
inactive	9590065	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590066	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590067	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590068	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590069	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590070	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9590071	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	=	Ki	nM	630.96	CHEMBL3094	Homo sapiens	pKi		6.2
inactive	9590072	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590073	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590074	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9590075	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593645	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593646	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593647	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593648	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593649	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	=	Ki	nM	630.96	CHEMBL3094	Homo sapiens	pKi		6.2
active	9593650	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	=	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593651	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593652	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593653	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593654	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593655	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593656	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593657	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593658	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593659	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	=	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593660	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593661	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593662	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593663	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593664	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593665	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593666	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593667	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593668	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593669	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593670	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593671	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	Ki	nM	1258.93	CHEMBL3094	Homo sapiens	pKi		5.9
inactive	9593672	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593673	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	251.19	CHEMBL3094	Homo sapiens	pKi		6.6
inactive	9593674	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593675	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593676	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	=	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593677	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593678	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C1CC(c2ccc(Cl)cc2)Cc2[nH]c3cc(Cl)ccc3c(=O)c21		CHEMBL1990432	=	Ki	nM	1258.93	CHEMBL3094	Homo sapiens	pKi		5.9
inactive	9593679	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593680	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593681	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593682	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	1000.0	CHEMBL3094	Homo sapiens	pKi		6.0
inactive	9593683	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593684	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593685	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593686	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593687	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593688	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593689	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593690	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593691	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	=	Ki	nM	630.96	CHEMBL3094	Homo sapiens	pKi		6.2
inactive	9593692	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593693	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593694	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593695	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593696	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593697	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593698	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593699	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593700	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	=	Ki	nM	1000.0	CHEMBL3094	Homo sapiens	pKi		6.0
inactive	9593701	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593702	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593703	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593704	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593705	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593706	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	=	Ki	nM	79.43	CHEMBL3094	Homo sapiens	pKi		7.1
inactive	9593707	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593708	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593709	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593710	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593711	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593712	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593713	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593714	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593715	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593716	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593717	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	=	Ki	nM	398.11	CHEMBL3094	Homo sapiens	pKi		6.4
inactive	9593718	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593719	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593720	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	1258.93	CHEMBL3094	Homo sapiens	pKi		5.9
inactive	9593721	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593722	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593723	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593724	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593725	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593726	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593727	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593728	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593729	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593730	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593731	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593732	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593733	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593734	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593735	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593736	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593737	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593738	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593739	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593740	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593741	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593742	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	199.53	CHEMBL3094	Homo sapiens	pKi		6.7
inactive	9593743	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593744	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593745	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593746	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593747	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593748	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593749	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	=	Ki	nM	794.33	CHEMBL3094	Homo sapiens	pKi		6.1
inactive	9593750	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593751	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593752	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593753	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593754	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593755	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593756	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593757	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593758	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593759	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593760	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593761	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593762	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593763	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593764	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593765	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593766	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593767	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593768	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593769	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593770	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593771	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	1000.0	CHEMBL3094	Homo sapiens	pKi		6.0
inactive	9593772	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593773	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593774	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593775	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593776	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593777	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593778	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	=	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593779	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593780	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593781	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	398.11	CHEMBL3094	Homo sapiens	pKi		6.4
active	9593782	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	=	Ki	nM	316.23	CHEMBL3094	Homo sapiens	pKi		6.5
inactive	9593783	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593784	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593785	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593786	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593787	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593788	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593789	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	=	Ki	nM	10.0	CHEMBL3094	Homo sapiens	pKi		8.0
inactive	9593790	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593791	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593792	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	=	Ki	nM	630.96	CHEMBL3094	Homo sapiens	pKi		6.2
inactive	9593793	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593794	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593795	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593796	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593797	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593798	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593799	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593800	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593801	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593802	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	630.96	CHEMBL3094	Homo sapiens	pKi		6.2
inactive	9593803	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593804	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593805	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593806	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593807	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593808	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593809	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593810	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593811	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593812	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	398.11	CHEMBL3094	Homo sapiens	pKi		6.4
inactive	9593813	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593814	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593815	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593816	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593817	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	=	Ki	nM	630.96	CHEMBL3094	Homo sapiens	pKi		6.2
inactive	9593818	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593819	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	1258.93	CHEMBL3094	Homo sapiens	pKi		5.9
inactive	9593820	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593821	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593822	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593823	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593824	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593825	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593826	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593827	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	1258.93	CHEMBL3094	Homo sapiens	pKi		5.9
inactive	9593828	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593829	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593830	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593831	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593832	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593833	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593834	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593835	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593836	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593837	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593838	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	=	Ki	nM	794.33	CHEMBL3094	Homo sapiens	pKi		6.1
inactive	9593839	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593840	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593841	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593842	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593843	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593844	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9593845	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	=	Ki	nM	501.19	CHEMBL3094	Homo sapiens	pKi		6.3
inactive	9593846	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593847	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593848	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593849	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593850	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593851	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593852	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593853	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593854	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593855	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593856	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593857	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593858	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593859	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593860	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593861	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593862	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593863	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593864	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593865	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593866	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593867	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593868	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593869	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593870	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593871	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593872	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593873	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593874	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593875	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593876	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9593877	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597450	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597451	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597452	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597453	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597454	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597455	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597456	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597457	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597458	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597459	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597460	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597461	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597462	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597463	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597464	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597465	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597466	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597467	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597468	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597469	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597470	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597471	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597472	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597473	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597474	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597475	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597476	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597477	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597478	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597479	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597480	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597481	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597482	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9597483	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	=	Ki	nM	1258.93	CHEMBL3094	Homo sapiens	pKi		5.9
inactive	9597484	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597485	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597486	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597487	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597488	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597489	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597490	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9597491	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	Ki	nM	251.19	CHEMBL3094	Homo sapiens	pKi		6.6
inactive	9597492	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597493	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597494	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597495	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597496	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597497	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597498	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597499	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597500	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597501	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597502	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597503	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597504	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597505	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597506	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597507	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597508	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597509	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597510	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9597511	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	=	Ki	nM	1000.0	CHEMBL3094	Homo sapiens	pKi		6.0
inactive	9597512	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597513	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597514	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597515	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597516	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597517	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9597518	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	794.33	CHEMBL3094	Homo sapiens	pKi		6.1
inactive	9597519	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597520	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597521	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597522	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597523	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597524	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597525	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597526	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597527	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597528	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597529	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597530	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597531	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597532	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597533	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9597534	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	=	Ki	nM	63.1	CHEMBL3094	Homo sapiens	pKi		7.2
inactive	9597535	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597536	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597537	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597538	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597539	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597540	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597541	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597542	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597543	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597544	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597545	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597546	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597547	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9597548	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	=	Ki	nM	251.19	CHEMBL3094	Homo sapiens	pKi		6.6
inactive	9597549	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597550	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597551	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597552	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597553	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597554	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597555	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9597556	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	=	Ki	nM	1258.93	CHEMBL3094	Homo sapiens	pKi		5.9
inactive	9597557	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597558	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597559	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597560	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597561	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597562	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597563	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597564	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597565	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597566	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597567	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597568	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597569	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597570	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597571	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597572	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597573	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597574	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597575	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597576	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
active	9597577	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Ki	nM	63.1	CHEMBL3094	Homo sapiens	pKi		7.2
inactive	9597578	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597579	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597580	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597581	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597582	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597583	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597584	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597585	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597586	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597587	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597588	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597589	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597590	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597591	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597592	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597593	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597594	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597595	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597596	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597597	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597598	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597599	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
inactive	9597600	CHEMBL1963728	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK5	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	<	Ki	nM	1584.89	CHEMBL3094	Homo sapiens	pKi		5.8
	10839395	CHEMBL2014961	Inhibition of MAPKAPK5 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	1.0	CHEMBL3094	Homo sapiens	INH	%	1.0
	10839562	CHEMBL2016326	Inhibition of PRAK assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	101.0	CHEMBL3094	Homo sapiens	Activity	%	101.0
	10840423	CHEMBL2015802	Inhibition of PRAK assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	110.0	CHEMBL3094	Homo sapiens	Activity	%	110.0
	10850665	CHEMBL2019785	Inhibition of human PRAK at 1 uM	B	Cn1cc(-c2cccc(-c3cnc(N)c(C(=O)N[C@H]4C5CC6CC4C[C@@](O)(C6)C5)n3)c2)cn1		CHEMBL2018022	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	10867542	CHEMBL2027432	Inhibition of PRAK at 2 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Inhibition	%	12.0	CHEMBL3094	Homo sapiens	INH	%	12.0
	10923966	CHEMBL2044160	Inhibition of PRAK at 1 uM incubated for 30 mins prior to substrate addition study done at apparent ATP Km for enzyme	B	C[C@H](/C=C\C(F)(F)F)Oc1cc(-c2cc(-c3cc(CN(C)C)cs3)cnc2N)ccc1C(N)=O		CHEMBL2042135	=	Inhibition	%	7.0	CHEMBL3094	Homo sapiens	INH	%	7.0
	10926140	CHEMBL2046219	Inhibition of human PRAK assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	Activity	%	72.0	CHEMBL3094	Homo sapiens	Activity	%	72.0
	10926141	CHEMBL2046219	Inhibition of human PRAK assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	Activity	%	66.0	CHEMBL3094	Homo sapiens	Activity	%	66.0
	10984756	CHEMBL2072052	Inhibition of human PRAK at 1 uM	B	Nc1cc(Nc2cnccn2)nc(-c2ccnc(N3CCNCC3)c2)c1		CHEMBL2069349	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
Not Active	10986937	CHEMBL2072241	Inhibition of PRAK at 10 uM	B	NS(=O)(=O)c1cc(-c2nc3ccccc3s2)cs1		CHEMBL2069711		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
	12047330	CHEMBL2157441	Inhibition of PRAK at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	9.3	CHEMBL3094	Homo sapiens	INH	%	9.3
	12074646	CHEMBL2161208	Inhibition of MAPKAP-K5 at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	12074697	CHEMBL2161418	Inhibition of PRAK at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	12094380	CHEMBL2166160	Inhibition of human PRAK at 10 uM	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL1235213	=	Inhibition	%	62.0	CHEMBL3094	Homo sapiens	INH	%	62.0
	12094412	CHEMBL2166177	Inhibition of PRAK	B	N[C@H]1CC[C@H](Nc2cc(Nc3ccc(F)c(Cl)c3)n3nccc3n2)CC1		CHEMBL2163999	=	IC50	nM	11000.0	CHEMBL3094	Homo sapiens	IC50	uM	11.0
	12150585	CHEMBL2188521	Inhibition of human recombinant MK5 by radiometric kinase assay	B	CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1		CHEMBL2178352	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	12170743	CHEMBL2209464	Inhibition of PRAK assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	109.0	CHEMBL3094	Homo sapiens	Activity	%	109.0
	12170874	CHEMBL2213193	Inhibition of PRAK assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	114.0	CHEMBL3094	Homo sapiens	Activity	%	114.0
	12172361	CHEMBL2210626	Inhibition of MAPKAPK5 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL3094	Homo sapiens	Activity	%	100.0
	12188411	CHEMBL2211132	Binding affinity to PRAK at 1 uM	B	Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1		CHEMBL2206921	<	Activity	%	50.0	CHEMBL3094	Homo sapiens	Activity	%	50.0
	12266563	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	107.0	CHEMBL3094	Homo sapiens	Residual Activity	%	107.0
	12266564	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	98.0	CHEMBL3094	Homo sapiens	Residual Activity	%	98.0
	12266565	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	110.0	CHEMBL3094	Homo sapiens	Residual Activity	%	110.0
	12266566	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	89.0	CHEMBL3094	Homo sapiens	Residual Activity	%	89.0
	12266567	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	89.0	CHEMBL3094	Homo sapiens	Residual Activity	%	89.0
	12266568	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	94.0	CHEMBL3094	Homo sapiens	Residual Activity	%	94.0
	12266569	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	62.0	CHEMBL3094	Homo sapiens	Residual Activity	%	62.0
	12266570	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	93.0	CHEMBL3094	Homo sapiens	Residual Activity	%	93.0
	12266571	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	81.0	CHEMBL3094	Homo sapiens	Residual Activity	%	81.0
	12266572	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	78.0	CHEMBL3094	Homo sapiens	Residual Activity	%	78.0
	12266573	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	84.0	CHEMBL3094	Homo sapiens	Residual Activity	%	84.0
	12266574	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	84.0	CHEMBL3094	Homo sapiens	Residual Activity	%	84.0
	12266575	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	74.0	CHEMBL3094	Homo sapiens	Residual Activity	%	74.0
	12266576	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	75.0	CHEMBL3094	Homo sapiens	Residual Activity	%	75.0
	12266577	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	42.0	CHEMBL3094	Homo sapiens	Residual Activity	%	42.0
	12266578	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	88.0	CHEMBL3094	Homo sapiens	Residual Activity	%	88.0
	12266579	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	104.0	CHEMBL3094	Homo sapiens	Residual Activity	%	104.0
	12266580	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	84.0	CHEMBL3094	Homo sapiens	Residual Activity	%	84.0
	12266581	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	59.0	CHEMBL3094	Homo sapiens	Residual Activity	%	59.0
	12266582	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	47.0	CHEMBL3094	Homo sapiens	Residual Activity	%	47.0
	12266583	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	72.0	CHEMBL3094	Homo sapiens	Residual Activity	%	72.0
	12266584	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	74.0	CHEMBL3094	Homo sapiens	Residual Activity	%	74.0
	12266585	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	85.0	CHEMBL3094	Homo sapiens	Residual Activity	%	85.0
	12266586	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	60.0	CHEMBL3094	Homo sapiens	Residual Activity	%	60.0
	12266587	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	86.0	CHEMBL3094	Homo sapiens	Residual Activity	%	86.0
	12266588	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	79.0	CHEMBL3094	Homo sapiens	Residual Activity	%	79.0
	12266589	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	71.0	CHEMBL3094	Homo sapiens	Residual Activity	%	71.0
	12266590	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	77.0	CHEMBL3094	Homo sapiens	Residual Activity	%	77.0
	12266591	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	78.0	CHEMBL3094	Homo sapiens	Residual Activity	%	78.0
	12266592	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	83.0	CHEMBL3094	Homo sapiens	Residual Activity	%	83.0
	12266593	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	73.0	CHEMBL3094	Homo sapiens	Residual Activity	%	73.0
	12266594	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	99.0	CHEMBL3094	Homo sapiens	Residual Activity	%	99.0
	12266595	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	75.0	CHEMBL3094	Homo sapiens	Residual Activity	%	75.0
	12266596	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	28.0	CHEMBL3094	Homo sapiens	Residual Activity	%	28.0
	12266597	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	81.0	CHEMBL3094	Homo sapiens	Residual Activity	%	81.0
	12266598	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	82.0	CHEMBL3094	Homo sapiens	Residual Activity	%	82.0
	12266599	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	47.0	CHEMBL3094	Homo sapiens	Residual Activity	%	47.0
	12266600	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	57.0	CHEMBL3094	Homo sapiens	Residual Activity	%	57.0
	12266601	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	92.0	CHEMBL3094	Homo sapiens	Residual Activity	%	92.0
	12266602	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	82.0	CHEMBL3094	Homo sapiens	Residual Activity	%	82.0
	12266603	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	96.0	CHEMBL3094	Homo sapiens	Residual Activity	%	96.0
	12266604	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	77.0	CHEMBL3094	Homo sapiens	Residual Activity	%	77.0
	12266605	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	55.0	CHEMBL3094	Homo sapiens	Residual Activity	%	55.0
	12266606	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	43.0	CHEMBL3094	Homo sapiens	Residual Activity	%	43.0
	12266607	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	70.0	CHEMBL3094	Homo sapiens	Residual Activity	%	70.0
	12266608	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	87.0	CHEMBL3094	Homo sapiens	Residual Activity	%	87.0
	12266609	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	84.0	CHEMBL3094	Homo sapiens	Residual Activity	%	84.0
	12266610	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	78.0	CHEMBL3094	Homo sapiens	Residual Activity	%	78.0
	12266611	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	93.0	CHEMBL3094	Homo sapiens	Residual Activity	%	93.0
	12266612	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	98.0	CHEMBL3094	Homo sapiens	Residual Activity	%	98.0
	12266613	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	95.0	CHEMBL3094	Homo sapiens	Residual Activity	%	95.0
	12266614	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	90.0	CHEMBL3094	Homo sapiens	Residual Activity	%	90.0
	12266615	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	49.0	CHEMBL3094	Homo sapiens	Residual Activity	%	49.0
	12266616	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	82.0	CHEMBL3094	Homo sapiens	Residual Activity	%	82.0
	12266617	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	72.0	CHEMBL3094	Homo sapiens	Residual Activity	%	72.0
	12266618	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	93.0	CHEMBL3094	Homo sapiens	Residual Activity	%	93.0
	12266619	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	105.0	CHEMBL3094	Homo sapiens	Residual Activity	%	105.0
	12266620	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	94.0	CHEMBL3094	Homo sapiens	Residual Activity	%	94.0
	12266621	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	97.0	CHEMBL3094	Homo sapiens	Residual Activity	%	97.0
	12266622	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	89.0	CHEMBL3094	Homo sapiens	Residual Activity	%	89.0
	12266623	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	95.0	CHEMBL3094	Homo sapiens	Residual Activity	%	95.0
	12266624	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	102.0	CHEMBL3094	Homo sapiens	Residual Activity	%	102.0
	12266625	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	101.0	CHEMBL3094	Homo sapiens	Residual Activity	%	101.0
	12266626	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	99.0	CHEMBL3094	Homo sapiens	Residual Activity	%	99.0
	12266627	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	102.0	CHEMBL3094	Homo sapiens	Residual Activity	%	102.0
	12266628	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	113.0	CHEMBL3094	Homo sapiens	Residual Activity	%	113.0
	12266629	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	107.0	CHEMBL3094	Homo sapiens	Residual Activity	%	107.0
	12266630	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	93.0	CHEMBL3094	Homo sapiens	Residual Activity	%	93.0
	12266631	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	96.0	CHEMBL3094	Homo sapiens	Residual Activity	%	96.0
	12266632	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	120.0	CHEMBL3094	Homo sapiens	Residual Activity	%	120.0
	12266633	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	101.0	CHEMBL3094	Homo sapiens	Residual Activity	%	101.0
	12266634	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	128.0	CHEMBL3094	Homo sapiens	Residual Activity	%	128.0
	12266635	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	125.0	CHEMBL3094	Homo sapiens	Residual Activity	%	125.0
	12266636	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	111.0	CHEMBL3094	Homo sapiens	Residual Activity	%	111.0
	12266637	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	120.0	CHEMBL3094	Homo sapiens	Residual Activity	%	120.0
	12266638	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	129.0	CHEMBL3094	Homo sapiens	Residual Activity	%	129.0
	12266639	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	106.0	CHEMBL3094	Homo sapiens	Residual Activity	%	106.0
	12266640	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	97.0	CHEMBL3094	Homo sapiens	Residual Activity	%	97.0
	12266641	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	125.0	CHEMBL3094	Homo sapiens	Residual Activity	%	125.0
	12266642	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	29.0	CHEMBL3094	Homo sapiens	Residual Activity	%	29.0
	12266643	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	85.0	CHEMBL3094	Homo sapiens	Residual Activity	%	85.0
	12266644	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	101.0	CHEMBL3094	Homo sapiens	Residual Activity	%	101.0
	12266645	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	105.0	CHEMBL3094	Homo sapiens	Residual Activity	%	105.0
	12266646	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	112.0	CHEMBL3094	Homo sapiens	Residual Activity	%	112.0
	12266647	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	110.0	CHEMBL3094	Homo sapiens	Residual Activity	%	110.0
	12266648	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	115.0	CHEMBL3094	Homo sapiens	Residual Activity	%	115.0
	12266649	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	113.0	CHEMBL3094	Homo sapiens	Residual Activity	%	113.0
	12266650	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	145.0	CHEMBL3094	Homo sapiens	Residual Activity	%	145.0
	12266651	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	99.0	CHEMBL3094	Homo sapiens	Residual Activity	%	99.0
	12266652	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	78.0	CHEMBL3094	Homo sapiens	Residual Activity	%	78.0
	12268293	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	96.0	CHEMBL3094	Homo sapiens	Residual Activity	%	96.0
	12268294	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	104.0	CHEMBL3094	Homo sapiens	Residual Activity	%	104.0
	12268295	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	92.0	CHEMBL3094	Homo sapiens	Residual Activity	%	92.0
	12268296	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	96.0	CHEMBL3094	Homo sapiens	Residual Activity	%	96.0
	12268297	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	92.0	CHEMBL3094	Homo sapiens	Residual Activity	%	92.0
	12268298	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	105.0	CHEMBL3094	Homo sapiens	Residual Activity	%	105.0
	12268299	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	87.0	CHEMBL3094	Homo sapiens	Residual Activity	%	87.0
	12268300	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	110.0	CHEMBL3094	Homo sapiens	Residual Activity	%	110.0
	12268301	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	110.0	CHEMBL3094	Homo sapiens	Residual Activity	%	110.0
	12268302	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	115.0	CHEMBL3094	Homo sapiens	Residual Activity	%	115.0
	12268303	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	97.0	CHEMBL3094	Homo sapiens	Residual Activity	%	97.0
	12268304	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	19.0	CHEMBL3094	Homo sapiens	Residual Activity	%	19.0
	12268305	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	125.0	CHEMBL3094	Homo sapiens	Residual Activity	%	125.0
	12268306	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	90.0	CHEMBL3094	Homo sapiens	Residual Activity	%	90.0
	12268307	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	80.0	CHEMBL3094	Homo sapiens	Residual Activity	%	80.0
	12268308	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	115.0	CHEMBL3094	Homo sapiens	Residual Activity	%	115.0
	12268309	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	114.0	CHEMBL3094	Homo sapiens	Residual Activity	%	114.0
	12268310	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	119.0	CHEMBL3094	Homo sapiens	Residual Activity	%	119.0
	12268311	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	110.0	CHEMBL3094	Homo sapiens	Residual Activity	%	110.0
	12268312	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	97.0	CHEMBL3094	Homo sapiens	Residual Activity	%	97.0
	12268313	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	112.0	CHEMBL3094	Homo sapiens	Residual Activity	%	112.0
	12268314	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	110.0	CHEMBL3094	Homo sapiens	Residual Activity	%	110.0
	12268315	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	68.0	CHEMBL3094	Homo sapiens	Residual Activity	%	68.0
	12268316	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	104.0	CHEMBL3094	Homo sapiens	Residual Activity	%	104.0
	12268317	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	91.0	CHEMBL3094	Homo sapiens	Residual Activity	%	91.0
	12268318	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	108.0	CHEMBL3094	Homo sapiens	Residual Activity	%	108.0
	12268319	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	96.0	CHEMBL3094	Homo sapiens	Residual Activity	%	96.0
	12268320	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	98.0	CHEMBL3094	Homo sapiens	Residual Activity	%	98.0
	12268321	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	118.0	CHEMBL3094	Homo sapiens	Residual Activity	%	118.0
	12268322	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	116.0	CHEMBL3094	Homo sapiens	Residual Activity	%	116.0
	12268323	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	104.0	CHEMBL3094	Homo sapiens	Residual Activity	%	104.0
	12268324	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	119.0	CHEMBL3094	Homo sapiens	Residual Activity	%	119.0
	12268325	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	105.0	CHEMBL3094	Homo sapiens	Residual Activity	%	105.0
	12268326	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	105.0	CHEMBL3094	Homo sapiens	Residual Activity	%	105.0
	12268327	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	84.0	CHEMBL3094	Homo sapiens	Residual Activity	%	84.0
	12268328	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	111.0	CHEMBL3094	Homo sapiens	Residual Activity	%	111.0
	12268329	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	102.0	CHEMBL3094	Homo sapiens	Residual Activity	%	102.0
	12268330	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	115.0	CHEMBL3094	Homo sapiens	Residual Activity	%	115.0
	12268331	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	73.0	CHEMBL3094	Homo sapiens	Residual Activity	%	73.0
	12268332	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	32.0	CHEMBL3094	Homo sapiens	Residual Activity	%	32.0
	12268333	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	100.0	CHEMBL3094	Homo sapiens	Residual Activity	%	100.0
	12268334	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	95.0	CHEMBL3094	Homo sapiens	Residual Activity	%	95.0
	12268335	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	59.0	CHEMBL3094	Homo sapiens	Residual Activity	%	59.0
	12268336	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	92.0	CHEMBL3094	Homo sapiens	Residual Activity	%	92.0
	12268337	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	100.0	CHEMBL3094	Homo sapiens	Residual Activity	%	100.0
	12268338	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	92.0	CHEMBL3094	Homo sapiens	Residual Activity	%	92.0
	12268339	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	95.0	CHEMBL3094	Homo sapiens	Residual Activity	%	95.0
	12268340	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	76.0	CHEMBL3094	Homo sapiens	Residual Activity	%	76.0
	12268341	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	76.0	CHEMBL3094	Homo sapiens	Residual Activity	%	76.0
	12268342	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	76.0	CHEMBL3094	Homo sapiens	Residual Activity	%	76.0
	12268343	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	91.0	CHEMBL3094	Homo sapiens	Residual Activity	%	91.0
	12268344	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	99.0	CHEMBL3094	Homo sapiens	Residual Activity	%	99.0
	12268345	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	81.0	CHEMBL3094	Homo sapiens	Residual Activity	%	81.0
	12268346	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	88.0	CHEMBL3094	Homo sapiens	Residual Activity	%	88.0
	12268347	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	110.0	CHEMBL3094	Homo sapiens	Residual Activity	%	110.0
	12268348	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	111.0	CHEMBL3094	Homo sapiens	Residual Activity	%	111.0
	12268349	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	105.0	CHEMBL3094	Homo sapiens	Residual Activity	%	105.0
	12268350	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	91.0	CHEMBL3094	Homo sapiens	Residual Activity	%	91.0
	12268351	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	109.0	CHEMBL3094	Homo sapiens	Residual Activity	%	109.0
	12268352	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	125.0	CHEMBL3094	Homo sapiens	Residual Activity	%	125.0
	12268353	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	122.0	CHEMBL3094	Homo sapiens	Residual Activity	%	122.0
	12268354	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	83.0	CHEMBL3094	Homo sapiens	Residual Activity	%	83.0
	12268355	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	105.0	CHEMBL3094	Homo sapiens	Residual Activity	%	105.0
	12268356	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	105.0	CHEMBL3094	Homo sapiens	Residual Activity	%	105.0
	12268357	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	87.0	CHEMBL3094	Homo sapiens	Residual Activity	%	87.0
	12268358	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	89.0	CHEMBL3094	Homo sapiens	Residual Activity	%	89.0
	12268359	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	110.0	CHEMBL3094	Homo sapiens	Residual Activity	%	110.0
	12268360	CHEMBL2219127	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	78.0	CHEMBL3094	Homo sapiens	Residual Activity	%	78.0
	12268361	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	65.0	CHEMBL3094	Homo sapiens	Residual Activity	%	65.0
	12268362	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	48.0	CHEMBL3094	Homo sapiens	Residual Activity	%	48.0
	12268363	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	24.0	CHEMBL3094	Homo sapiens	Residual Activity	%	24.0
	12268364	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	117.0	CHEMBL3094	Homo sapiens	Residual Activity	%	117.0
	12268365	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	94.0	CHEMBL3094	Homo sapiens	Residual Activity	%	94.0
	12268366	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	110.0	CHEMBL3094	Homo sapiens	Residual Activity	%	110.0
	12268367	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	54.0	CHEMBL3094	Homo sapiens	Residual Activity	%	54.0
	12268368	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	117.0	CHEMBL3094	Homo sapiens	Residual Activity	%	117.0
	12268369	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	56.0	CHEMBL3094	Homo sapiens	Residual Activity	%	56.0
	12268370	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	78.0	CHEMBL3094	Homo sapiens	Residual Activity	%	78.0
	12268371	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	77.0	CHEMBL3094	Homo sapiens	Residual Activity	%	77.0
	12268372	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	91.0	CHEMBL3094	Homo sapiens	Residual Activity	%	91.0
	12268373	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	74.0	CHEMBL3094	Homo sapiens	Residual Activity	%	74.0
	12268374	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	33.0	CHEMBL3094	Homo sapiens	Residual Activity	%	33.0
	12268375	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	11.0	CHEMBL3094	Homo sapiens	Residual Activity	%	11.0
	12268376	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	81.0	CHEMBL3094	Homo sapiens	Residual Activity	%	81.0
	12268377	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	133.0	CHEMBL3094	Homo sapiens	Residual Activity	%	133.0
	12268378	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	52.0	CHEMBL3094	Homo sapiens	Residual Activity	%	52.0
	12268379	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	76.0	CHEMBL3094	Homo sapiens	Residual Activity	%	76.0
	12268380	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	45.0	CHEMBL3094	Homo sapiens	Residual Activity	%	45.0
	12268381	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	44.0	CHEMBL3094	Homo sapiens	Residual Activity	%	44.0
	12268382	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	39.0	CHEMBL3094	Homo sapiens	Residual Activity	%	39.0
	12268383	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	70.0	CHEMBL3094	Homo sapiens	Residual Activity	%	70.0
	12268384	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	51.0	CHEMBL3094	Homo sapiens	Residual Activity	%	51.0
	12268385	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	105.0	CHEMBL3094	Homo sapiens	Residual Activity	%	105.0
	12268386	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	82.0	CHEMBL3094	Homo sapiens	Residual Activity	%	82.0
	12268387	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	40.0	CHEMBL3094	Homo sapiens	Residual Activity	%	40.0
	12268388	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	70.0	CHEMBL3094	Homo sapiens	Residual Activity	%	70.0
	12268389	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	79.0	CHEMBL3094	Homo sapiens	Residual Activity	%	79.0
	12268390	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	59.0	CHEMBL3094	Homo sapiens	Residual Activity	%	59.0
	12268391	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	90.0	CHEMBL3094	Homo sapiens	Residual Activity	%	90.0
	12268392	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	70.0	CHEMBL3094	Homo sapiens	Residual Activity	%	70.0
	12268393	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	37.0	CHEMBL3094	Homo sapiens	Residual Activity	%	37.0
	12268394	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	42.0	CHEMBL3094	Homo sapiens	Residual Activity	%	42.0
	12268395	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	85.0	CHEMBL3094	Homo sapiens	Residual Activity	%	85.0
	12268396	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	72.0	CHEMBL3094	Homo sapiens	Residual Activity	%	72.0
	12268397	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	65.0	CHEMBL3094	Homo sapiens	Residual Activity	%	65.0
	12268398	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	62.0	CHEMBL3094	Homo sapiens	Residual Activity	%	62.0
	12268399	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	77.0	CHEMBL3094	Homo sapiens	Residual Activity	%	77.0
	12268400	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	99.0	CHEMBL3094	Homo sapiens	Residual Activity	%	99.0
	12268401	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	112.0	CHEMBL3094	Homo sapiens	Residual Activity	%	112.0
	12268402	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	109.0	CHEMBL3094	Homo sapiens	Residual Activity	%	109.0
	12268403	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	68.0	CHEMBL3094	Homo sapiens	Residual Activity	%	68.0
	12268404	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	7.0	CHEMBL3094	Homo sapiens	Residual Activity	%	7.0
	12268405	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	79.0	CHEMBL3094	Homo sapiens	Residual Activity	%	79.0
	12268406	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	90.0	CHEMBL3094	Homo sapiens	Residual Activity	%	90.0
	12268407	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	101.0	CHEMBL3094	Homo sapiens	Residual Activity	%	101.0
	12268408	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	88.0	CHEMBL3094	Homo sapiens	Residual Activity	%	88.0
	12268409	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	80.0	CHEMBL3094	Homo sapiens	Residual Activity	%	80.0
	12268410	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	99.0	CHEMBL3094	Homo sapiens	Residual Activity	%	99.0
	12268411	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	94.0	CHEMBL3094	Homo sapiens	Residual Activity	%	94.0
	12268412	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	46.0	CHEMBL3094	Homo sapiens	Residual Activity	%	46.0
	12268413	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	18.0	CHEMBL3094	Homo sapiens	Residual Activity	%	18.0
	12268414	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	98.0	CHEMBL3094	Homo sapiens	Residual Activity	%	98.0
	12268415	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	59.0	CHEMBL3094	Homo sapiens	Residual Activity	%	59.0
	12268416	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	84.0	CHEMBL3094	Homo sapiens	Residual Activity	%	84.0
	12268417	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	76.0	CHEMBL3094	Homo sapiens	Residual Activity	%	76.0
	12268418	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	74.0	CHEMBL3094	Homo sapiens	Residual Activity	%	74.0
	12268419	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	58.0	CHEMBL3094	Homo sapiens	Residual Activity	%	58.0
	12268420	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	84.0	CHEMBL3094	Homo sapiens	Residual Activity	%	84.0
	12268421	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	17.0	CHEMBL3094	Homo sapiens	Residual Activity	%	17.0
	12268422	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	57.0	CHEMBL3094	Homo sapiens	Residual Activity	%	57.0
	12268423	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	92.0	CHEMBL3094	Homo sapiens	Residual Activity	%	92.0
	12268424	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	74.0	CHEMBL3094	Homo sapiens	Residual Activity	%	74.0
	12268425	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	78.0	CHEMBL3094	Homo sapiens	Residual Activity	%	78.0
	12268426	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	65.0	CHEMBL3094	Homo sapiens	Residual Activity	%	65.0
	12268427	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	95.0	CHEMBL3094	Homo sapiens	Residual Activity	%	95.0
	12268428	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	99.0	CHEMBL3094	Homo sapiens	Residual Activity	%	99.0
	12268429	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	93.0	CHEMBL3094	Homo sapiens	Residual Activity	%	93.0
	12268430	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	118.0	CHEMBL3094	Homo sapiens	Residual Activity	%	118.0
	12268431	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	73.0	CHEMBL3094	Homo sapiens	Residual Activity	%	73.0
	12268432	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	65.0	CHEMBL3094	Homo sapiens	Residual Activity	%	65.0
	12268433	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	107.0	CHEMBL3094	Homo sapiens	Residual Activity	%	107.0
	12268434	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	83.0	CHEMBL3094	Homo sapiens	Residual Activity	%	83.0
	12268435	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	111.0	CHEMBL3094	Homo sapiens	Residual Activity	%	111.0
	12268436	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	89.0	CHEMBL3094	Homo sapiens	Residual Activity	%	89.0
	12268437	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	37.0	CHEMBL3094	Homo sapiens	Residual Activity	%	37.0
	12268438	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	49.0	CHEMBL3094	Homo sapiens	Residual Activity	%	49.0
	12268439	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	85.0	CHEMBL3094	Homo sapiens	Residual Activity	%	85.0
	12268440	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-2.0	CHEMBL3094	Homo sapiens	Residual Activity	%	-2.0
	12268441	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	102.0	CHEMBL3094	Homo sapiens	Residual Activity	%	102.0
	12268442	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	70.0	CHEMBL3094	Homo sapiens	Residual Activity	%	70.0
	12268443	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	106.0	CHEMBL3094	Homo sapiens	Residual Activity	%	106.0
	12268444	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	102.0	CHEMBL3094	Homo sapiens	Residual Activity	%	102.0
	12268445	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	79.0	CHEMBL3094	Homo sapiens	Residual Activity	%	79.0
	12268446	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	64.0	CHEMBL3094	Homo sapiens	Residual Activity	%	64.0
	12268447	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	42.0	CHEMBL3094	Homo sapiens	Residual Activity	%	42.0
	12268448	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	104.0	CHEMBL3094	Homo sapiens	Residual Activity	%	104.0
	12268449	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	40.0	CHEMBL3094	Homo sapiens	Residual Activity	%	40.0
	12268450	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	24.0	CHEMBL3094	Homo sapiens	Residual Activity	%	24.0
	12268451	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	90.0	CHEMBL3094	Homo sapiens	Residual Activity	%	90.0
	12268452	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	101.0	CHEMBL3094	Homo sapiens	Residual Activity	%	101.0
	12268453	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	63.0	CHEMBL3094	Homo sapiens	Residual Activity	%	63.0
	12268454	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	79.0	CHEMBL3094	Homo sapiens	Residual Activity	%	79.0
	12268455	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	74.0	CHEMBL3094	Homo sapiens	Residual Activity	%	74.0
	12268456	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	84.0	CHEMBL3094	Homo sapiens	Residual Activity	%	84.0
	12268457	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	49.0	CHEMBL3094	Homo sapiens	Residual Activity	%	49.0
	12268458	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	111.0	CHEMBL3094	Homo sapiens	Residual Activity	%	111.0
	12268459	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	114.0	CHEMBL3094	Homo sapiens	Residual Activity	%	114.0
	12268460	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	112.0	CHEMBL3094	Homo sapiens	Residual Activity	%	112.0
	12268461	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	71.0	CHEMBL3094	Homo sapiens	Residual Activity	%	71.0
	12268462	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL3094	Homo sapiens	Residual Activity	%	0.0
	12268463	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	108.0	CHEMBL3094	Homo sapiens	Residual Activity	%	108.0
	12268464	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	104.0	CHEMBL3094	Homo sapiens	Residual Activity	%	104.0
	12268465	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	81.0	CHEMBL3094	Homo sapiens	Residual Activity	%	81.0
	12268466	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	115.0	CHEMBL3094	Homo sapiens	Residual Activity	%	115.0
	12268467	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	100.0	CHEMBL3094	Homo sapiens	Residual Activity	%	100.0
	12268468	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	124.0	CHEMBL3094	Homo sapiens	Residual Activity	%	124.0
	12268469	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	113.0	CHEMBL3094	Homo sapiens	Residual Activity	%	113.0
	12268470	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	70.0	CHEMBL3094	Homo sapiens	Residual Activity	%	70.0
	12268471	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	107.0	CHEMBL3094	Homo sapiens	Residual Activity	%	107.0
	12268472	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	115.0	CHEMBL3094	Homo sapiens	Residual Activity	%	115.0
	12268473	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	43.0	CHEMBL3094	Homo sapiens	Residual Activity	%	43.0
	12268474	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	65.0	CHEMBL3094	Homo sapiens	Residual Activity	%	65.0
	12268475	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	67.0	CHEMBL3094	Homo sapiens	Residual Activity	%	67.0
	12268476	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	116.0	CHEMBL3094	Homo sapiens	Residual Activity	%	116.0
	12268477	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	58.0	CHEMBL3094	Homo sapiens	Residual Activity	%	58.0
	12268478	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	53.0	CHEMBL3094	Homo sapiens	Residual Activity	%	53.0
	12268479	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	112.0	CHEMBL3094	Homo sapiens	Residual Activity	%	112.0
	12268480	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	112.0	CHEMBL3094	Homo sapiens	Residual Activity	%	112.0
	12268481	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	80.0	CHEMBL3094	Homo sapiens	Residual Activity	%	80.0
	12268482	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	124.0	CHEMBL3094	Homo sapiens	Residual Activity	%	124.0
	12268483	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	88.0	CHEMBL3094	Homo sapiens	Residual Activity	%	88.0
	12268484	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	117.0	CHEMBL3094	Homo sapiens	Residual Activity	%	117.0
	12268485	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	27.0	CHEMBL3094	Homo sapiens	Residual Activity	%	27.0
	12268486	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	90.0	CHEMBL3094	Homo sapiens	Residual Activity	%	90.0
	12268487	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	59.0	CHEMBL3094	Homo sapiens	Residual Activity	%	59.0
	12268488	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	69.0	CHEMBL3094	Homo sapiens	Residual Activity	%	69.0
	12268489	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	108.0	CHEMBL3094	Homo sapiens	Residual Activity	%	108.0
	12268490	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	2.0	CHEMBL3094	Homo sapiens	Residual Activity	%	2.0
	12268491	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	102.0	CHEMBL3094	Homo sapiens	Residual Activity	%	102.0
	12268492	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	85.0	CHEMBL3094	Homo sapiens	Residual Activity	%	85.0
	12268493	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	14.0	CHEMBL3094	Homo sapiens	Residual Activity	%	14.0
	12268494	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	98.0	CHEMBL3094	Homo sapiens	Residual Activity	%	98.0
	12268495	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	71.0	CHEMBL3094	Homo sapiens	Residual Activity	%	71.0
	12268496	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	56.0	CHEMBL3094	Homo sapiens	Residual Activity	%	56.0
	12268497	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	105.0	CHEMBL3094	Homo sapiens	Residual Activity	%	105.0
	12268498	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	12.0	CHEMBL3094	Homo sapiens	Residual Activity	%	12.0
	12268499	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	90.0	CHEMBL3094	Homo sapiens	Residual Activity	%	90.0
	12268500	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	44.0	CHEMBL3094	Homo sapiens	Residual Activity	%	44.0
	12268501	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	90.0	CHEMBL3094	Homo sapiens	Residual Activity	%	90.0
	12268502	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	88.0	CHEMBL3094	Homo sapiens	Residual Activity	%	88.0
	12268503	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	62.0	CHEMBL3094	Homo sapiens	Residual Activity	%	62.0
	12268504	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	94.0	CHEMBL3094	Homo sapiens	Residual Activity	%	94.0
	12268505	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	89.0	CHEMBL3094	Homo sapiens	Residual Activity	%	89.0
	12268506	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	73.0	CHEMBL3094	Homo sapiens	Residual Activity	%	73.0
	12268507	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	94.0	CHEMBL3094	Homo sapiens	Residual Activity	%	94.0
	12268508	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	30.0	CHEMBL3094	Homo sapiens	Residual Activity	%	30.0
	12268509	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	91.0	CHEMBL3094	Homo sapiens	Residual Activity	%	91.0
	12268510	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	94.0	CHEMBL3094	Homo sapiens	Residual Activity	%	94.0
	12268511	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	63.0	CHEMBL3094	Homo sapiens	Residual Activity	%	63.0
	12268512	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	28.0	CHEMBL3094	Homo sapiens	Residual Activity	%	28.0
	12268513	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	77.0	CHEMBL3094	Homo sapiens	Residual Activity	%	77.0
	12268514	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	76.0	CHEMBL3094	Homo sapiens	Residual Activity	%	76.0
	12268515	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	93.0	CHEMBL3094	Homo sapiens	Residual Activity	%	93.0
	12268516	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	90.0	CHEMBL3094	Homo sapiens	Residual Activity	%	90.0
	12268517	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	80.0	CHEMBL3094	Homo sapiens	Residual Activity	%	80.0
	12268518	CHEMBL2219128	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	101.0	CHEMBL3094	Homo sapiens	Residual Activity	%	101.0
	12647867	CHEMBL2329059	Inhibition of PRAK (unknown origin) at 1 uM	B	CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325895	=	Inhibition	%	4.0	CHEMBL3094	Homo sapiens	INH	%	4.0
	12647868	CHEMBL2329059	Inhibition of PRAK (unknown origin) at 1 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	-2.0	CHEMBL3094	Homo sapiens	INH	%	-2.0
	12647869	CHEMBL2329059	Inhibition of PRAK (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C#N		CHEMBL2325906	=	Inhibition	%	1.0	CHEMBL3094	Homo sapiens	INH	%	1.0
	12647870	CHEMBL2329059	Inhibition of PRAK (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C		CHEMBL2325903	=	Inhibition	%	7.0	CHEMBL3094	Homo sapiens	INH	%	7.0
	12649561	CHEMBL2329518	Inhibition of PRAK (unknown origin) at 10 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	-3.0	CHEMBL3094	Homo sapiens	INH	%	-3.0
	12649562	CHEMBL2329518	Inhibition of PRAK (unknown origin) at 10 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)O		CHEMBL2325904	=	Inhibition	%	23.0	CHEMBL3094	Homo sapiens	INH	%	23.0
	12649563	CHEMBL2329518	Inhibition of PRAK (unknown origin) at 10 uM	B	CC(C)NC(=O)c1c[nH]c2ncc(C3CC3)nc12		CHEMBL2325901	=	Inhibition	%	24.0	CHEMBL3094	Homo sapiens	INH	%	24.0
	12672911	CHEMBL2341623	Inhibition of recombinant PRAK (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	74.0	CHEMBL3094	Homo sapiens	Activity	%	74.0
	12672912	CHEMBL2341623	Inhibition of recombinant PRAK (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	76.0	CHEMBL3094	Homo sapiens	Activity	%	76.0
	12693179	CHEMBL2345780	Inhibition of PRAK (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	nM	10000.0
	12727678	CHEMBL2351142	Inhibition of PRAK (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	94.0	CHEMBL3094	Homo sapiens	Activity	%	94.0
	12728964	CHEMBL2349898	Inhibition of PRAK (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	96.0	CHEMBL3094	Homo sapiens	Activity	%	96.0
	12729911	CHEMBL2350056	Inhibition of MAPKAPK5 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	87.0	CHEMBL3094	Homo sapiens	Activity	%	87.0
	12730107	CHEMBL2351142	Inhibition of PRAK (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	94.0	CHEMBL3094	Homo sapiens	Activity	%	94.0
	13281281	CHEMBL2378206	Inhibition of PRAK (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3ncn4cc(F)cc(F)c34)nc12)C(=O)N1CC(C#N)C1	Outside typical range	CHEMBL2376158	=	Inhibition	%	-12.0	CHEMBL3094	Homo sapiens	INH	%	-12.0
	13281282	CHEMBL2378206	Inhibition of PRAK (unknown origin) at 10 uM relative to control	B	Cn1nc(-c2cnc3[nH]cc(C(=O)N[C@@H](C(=O)N4CC(C#N)C4)C4CC4)c3n2)c2ccc(Cl)cc21		CHEMBL2376154	=	Inhibition	%	22.0	CHEMBL3094	Homo sapiens	INH	%	22.0
	13281283	CHEMBL2378206	Inhibition of PRAK (unknown origin) at 10 uM relative to control	B	CC[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376153	=	Inhibition	%	0.0	CHEMBL3094	Homo sapiens	INH	%	0.0
	13281284	CHEMBL2378206	Inhibition of PRAK (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376152	=	Inhibition	%	-2.0	CHEMBL3094	Homo sapiens	INH	%	-2.0
	13281285	CHEMBL2378206	Inhibition of PRAK (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376144	=	Inhibition	%	-4.0	CHEMBL3094	Homo sapiens	INH	%	-4.0
	13281286	CHEMBL2378206	Inhibition of PRAK (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3cn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376143	=	Inhibition	%	1.0	CHEMBL3094	Homo sapiens	INH	%	1.0
	13351570	CHEMBL2399774	Inhibition of human PRAK at 10 uM relative to control	B	Cl.O=c1[nH]nc2c(NCCCc3ccncc3)cc(Cl)cn12		CHEMBL2397859	=	Inhibition	%	14.0	CHEMBL3094	Homo sapiens	INH	%	14.0
	13375786	CHEMBL2404180	Inhibition of MAPKAPK5 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	3.0	CHEMBL3094	Homo sapiens	INH	%	3.0
	13415527	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	41.0	CHEMBL3094	Homo sapiens	INH	%	41.0
	13415528	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1)N1CCOCC1		CHEMBL2420907	=	Inhibition	%	14.0	CHEMBL3094	Homo sapiens	INH	%	14.0
	13415529	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CN(C)C(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420906	=	Inhibition	%	18.0	CHEMBL3094	Homo sapiens	INH	%	18.0
	13415530	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CNC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420905	=	Inhibition	%	21.0	CHEMBL3094	Homo sapiens	INH	%	21.0
	13415531	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OCC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2417586	=	Inhibition	%	43.0	CHEMBL3094	Homo sapiens	INH	%	43.0
	13415532	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420904	=	Inhibition	%	0.0	CHEMBL3094	Homo sapiens	INH	%	0.0
	13415533	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	COC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420903	=	Inhibition	%	21.0	CHEMBL3094	Homo sapiens	INH	%	21.0
	13415534	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420902	=	Inhibition	%	23.0	CHEMBL3094	Homo sapiens	INH	%	23.0
	13415535	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	7.0	CHEMBL3094	Homo sapiens	INH	%	7.0
	13415536	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	8.0	CHEMBL3094	Homo sapiens	INH	%	8.0
	13415537	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	18.0	CHEMBL3094	Homo sapiens	INH	%	18.0
	13415538	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CC1)CC(O)CCN2		CHEMBL2420898	=	Inhibition	%	18.0	CHEMBL3094	Homo sapiens	INH	%	18.0
	13415539	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCNC2(CCN(c3ncnc4[nH]cnc34)CC2)C1		CHEMBL2420897	=	Inhibition	%	32.0	CHEMBL3094	Homo sapiens	INH	%	32.0
	13415540	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCC(O)CN2)CC1		CHEMBL2420928	=	Inhibition	%	49.0	CHEMBL3094	Homo sapiens	INH	%	49.0
	13415541	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420927	=	Inhibition	%	30.0	CHEMBL3094	Homo sapiens	INH	%	30.0
	13415542	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCOC3)CC2)c2nc[nH]c2n1		CHEMBL2420926	=	Inhibition	%	9.0	CHEMBL3094	Homo sapiens	INH	%	9.0
	13415543	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCO3)CC2)c2nc[nH]c2n1		CHEMBL2420925	=	Inhibition	%	24.0	CHEMBL3094	Homo sapiens	INH	%	24.0
	13415544	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCC3)CC2)c2nc[nH]c2n1		CHEMBL2420924	=	Inhibition	%	6.0	CHEMBL3094	Homo sapiens	INH	%	6.0
	13415545	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC12CCNCC2		CHEMBL2420923	=	Inhibition	%	7.0	CHEMBL3094	Homo sapiens	INH	%	7.0
	13415546	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCCNC2)C1		CHEMBL2420922	=	Inhibition	%	5.0	CHEMBL3094	Homo sapiens	INH	%	5.0
	13415547	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCNCC2)C1		CHEMBL2420921	=	Inhibition	%	0.0	CHEMBL3094	Homo sapiens	INH	%	0.0
	13415548	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCNC2)CC1		CHEMBL2420920	=	Inhibition	%	18.0	CHEMBL3094	Homo sapiens	INH	%	18.0
	13415549	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCNC2)CC1		CHEMBL2420919	=	Inhibition	%	11.0	CHEMBL3094	Homo sapiens	INH	%	11.0
	13415550	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCN2)CC1		CHEMBL2420918	=	Inhibition	%	15.0	CHEMBL3094	Homo sapiens	INH	%	15.0
	13415551	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCCN2)CC1		CHEMBL2420917	=	Inhibition	%	25.0	CHEMBL3094	Homo sapiens	INH	%	25.0
	13415552	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(S(=O)(=O)c2cccc3cnccc23)CC1		CHEMBL2420916	=	Inhibition	%	0.0	CHEMBL3094	Homo sapiens	INH	%	0.0
	13415553	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC23CCNCC3)c2nc[nH]c2n1		CHEMBL2420915	=	Inhibition	%	8.0	CHEMBL3094	Homo sapiens	INH	%	8.0
	13415554	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCCNC3)C2)c2nc[nH]c2n1		CHEMBL2420914	=	Inhibition	%	8.0	CHEMBL3094	Homo sapiens	INH	%	8.0
	13415555	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCNCC3)C2)c2nc[nH]c2n1		CHEMBL2420913	=	Inhibition	%	3.0	CHEMBL3094	Homo sapiens	INH	%	3.0
	13415556	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420912	=	Inhibition	%	41.0	CHEMBL3094	Homo sapiens	INH	%	41.0
	13415557	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420911	=	Inhibition	%	51.0	CHEMBL3094	Homo sapiens	INH	%	51.0
	13415558	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420910	=	Inhibition	%	29.0	CHEMBL3094	Homo sapiens	INH	%	29.0
	13415559	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420909	=	Inhibition	%	11.0	CHEMBL3094	Homo sapiens	INH	%	11.0
	13415560	CHEMBL2424331	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL2420908	=	Inhibition	%	40.0	CHEMBL3094	Homo sapiens	INH	%	40.0
	13418842	CHEMBL2422671	Inhibition of MAPKAPK5 (unknown origin)	B	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	=	IC50	nM	100.0	CHEMBL3094	Homo sapiens	pIC50		7.0
	13419691	CHEMBL2422263	Inhibition of PRAK (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	12.0	CHEMBL3094	Homo sapiens	INH	%	12.0
	13419692	CHEMBL2422263	Inhibition of PRAK (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	8.0	CHEMBL3094	Homo sapiens	INH	%	8.0
	13419693	CHEMBL2422263	Inhibition of PRAK (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	14.0	CHEMBL3094	Homo sapiens	INH	%	14.0
	13420989	CHEMBL2424122	Inhibition of PRAK (unknown origin) by microfluidic mobility shift assay	B	c1nc(N2CCC3(CCCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420911	=	IC50	nM	41000.0	CHEMBL3094	Homo sapiens	IC50	uM	41.0
	13420990	CHEMBL2424122	Inhibition of PRAK (unknown origin) by microfluidic mobility shift assay	B	c1nc(N2CCC3(CCCCN3)CC2)c2nc[nH]c2n1	Outside typical range	CHEMBL2420909	=	IC50	nM	226000.0	CHEMBL3094	Homo sapiens	IC50	uM	226.0
	13439821	CHEMBL2426966	Competitive binding affinity to MAPKAPK5 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	13440835	CHEMBL2429578	Inhibition of PRAK (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc4c(N)ncnc43)cc2)cc1	Outside typical range	CHEMBL2425144	=	Inhibition	%	-12.0	CHEMBL3094	Homo sapiens	INH	%	-12.0
	13445654	CHEMBL2426966	Competitive binding affinity to MAPKAPK5 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	13451641	CHEMBL2426966	Competitive binding affinity to MAPKAPK5 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	13453013	CHEMBL2429578	Inhibition of PRAK (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cccnc3)cc2)cc1		CHEMBL2425156	=	Inhibition	%	-8.0	CHEMBL3094	Homo sapiens	INH	%	-8.0
	13453061	CHEMBL2429578	Inhibition of PRAK (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc(C)c3)cc2)cc1		CHEMBL2425145	=	Inhibition	%	-10.0	CHEMBL3094	Homo sapiens	INH	%	-10.0
	13464319	CHEMBL2433450	Inhibition of human PRAK assessed as residual activity at 1 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	82.0	CHEMBL3094	Homo sapiens	Activity	%	82.0
	13464346	CHEMBL2433479	Inhibition of human PRAK assessed as residual activity at 10 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	88.0	CHEMBL3094	Homo sapiens	Activity	%	88.0
	13465290	CHEMBL2432957	Inhibition of human PRAK assessed as residual activity at 25 uM relative to control	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	82.0	CHEMBL3094	Homo sapiens	Activity	%	82.0
	13465313	CHEMBL2433479	Inhibition of human PRAK assessed as residual activity at 10 uM relative to control	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	77.0	CHEMBL3094	Homo sapiens	Activity	%	77.0
	13465339	CHEMBL2433450	Inhibition of human PRAK assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	82.42	CHEMBL3094	Homo sapiens	Activity	%	82.42
	13465370	CHEMBL2433479	Inhibition of human PRAK assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	83.65	CHEMBL3094	Homo sapiens	Activity	%	83.65
	13465401	CHEMBL2433450	Inhibition of human PRAK assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	94.52	CHEMBL3094	Homo sapiens	Activity	%	94.52
	13465432	CHEMBL2433479	Inhibition of human PRAK assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	89.36	CHEMBL3094	Homo sapiens	Activity	%	89.36
Not Active	13508498	CHEMBL2447372	Inhibition of MAPKAPK5 (unknown origin) at 30 uM	B	O=C(Nc1ccc2c(c1)B(O)OC2)c1c(C(F)(F)F)ccc(Cl)c1F		CHEMBL2441375		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
	13871765	CHEMBL3100930	Inhibition of human PRAK assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	105.0	CHEMBL3094	Homo sapiens	Activity	%	105.0
	13953213	CHEMBL3132632	Inhibition of human PRAK assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	115.0	CHEMBL3094	Homo sapiens	Activity	%	115.0
	13953216	CHEMBL3132632	Inhibition of human PRAK assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	112.0	CHEMBL3094	Homo sapiens	Activity	%	112.0
	13953252	CHEMBL3132632	Inhibition of human PRAK assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	102.0	CHEMBL3094	Homo sapiens	Activity	%	102.0
	13966038	CHEMBL3136653	Inhibition of human full length PRAK expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	77.0	CHEMBL3094	Homo sapiens	INH	%	77.0
	13973313	CHEMBL3135051	Inhibition of human full length PRAK expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	3.5	CHEMBL3094	Homo sapiens	INH	%	3.5
	13974031	CHEMBL3136623	Inhibition of human full length PRAK expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	4.0	CHEMBL3094	Homo sapiens	INH	%	4.0
	13974122	CHEMBL3135768	Inhibition of human full length PRAK expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	0.0	CHEMBL3094	Homo sapiens	INH	%	0.0
	13974213	CHEMBL3135286	Inhibition of human full length PRAK expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	51.5	CHEMBL3094	Homo sapiens	INH	%	51.5
	13974951	CHEMBL3136973	Inhibition of human full length PRAK expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	40.0	CHEMBL3094	Homo sapiens	INH	%	40.0
	13975042	CHEMBL3136120	Inhibition of human full length PRAK expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	0.0	CHEMBL3094	Homo sapiens	INH	%	0.0
	13975133	CHEMBL3135844	Inhibition of human full length PRAK expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	0.0	CHEMBL3094	Homo sapiens	INH	%	0.0
	13975224	CHEMBL3136382	Inhibition of human full length PRAK expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	7.0	CHEMBL3094	Homo sapiens	INH	%	7.0
	13975867	CHEMBL3135482	Inhibition of human full length PRAK expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	51.5	CHEMBL3094	Homo sapiens	INH	%	51.5
	13975960	CHEMBL3137014	Inhibition of human full length PRAK expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	8.5	CHEMBL3094	Homo sapiens	INH	%	8.5
	13976051	CHEMBL3135407	Inhibition of human full length PRAK expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	35.0	CHEMBL3094	Homo sapiens	INH	%	35.0
	13976142	CHEMBL3135079	Inhibition of human full length PRAK expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	20.5	CHEMBL3094	Homo sapiens	INH	%	20.5
	14582545	CHEMBL3242546	Inhibition of human MAPKAP-K5 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	104.0	CHEMBL3094	Homo sapiens	Activity	%	104.0
	14593767	CHEMBL3241183	Inhibition of human MAPKAPK5	B	Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3133821	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	14648086	CHEMBL3266644	Inhibition of human PRAK at 1 uM relative to control	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	14648087	CHEMBL3266644	Inhibition of human PRAK at 1 uM relative to control	B	N[C@H]1CC[C@H](Nc2ccc3ncc(-c4cnc(Nc5ncccc5F)nc4)n3n2)CC1		CHEMBL3264059	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	15018680	CHEMBL3361572	Inhibition of PRAK (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	3.5	CHEMBL3094	Homo sapiens	INH	%	3.5
	15072463	CHEMBL3380111	Inhibition of PRAK (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	88.0	CHEMBL3094	Homo sapiens	Activity	%	88.0
	15112139	CHEMBL3388151	Inhibition of MAPKAPK5 (unknown origin)	B	COc1ccc(-c2cccc3nc(NC(=O)C4CC4)nn23)cc1		CHEMBL3360318	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	nM	10000.0
	15122495	CHEMBL3367701	Inhibition of human PRAK assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3ccc(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331445	=	Activity	%	36.0	CHEMBL3094	Homo sapiens	Activity	%	36.0
	15126972	CHEMBL3367701	Inhibition of human PRAK assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3cc(O)c(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331446	=	Activity	%	28.0	CHEMBL3094	Homo sapiens	Activity	%	28.0
	15127004	CHEMBL3367701	Inhibition of human PRAK assessed as residual activity at 10 uM by KinaseProfiler assay	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Activity	%	60.0	CHEMBL3094	Homo sapiens	Activity	%	60.0
	15150083	CHEMBL3395948	Inhibition of MAPKAPK5 (MK5) (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	15150084	CHEMBL3395948	Inhibition of MAPKAPK5 (MK5) (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	15150085	CHEMBL3395948	Inhibition of MAPKAPK5 (MK5) (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	15150086	CHEMBL3395948	Inhibition of MAPKAPK5 (MK5) (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	15150087	CHEMBL3395948	Inhibition of MAPKAPK5 (MK5) (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	15191027	CHEMBL3412794	Inhibition of MAPKAPK5 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1NC(=S)Nc1ccccc1		CHEMBL3408381	=	Inhibition	%	2.0	CHEMBL3094	Homo sapiens	INH	%	2.0
	15191028	CHEMBL3412794	Inhibition of MAPKAPK5 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(-c2ccccc2)nn1-c1ccccc1		CHEMBL3408382	=	Inhibition	%	21.0	CHEMBL3094	Homo sapiens	INH	%	21.0
	15191029	CHEMBL3412794	Inhibition of MAPKAPK5 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408383	=	Inhibition	%	4.0	CHEMBL3094	Homo sapiens	INH	%	4.0
	15191030	CHEMBL3412794	Inhibition of MAPKAPK5 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408384	=	Inhibition	%	5.0	CHEMBL3094	Homo sapiens	INH	%	5.0
	15191031	CHEMBL3412794	Inhibition of MAPKAPK5 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	COc1ccc(-n2nc(C(C)=O)s/c2=N\c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)cc1		CHEMBL3408385	=	Inhibition	%	6.0	CHEMBL3094	Homo sapiens	INH	%	6.0
	15191032	CHEMBL3412794	Inhibition of MAPKAPK5 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408386	=	Inhibition	%	8.0	CHEMBL3094	Homo sapiens	INH	%	8.0
	15191033	CHEMBL3412794	Inhibition of MAPKAPK5 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408387	=	Inhibition	%	9.0	CHEMBL3094	Homo sapiens	INH	%	9.0
	15191034	CHEMBL3412794	Inhibition of MAPKAPK5 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408388	=	Inhibition	%	0.0	CHEMBL3094	Homo sapiens	INH	%	0.0
	15191035	CHEMBL3412794	Inhibition of MAPKAPK5 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408389	=	Inhibition	%	0.0	CHEMBL3094	Homo sapiens	INH	%	0.0
	15191036	CHEMBL3412794	Inhibition of MAPKAPK5 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(C(=O)Nc2ccccc2)nn1-c1ccccc1		CHEMBL3408390	=	Inhibition	%	0.0	CHEMBL3094	Homo sapiens	INH	%	0.0
	15191037	CHEMBL3412794	Inhibition of MAPKAPK5 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\SCC(=O)N1c1ccccc1		CHEMBL3408391	=	Inhibition	%	2.0	CHEMBL3094	Homo sapiens	INH	%	2.0
	15191038	CHEMBL3412794	Inhibition of MAPKAPK5 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\scc(-c2ccccc2)n1-c1ccccc1		CHEMBL3408392	=	Inhibition	%	21.0	CHEMBL3094	Homo sapiens	INH	%	21.0
	15191039	CHEMBL3412794	Inhibition of MAPKAPK5 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(c3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408393	=	Inhibition	%	5.0	CHEMBL3094	Homo sapiens	INH	%	5.0
	15191040	CHEMBL3412794	Inhibition of MAPKAPK5 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408394	=	Inhibition	%	3.0	CHEMBL3094	Homo sapiens	INH	%	3.0
	15191041	CHEMBL3412794	Inhibition of MAPKAPK5 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408395	=	Inhibition	%	3.0	CHEMBL3094	Homo sapiens	INH	%	3.0
	15191042	CHEMBL3412794	Inhibition of MAPKAPK5 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(C(=O)Nc3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408396	=	Inhibition	%	0.0	CHEMBL3094	Homo sapiens	INH	%	0.0
	15251863	CHEMBL3427945	Inhibition of PRAK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	60.0	CHEMBL3094	Homo sapiens	Activity	%	60.0
	15251934	CHEMBL3427945	Inhibition of PRAK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	22.0	CHEMBL3094	Homo sapiens	Activity	%	22.0
	15252036	CHEMBL3427945	Inhibition of PRAK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	74.0	CHEMBL3094	Homo sapiens	Activity	%	74.0
	15252681	CHEMBL3427945	Inhibition of PRAK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	67.0	CHEMBL3094	Homo sapiens	Activity	%	67.0
	15252783	CHEMBL3427945	Inhibition of PRAK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	59.0	CHEMBL3094	Homo sapiens	Activity	%	59.0
	15252885	CHEMBL3427945	Inhibition of PRAK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	62.0	CHEMBL3094	Homo sapiens	Activity	%	62.0
	15253559	CHEMBL3427945	Inhibition of PRAK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	85.0	CHEMBL3094	Homo sapiens	Activity	%	85.0
	15253661	CHEMBL3427945	Inhibition of PRAK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	95.0	CHEMBL3094	Homo sapiens	Activity	%	95.0
	15253763	CHEMBL3427945	Inhibition of PRAK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	68.0	CHEMBL3094	Homo sapiens	Activity	%	68.0
	15254429	CHEMBL3427945	Inhibition of PRAK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	18.0	CHEMBL3094	Homo sapiens	Activity	%	18.0
	15254531	CHEMBL3427945	Inhibition of PRAK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	79.0	CHEMBL3094	Homo sapiens	Activity	%	79.0
	15254633	CHEMBL3427945	Inhibition of PRAK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	53.0	CHEMBL3094	Homo sapiens	Activity	%	53.0
	15255324	CHEMBL3427945	Inhibition of PRAK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	83.0	CHEMBL3094	Homo sapiens	Activity	%	83.0
	15255426	CHEMBL3427945	Inhibition of PRAK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	85.0	CHEMBL3094	Homo sapiens	Activity	%	85.0
	15255529	CHEMBL3427945	Inhibition of PRAK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	72.0	CHEMBL3094	Homo sapiens	Activity	%	72.0
	15256260	CHEMBL3427945	Inhibition of PRAK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	69.0	CHEMBL3094	Homo sapiens	Activity	%	69.0
	15756927	CHEMBL3631283	Inhibition of MAPKAPK5 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	-1.68	CHEMBL3094	Homo sapiens	INH	%	-1.68
	15757796	CHEMBL3631283	Inhibition of MAPKAPK5 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	4.25	CHEMBL3094	Homo sapiens	INH	%	4.25
	15758775	CHEMBL3631283	Inhibition of MAPKAPK5 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	5.26	CHEMBL3094	Homo sapiens	INH	%	5.26
321194	16291962	CHEMBL3707610	IMAP Assay: The ability of compounds to inhibit activated phospho-p38alpha is evaluated using a p38alpha /MK2 and a p38alpha /PRAK cascade assay format. The kinase activity of p38alpha is determined by its ability to phosphorylate GST-MK2 or GST-PRAK. Activation of MK2 or PRAK by p38alpha is quantitated by measuring the phosphorylation of a fluorescently-labeled, MK2/PRAK specific peptide substrate, Hsp27 peptide (FITC-KKKALSRQLSVAA). The phosphorylation of the Hsp27 peptide is quantified using IMAP technology (Molecular Devices, Sunnyvale Calif.). Kinase reactions are carried out in a 384-well plate (Greiner, 781280) in 20 mM HEPES pH 7.5, 10 mM MgCl2, 0.01% Triton X-100, 0.01% BSA, 1 mM DTT, and 2% DMSO. The inhibitor concentration is varied between 0.02-30,000 nM, while the Hsp27 peptide substrate and MgATP are held constant at 1 uM and 10 uM, respectively. Activated p38alpha is added to a final concentration of 30 uM for reactions with nonphosphorylated 1 nM GST-MK2.	B	Cc1cnc(-c2ccnc(C(C)(C)O)n2)cc1-n1c(C)cc(OCc2ncc(F)cc2F)c(Cl)c1=O		CHEMBL3704901	=	IC50	nM	8100.0	CHEMBL3094	Homo sapiens	IC50	nM	8100.0
	16376478	CHEMBL3734502	Inhibition of recombinant human PRAK using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay	B	Cl.NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL3732044	=	Inhibition	%	4.0	CHEMBL3094	Homo sapiens	INH	%	4.0
	16397406	CHEMBL3743116	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3739750	=	Inhibition	%	43.0	CHEMBL3094	Homo sapiens	INH	%	43.0
	16397407	CHEMBL3743116	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740247	=	Inhibition	%	65.0	CHEMBL3094	Homo sapiens	INH	%	65.0
	16397408	CHEMBL3743116	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3739587	=	Inhibition	%	45.0	CHEMBL3094	Homo sapiens	INH	%	45.0
	16397409	CHEMBL3743116	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740131	=	Inhibition	%	54.0	CHEMBL3094	Homo sapiens	INH	%	54.0
	16397410	CHEMBL3743116	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3742349	=	Inhibition	%	34.0	CHEMBL3094	Homo sapiens	INH	%	34.0
	16397411	CHEMBL3743116	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3741526	=	Inhibition	%	98.0	CHEMBL3094	Homo sapiens	INH	%	98.0
	16397412	CHEMBL3743116	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1C(=O)Nc1ccccc1		CHEMBL3740930	=	Inhibition	%	54.0	CHEMBL3094	Homo sapiens	INH	%	54.0
	16397413	CHEMBL3743116	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc(C(=O)c3c(C)[nH]c(-c4ccccc4)c3-c3ccccc3)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL3740713	=	Inhibition	%	34.0	CHEMBL3094	Homo sapiens	INH	%	34.0
	16397414	CHEMBL3743116	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccc(Cl)cc2)nc1C(=O)Nc1ccccc1		CHEMBL3740385	=	Inhibition	%	56.0	CHEMBL3094	Homo sapiens	INH	%	56.0
	16397415	CHEMBL3743116	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1-c1ccccc1		CHEMBL3741069	=	Inhibition	%	56.0	CHEMBL3094	Homo sapiens	INH	%	56.0
	16397416	CHEMBL3743116	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccccc3)cc12		CHEMBL3740582	=	Inhibition	%	56.0	CHEMBL3094	Homo sapiens	INH	%	56.0
	16397417	CHEMBL3743116	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc3c(-c4c(C)[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(C)c3n2)cc1		CHEMBL3742060	=	Inhibition	%	43.0	CHEMBL3094	Homo sapiens	INH	%	43.0
	16397418	CHEMBL3743116	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccc(Cl)cc3)cc12		CHEMBL3741655	=	Inhibition	%	46.0	CHEMBL3094	Homo sapiens	INH	%	46.0
	16397419	CHEMBL3743116	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccccc3)nc12		CHEMBL3740923	=	Inhibition	%	32.0	CHEMBL3094	Homo sapiens	INH	%	32.0
	16397420	CHEMBL3743116	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc3c(-c4c[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(O)c3n2)cc1		CHEMBL3739586	=	Inhibition	%	34.0	CHEMBL3094	Homo sapiens	INH	%	34.0
	16397421	CHEMBL3743116	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccc(Cl)cc3)nc12		CHEMBL3742200	=	Inhibition	%	34.0	CHEMBL3094	Homo sapiens	INH	%	34.0
	16397422	CHEMBL3743116	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1ccc(NC(=O)c2ccccc2)c(=O)o1		CHEMBL3740003	=	Inhibition	%	43.0	CHEMBL3094	Homo sapiens	INH	%	43.0
	16397423	CHEMBL3743116	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1c(C(=O)c2coc3ccc(O)cc23)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3741960	=	Inhibition	%	56.0	CHEMBL3094	Homo sapiens	INH	%	56.0
	16397424	CHEMBL3743116	Inhibition of MAPKAPK5 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1c(C(=O)c2coc3c2cc(O)c2ccccc23)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740492	=	Inhibition	%	54.0	CHEMBL3094	Homo sapiens	INH	%	54.0
	16413505	CHEMBL3742675	Inhibition of PRAK (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	16421932	CHEMBL3750414	Inhibition of MK5 (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	16425298	CHEMBL3751086	Inhibition of PRAK (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	2.0	CHEMBL3094	Homo sapiens	INH	%	2.0
	16431891	CHEMBL3747984	Inhibition of human MAPKAPK5 using [KKLNRTLSVA] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	16451588	CHEMBL3761169	Inhibition of PRAK (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	5.7	CHEMBL3094	Homo sapiens	INH	%	5.7
	16474698	CHEMBL3767318	Inhibition of MAPKAPK5 (unknown origin) at 10 uM	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(F)cc5)cc4)SC3=S)cc2)CC1		CHEMBL3765499	=	Inhibition	%	5.2	CHEMBL3094	Homo sapiens	INH	%	5.2
	16495198	CHEMBL3777526	Inhibition of N-terminal His6-tagged recombinant human PRAK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-16.0	CHEMBL3094	Homo sapiens	Activity	%	-16.0
	16496117	CHEMBL3777526	Inhibition of N-terminal His6-tagged recombinant human PRAK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-2.0	CHEMBL3094	Homo sapiens	Activity	%	-2.0
	16508907	CHEMBL3777526	Inhibition of N-terminal His6-tagged recombinant human PRAK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	2.0	CHEMBL3094	Homo sapiens	Activity	%	2.0
	16540877	CHEMBL3790004	Inhibition of MAPKAPK5 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	16540878	CHEMBL3790004	Inhibition of MAPKAPK5 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787614	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	16540879	CHEMBL3790004	Inhibition of MAPKAPK5 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	3700.0	CHEMBL3094	Homo sapiens	IC50	uM	3.7
	16540880	CHEMBL3790004	Inhibition of MAPKAPK5 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3785500	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	16540881	CHEMBL3790004	Inhibition of MAPKAPK5 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	16593503	CHEMBL3812357	Inhibition of His-tagged full length human recombinant MAPKAPK5 expressed in baculovirus at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL3094	Homo sapiens	INH	%	40.0
	16612687	CHEMBL3815724	Inhibition of human PRAK (1 to 471 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-17.0	CHEMBL3094	Homo sapiens	Activity	%	-17.0
	16612688	CHEMBL3815724	Inhibition of human PRAK (1 to 471 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	2.0	CHEMBL3094	Homo sapiens	Activity	%	2.0
	16612689	CHEMBL3815724	Inhibition of human PRAK (1 to 471 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	4.0	CHEMBL3094	Homo sapiens	Activity	%	4.0
	16612690	CHEMBL3815724	Inhibition of human PRAK (1 to 471 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-10.0	CHEMBL3094	Homo sapiens	Activity	%	-10.0
	16614528	CHEMBL3816726	Inhibition of human MAPKAPK5 at 1 uM using [KKLNRTLSVA] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-5.0	CHEMBL3094	Homo sapiens	INH	%	-5.0
	16628512	CHEMBL3820628	Inhibition of MAPKAPK5 (unknown origin) at 1 uM	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	<	Inhibition	%	80.0	CHEMBL3094	Homo sapiens	INH	%	80.0
	16654156	CHEMBL3829167	Inhibition of human PRAK (1 to 471 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	72.0	CHEMBL3094	Homo sapiens	Activity	%	72.0
	16837450	CHEMBL3876113	Inhibition of human recombinant full length His-tagged MAPKAPK5 expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	nM	10000.0
Inactive	17916975	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916976	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916977	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916978	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916979	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916980	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916981	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916982	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916983	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916984	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916985	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916986	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916987	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916988	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916989	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916990	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916991	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916992	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916993	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916994	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916995	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916996	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916997	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916998	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916999	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917000	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917001	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917002	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917003	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917004	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917005	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917006	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917007	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917008	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917009	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917010	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917011	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Active	17917012	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	272.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	272.0
Inactive	17917013	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Active	17917014	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	589.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	589.0
Inactive	17917015	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917016	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917017	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917018	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917019	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917020	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917021	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917022	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917023	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917024	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917025	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917026	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917027	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917028	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917029	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917030	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917031	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917032	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917033	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917034	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917035	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917036	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917037	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917038	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917039	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917040	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917041	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917042	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917043	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917044	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917045	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917046	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917047	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917048	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917049	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917050	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917051	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917052	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917053	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917054	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917055	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917056	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917057	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917058	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917059	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917060	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917061	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917062	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917063	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917064	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917065	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17917066	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	3118.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	3118.0
Inactive	17917067	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917068	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917069	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917070	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917071	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917072	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917073	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917074	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917075	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917076	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917077	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917078	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917079	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917080	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917081	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917082	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917083	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917084	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917085	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917086	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917087	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917088	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917089	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917090	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917091	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917092	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917093	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917094	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917095	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917096	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917097	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917098	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917099	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917100	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917101	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917102	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917103	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917104	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917105	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917106	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917107	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917108	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917109	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917110	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917111	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917112	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917113	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917114	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917115	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917116	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917117	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17917118	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	1114.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	1114.0
Inactive	17917119	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917120	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917121	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917122	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917123	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917124	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917125	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917126	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917127	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917128	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917129	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917130	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917131	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917132	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917133	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917134	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917135	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917136	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917137	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917138	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917139	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917140	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917141	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917142	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917143	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917144	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917145	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917146	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917147	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917148	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917149	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917150	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917151	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917152	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917153	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917154	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917155	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917156	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917157	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917158	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917159	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917160	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917161	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917162	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917163	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917164	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917165	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917166	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917167	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917168	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917169	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917170	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917171	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917172	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917173	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917174	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917175	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917176	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917177	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917178	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917179	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917180	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917181	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917182	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917183	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917184	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917185	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917186	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917187	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917188	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917189	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917190	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917191	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917192	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917193	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917194	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917195	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917196	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917197	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917198	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917199	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917200	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917201	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917202	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917203	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917204	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917205	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917206	CHEMBL3991780	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL3094	Homo sapiens	Kd apparent	nM	30000.0
	18114267	CHEMBL4025227	Inhibition of wild-type human partial length MAPKAPK5 (M1 to D322 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL3094	Homo sapiens	Activity	%	100.0
	18120794	CHEMBL4026678	Inhibition of full length recombinant human N-terminal His6-tagged PRAK expressed in baculovirus infected Sf21 cells	B	Cc1ccc(Oc2nc3cc(-c4ccc(-c5ccccc5)cc4)c(Cl)cc3[nH]2)cc1C(=O)O		CHEMBL4082745	<	IC50	nM	10000.0	CHEMBL3094	Homo sapiens	IC50	uM	10.0
	18203751	CHEMBL4044038	Inhibition of wild-type human partial length MAPKAPK5 (M1 to D322 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL3094	Homo sapiens	Activity	%	100.0
	18232127	CHEMBL4050375	Inhibition of human PRAK assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	92.0	CHEMBL3094	Homo sapiens	Activity	%	92.0
	18253863	CHEMBL4055216	Inhibition of wild-type human partial length MAPKAPK5 (M1 to D322 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL3094	Homo sapiens	Activity	%	100.0
	18253864	CHEMBL4055216	Inhibition of wild-type human partial length MAPKAPK5 (M1 to D322 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL3094	Homo sapiens	Activity	%	100.0
	18265756	CHEMBL4057206	Inhibition of PRAK (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-1.7	CHEMBL3094	Homo sapiens	INH	%	-1.7
	18265963	CHEMBL4057413	Inhibition of PRAK (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-0.3	CHEMBL3094	Homo sapiens	INH	%	-0.3
	18266190	CHEMBL4057640	Inhibition of PRAK (unknown origin) at 0.078 uM relative to control	B	COC(=O)Nc1noc2cc(-c3c(-c4ccccn4)n[nH]c3C)ccc12		CHEMBL4066592	=	Inhibition	%	-3.0	CHEMBL3094	Homo sapiens	INH	%	-3.0
Active	18275800	CHEMBL4118760	Binding affinity to MAPKAPK5 in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL3094	Homo sapiens	Activity		
Active	18275945	CHEMBL4118905	Binding affinity to MAPKAPK5 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL3094	Homo sapiens	Activity		
	18282213	CHEMBL4120168	Inhibition of full length recombinant His-tagged human PRAK expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	8.1	CHEMBL3094	Homo sapiens	INH	%	8.1
	18282532	CHEMBL4120168	Inhibition of full length recombinant His-tagged human PRAK expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	-0.8	CHEMBL3094	Homo sapiens	INH	%	-0.8
	18282667	CHEMBL4120252	Inhibition of PRAK (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-1.7	CHEMBL3094	Homo sapiens	INH	%	-1.7
	18282883	CHEMBL4120468	Inhibition of PRAK (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	1.3	CHEMBL3094	Homo sapiens	INH	%	1.3
	18283097	CHEMBL4120682	Inhibition of PRAK (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	3.3	CHEMBL3094	Homo sapiens	INH	%	3.3
	18440293	CHEMBL4157117	Binding affinity to wild-type human partial length MAPKAPK5 (M1 to D322 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL3094	Homo sapiens	Activity	%	100.0
	18449875	CHEMBL4178109	Inhibition of human PRAK (1 to 471 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	105.0	CHEMBL3094	Homo sapiens	Activity	%	105.0
	18463797	CHEMBL4181213	Inhibition of recombinant human full length N-terminal His6-tagged PRAK expressed in baculovirus Sf21 insect cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	10.0	CHEMBL3094	Homo sapiens	INH	%	10.0
	18484249	CHEMBL4185896	Binding affinity to wild-type human partial length MAPKAPK5 (M1 to D322 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	99.0	CHEMBL3094	Homo sapiens	Activity	%	99.0
	18484733	CHEMBL4185896	Binding affinity to wild-type human partial length MAPKAPK5 (M1 to D322 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	55.0	CHEMBL3094	Homo sapiens	Activity	%	55.0
	18507636	CHEMBL4191155	Inhibition of recombinant full-length human PRAK at 1 uM using KKLRRTLSVA as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1	Outside typical range	CHEMBL4207014	=	Inhibition	%	-11.0	CHEMBL3094	Homo sapiens	INH	%	-11.0
	18653411	CHEMBL4230200	Inhibition of PRAK (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	-1.0	CHEMBL3094	Homo sapiens	INH	%	-1.0
	18653412	CHEMBL4230200	Inhibition of PRAK (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	7.0	CHEMBL3094	Homo sapiens	INH	%	7.0
	18655439	CHEMBL4230796	Binding affinity to wild-type human partial length MAPKAPK5 (M1 to D322 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL3094	Homo sapiens	Activity	%	100.0
	18674854	CHEMBL4235420	Inhibition of PRAK (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	10000.0	CHEMBL3094	Homo sapiens	Ki	nM	10000.0
Not Determined	18674855	CHEMBL4235420	Inhibition of PRAK (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242		Ki			CHEMBL3094	Homo sapiens	Ki		
	18674856	CHEMBL4235420	Inhibition of PRAK (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	>	Ki	nM	10000.0	CHEMBL3094	Homo sapiens	Ki	nM	10000.0
	18708930	CHEMBL4256650	Inhibition of PRAK (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1ccc[nH]c1=O		CHEMBL4286709	=	Inhibition	%	19.0	CHEMBL3094	Homo sapiens	INH	%	19.0
	18708975	CHEMBL4256650	Inhibition of PRAK (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cn1cc(-c2c[nH]c(=O)c(N)c2)cn1		CHEMBL4288628	=	Inhibition	%	99.0	CHEMBL3094	Homo sapiens	INH	%	99.0
	18708983	CHEMBL4256650	Inhibition of PRAK (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccncc2)c[nH]c1=O		CHEMBL12856	=	Inhibition	%	0.0	CHEMBL3094	Homo sapiens	INH	%	0.0
	18709020	CHEMBL4256650	Inhibition of PRAK (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1ncc(-c2ccncc2)cc1N		CHEMBL4291350	=	Inhibition	%	1.0	CHEMBL3094	Homo sapiens	INH	%	1.0
	18709049	CHEMBL4256650	Inhibition of PRAK (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc3ccccc23)c[nH]c1=O		CHEMBL4280308	=	Inhibition	%	15.0	CHEMBL3094	Homo sapiens	INH	%	15.0
	18709078	CHEMBL4256650	Inhibition of PRAK (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CNc1nccc(-c2c[nH]c(=O)c(N)c2)n1		CHEMBL4292538	=	Inhibition	%	88.0	CHEMBL3094	Homo sapiens	INH	%	88.0
	18709107	CHEMBL4256650	Inhibition of PRAK (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O		CHEMBL4282263	=	Inhibition	%	24.0	CHEMBL3094	Homo sapiens	INH	%	24.0
	18709154	CHEMBL4256650	Inhibition of PRAK (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cc1nc(O)c(N)cc1-c1ccncc1		CHEMBL302219	=	Inhibition	%	24.0	CHEMBL3094	Homo sapiens	INH	%	24.0
	18709184	CHEMBL4256676	Inhibition of PRAK (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccncc2)c[nH]c1=O)c1ccccc1		CHEMBL1738828	=	Inhibition	%	1.0	CHEMBL3094	Homo sapiens	INH	%	1.0
	18709213	CHEMBL4256650	Inhibition of PRAK (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1cccc(C(=O)Nc2cc(-c3ccncc3)c[nH]c2=O)c1		CHEMBL4285109	=	Inhibition	%	10.0	CHEMBL3094	Homo sapiens	INH	%	10.0
	18709255	CHEMBL4256676	Inhibition of PRAK (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccncc4)c[nH]c3=O)cc2)CC1		CHEMBL4286130	=	Inhibition	%	10.0	CHEMBL3094	Homo sapiens	INH	%	10.0
	18709288	CHEMBL4256676	Inhibition of PRAK (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O)c1ccccc1		CHEMBL4291472	=	Inhibition	%	71.0	CHEMBL3094	Homo sapiens	INH	%	71.0
	18751214	CHEMBL4263923	Inhibition of PRAK (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	3.0	CHEMBL3094	Homo sapiens	INH	%	3.0
	18752012	CHEMBL4264385	Binding affinity to wild-type human partial length MAPKAPK5 (M1 to D322 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	93.0	CHEMBL3094	Homo sapiens	Activity	%	93.0
	18761571	CHEMBL4266622	Inhibition of recombinant human full length N-terminal His6-tagged PRAK expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1	Outside typical range	CHEMBL4279192	=	Inhibition	%	-20.0	CHEMBL3094	Homo sapiens	INH	%	-20.0
	18761842	CHEMBL4266622	Inhibition of recombinant human full length N-terminal His6-tagged PRAK expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1	Outside typical range	CHEMBL4278882	=	Inhibition	%	-33.0	CHEMBL3094	Homo sapiens	INH	%	-33.0
	18762005	CHEMBL4266622	Inhibition of recombinant human full length N-terminal His6-tagged PRAK expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1	Outside typical range	CHEMBL4290222	=	Inhibition	%	-13.0	CHEMBL3094	Homo sapiens	INH	%	-13.0
	18762090	CHEMBL4266645	Inhibition of PRAK (unknown origin)	B	O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1		CHEMBL297453	=	IC50	nM	1000.0	CHEMBL3094	Homo sapiens	IC50	uM	1.0
	18762146	CHEMBL4266678	Inhibition of PRAK (unknown origin) at 50 uM	B	COc1ccc(/C=C/C(=O)c2c(O)cc(OC)cc2OC)cc1		CHEMBL243829	=	Inhibition	%	91.0	CHEMBL3094	Homo sapiens	INH	%	91.0
	18764497	CHEMBL4267068	Inhibition of human PRAK at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL3094	Homo sapiens	INH	%	70.0
	18764498	CHEMBL4267068	Inhibition of human PRAK at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL3094	Homo sapiens	INH	%	70.0
	18764499	CHEMBL4267068	Inhibition of human PRAK at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL3094	Homo sapiens	INH	%	70.0
	18858049	CHEMBL4307895	Binding affinity to wild-type human partial length MAPKAPK5 (M1 to D322 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	71.0	CHEMBL3094	Homo sapiens	Activity	%	71.0
	18938055	CHEMBL4327754	Inhibition of human MAPKAPK5 assessed as residual activity at 1 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	95.7	CHEMBL3094	Homo sapiens	Activity	%	95.7
	18938056	CHEMBL4327754	Inhibition of human MAPKAPK5 assessed as residual activity at 1 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	93.19	CHEMBL3094	Homo sapiens	Activity	%	93.19
	18938599	CHEMBL4328118	Inhibition of human MAPKAPK5 assessed as residual activity at 100 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL3094	Homo sapiens	Activity	%	65.0
	18938979	CHEMBL4328482	Inhibition of human MAPKAPK5 using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	295.0	CHEMBL3094	Homo sapiens	IC50	10'-7M	2.95
	18953731	CHEMBL4331952	Inhibition of PRAK (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccccc3F)c12		CHEMBL4449552	=	Inhibition	%	11.0	CHEMBL3094	Homo sapiens	INH	%	11.0
	18953787	CHEMBL4331952	Inhibition of PRAK (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(NC3CCCCC3)c12		CHEMBL4440433	=	Inhibition	%	3.0	CHEMBL3094	Homo sapiens	INH	%	3.0
	18953866	CHEMBL4331952	Inhibition of PRAK (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(OC3CCCCC3)c12		CHEMBL4524629	=	Inhibition	%	7.0	CHEMBL3094	Homo sapiens	INH	%	7.0
	18953958	CHEMBL4332011	Inhibition of PRAK (unknown origin) at 1 uM relative to control	B	CC(C)n1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cn1		CHEMBL4589022	=	Inhibition	%	19.0	CHEMBL3094	Homo sapiens	INH	%	19.0
	18954022	CHEMBL4332011	Inhibition of PRAK (unknown origin) at 1 uM relative to control	B	c1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cc(N2CCOCC2)n1		CHEMBL4460272	=	Inhibition	%	4.0	CHEMBL3094	Homo sapiens	INH	%	4.0
	18954089	CHEMBL4331952	Inhibition of PRAK (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccc4ncsc4c3)c12		CHEMBL4588446	=	Inhibition	%	10.0	CHEMBL3094	Homo sapiens	INH	%	10.0
	18958960	CHEMBL4333482	Binding affinity to wild-type human partial length MAPKAPK5 (M1 to D322 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	91.0	CHEMBL3094	Homo sapiens	Activity	%	91.0
	19032199	CHEMBL4349792	Inhibition of recombinant human full length MAPKAPK5 (M1 to Q471) expressed in Escherichia coli at 20 nM using phosphatidylserine as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cn1cc(-c2n[nH]c3ccc(NCc4cc(F)ccc4S(C)(=O)=O)cc23)cn1		CHEMBL4555442	=	Inhibition	%	6.0	CHEMBL3094	Homo sapiens	INH	%	6.0
Active	19041169	CHEMBL4352430	Inhibition of human MAPKAPK5 at 10 uM using KKLNRTLSVA as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
	19059673	CHEMBL4357974	Binding affinity to wild-type human partial length MAPKAPK5 (M1 to D322 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL3094	Homo sapiens	Activity	%	100.0
	19090238	CHEMBL4365812	Inhibition of wild-type human partial length MAPKAPK5 (M1 to D322 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL3094	Homo sapiens	Activity	%	100.0
	19091991	CHEMBL4366465	Inhibition of human MAPKAPK5 at 100 nM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	5.14	CHEMBL3094	Homo sapiens	INH	%	5.14
	19159501	CHEMBL4382605	Binding affinity to wild-type human partial length MAPKAPK5 (M1 to D322 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	100.0	CHEMBL3094	Homo sapiens	Activity	%	100.0
	19181125	CHEMBL4387336	Inhibition of recombinant full length human His-tagged PRAK expressed in baculovirus expression system at 0.1 uM using serine/threonine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	5.0	CHEMBL3094	Homo sapiens	INH	%	5.0
	19181350	CHEMBL4387336	Inhibition of recombinant full length human His-tagged PRAK expressed in baculovirus expression system at 0.1 uM using serine/threonine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	13.5	CHEMBL3094	Homo sapiens	INH	%	13.5
	19191506	CHEMBL4389324	Inhibition of wild-type human partial length MAPKAPK5 (M1 to D322 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL3094	Homo sapiens	INH	%	100.0
	19191987	CHEMBL4389801	Inhibition of wild-type human partial length MAPKAPK5 (M1 to D322 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL3094	Homo sapiens	INH	%	100.0
	19200243	CHEMBL4391427	Binding affinity to wild-type human partial length MAPKAPK5 (M1 to D322 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	42.0	CHEMBL3094	Homo sapiens	Activity	%	42.0
	19266488	CHEMBL4405438	Inhibition of wild-type human partial length MAPKAPK5 (M1 to D322 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	19276088	CHEMBL4408091	Inhibition of recombinant human full length PRAK at 1 uM using KKLRRTLSVA as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	1.0	CHEMBL3094	Homo sapiens	INH	%	1.0
	19411455	CHEMBL4427710	Inhibition of MAPKAPK5 (unknown origin)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	>=	IC50	nM	5000.0	CHEMBL3094	Homo sapiens	IC50	uM	5.0
	19411511	CHEMBL4427654	Inhibition of MAPKAPK5 (unknown origin) at 1 uM relative to control	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	<=	Inhibition	%	16.0	CHEMBL3094	Homo sapiens	INH	%	16.0
	19476602	CHEMBL4479750	Inhibition of full-length recombinant human His-tagged MAPKAPK5 expressed in baculovirus expression system by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	9600.0	CHEMBL3094	Homo sapiens	IC50	nM	9600.0
	19476702	CHEMBL4479750	Inhibition of full-length recombinant human His-tagged MAPKAPK5 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	19000.0	CHEMBL3094	Homo sapiens	IC50	nM	19000.0
	19476802	CHEMBL4479750	Inhibition of full-length recombinant human His-tagged MAPKAPK5 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	1400.0	CHEMBL3094	Homo sapiens	IC50	nM	1400.0
	19476902	CHEMBL4479750	Inhibition of full-length recombinant human His-tagged MAPKAPK5 expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	>	IC50	nM	100000.0	CHEMBL3094	Homo sapiens	IC50	nM	100000.0
	20600586	CHEMBL4603538	Inhibition of recombinant full length human His-tagged PRAK expressed in baculovirus expression system using serine/threonine-4 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL3094	Homo sapiens	IC50	uM	100.0
	22392146	CHEMBL4667241	Inhibition of recombinant human His-tagged full length PRAK expressed in baculovirus expression system using Ser/Thr 04 as substrate at 10 uM incubated for 60 mins by Z'-lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	5.0	CHEMBL3094	Homo sapiens	INH	%	5.0
	22423489	CHEMBL4674320	Inhibition of human MAPKAPK5 using KKLNRTLSVA as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	94.19	CHEMBL3094	Homo sapiens	Activity	%	94.19
	22423490	CHEMBL4674320	Inhibition of human MAPKAPK5 using KKLNRTLSVA as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	69.01	CHEMBL3094	Homo sapiens	Activity	%	69.01
	22752711	CHEMBL4700178	Inhibition of human PRAK at 1 uM by kinase-profiling analysis	B	C#Cc1nc(Nc2ccccc2)nc2[nH]cnc12		CHEMBL4094562	=	Inhibition	%	29.0	CHEMBL3094	Homo sapiens	INH	%	29.0
Not Determined	22752712	CHEMBL4700178	Inhibition of human PRAK at 1 uM by kinase-profiling analysis	B	C#Cc1nc(Nc2ccc(S(N)(=O)=O)cc2)nc2[nH]cnc12		CHEMBL4074015		Inhibition	%		CHEMBL3094	Homo sapiens	INH		
	22809792	CHEMBL4713327	Inhibition of recombinant full length human PRAK assessed as residual activity at 1 uM using KKLRRTLSVA as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	97.0	CHEMBL3094	Homo sapiens	Activity	%	97.0
	22818125	CHEMBL4715348	Inhibition of recombinant human N-terminal His6-tagged full-length PRAK expressed in baculovirus infected Sf21 insect cells at 2 uM using PRAK substrate peptide relative to control	B	C[C@@H](c1ccc2ncccc2c1)c1nnc2sc(-c3cnn(C)c3)nn12		CHEMBL4791034	<	Inhibition	%	50.0	CHEMBL3094	Homo sapiens	INH	%	50.0
	22820560	CHEMBL4716282	Inhibition of N-terminal His6-tagged human full-length PRAK expressed in baculovirus-infected Sf21 cells assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	109.0	CHEMBL3094	Homo sapiens	Activity	%	109.0
	22820561	CHEMBL4716282	Inhibition of N-terminal His6-tagged human full-length PRAK expressed in baculovirus-infected Sf21 cells assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	91.0	CHEMBL3094	Homo sapiens	Activity	%	91.0
	22843686	CHEMBL4720672	Inhibition of human MAPKAPK5 using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	129.0	CHEMBL3094	Homo sapiens	IC50	10^-7M	1.29
	22844034	CHEMBL4721020	Inhibition of human MAPKAPK5 assessed as residual activity using KKLNRTLSVA as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	98.84	CHEMBL3094	Homo sapiens	Activity	%	98.84
	22844780	CHEMBL4721455	Inhibition of wild-type human partial length MAPKAPK5 (M1 to D322 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	81.81	CHEMBL3094	Homo sapiens	Activity	%	81.81
	22952975	CHEMBL4766912	Inhibition of recombinant full length human PRAK assessed as residual activity at 10 uM using KKLRRTLSVA as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	86.0	CHEMBL3094	Homo sapiens	Activity	%	86.0
	23122659	CHEMBL4805010	Inhibition of human MAPKAPK5 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	62.0	CHEMBL3094	Homo sapiens	Activity	%	62.0
	23123354	CHEMBL4805598	Inhibition of human MAPKAPK5 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	63.0	CHEMBL3094	Homo sapiens	Activity	%	63.0
	23123813	CHEMBL4806057	Inhibition of DNA-tagged human MAPKAPK5 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL3094	Homo sapiens	Activity	%	100.0
	23124798	CHEMBL4806615	Inhibition of human MAPKAPK5 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL3094	Homo sapiens	Activity	%	100.0
	23124799	CHEMBL4806615	Inhibition of human MAPKAPK5 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	64.0	CHEMBL3094	Homo sapiens	Activity	%	64.0
	23128269	CHEMBL4807898	Inhibition of MAPKAPK5 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL3094	Homo sapiens	Activity	%	75.0
	23128270	CHEMBL4807898	Inhibition of MAPKAPK5 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL3094	Homo sapiens	Activity	%	75.0
	23128271	CHEMBL4807898	Inhibition of MAPKAPK5 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL3094	Homo sapiens	Activity	%	75.0
	23213433	CHEMBL4822967	Inhibition of human recombinant PRAK in presence of ATP by Z-lyte kinase assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	Inhibition	%	60.0	CHEMBL3094	Homo sapiens	INH	%	60.0
Not Active	23317494	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	91.0	CHEMBL3094	Homo sapiens	% Control	%	91.0
Not Active	23317962	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23318629	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	90.0	CHEMBL3094	Homo sapiens	% Control	%	90.0
Not Active	23319112	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23319749	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	67.9	CHEMBL3094	Homo sapiens	% Control	%	67.9
Not Active	23320224	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23320902	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23321370	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	84.0	CHEMBL3094	Homo sapiens	% Control	%	84.0
Not Active	23322000	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	65.0	CHEMBL3094	Homo sapiens	% Control	%	65.0
Not Active	23322468	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	87.0	CHEMBL3094	Homo sapiens	% Control	%	87.0
Not Active	23323157	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	76.0	CHEMBL3094	Homo sapiens	% Control	%	76.0
Not Active	23323625	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23324113	CHEMBL4880732	PRAK (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	6.0	CHEMBL3094	Homo sapiens	% inhibition	%	6.0
Not Active	23324479	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23325114	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	99.0	CHEMBL3094	Homo sapiens	% Control	%	99.0
Not Active	23325582	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	76.0	CHEMBL3094	Homo sapiens	% Control	%	76.0
Not Active	23326229	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23326697	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	89.0	CHEMBL3094	Homo sapiens	% Control	%	89.0
Not Active	23327397	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23327865	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23328452	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	84.0	CHEMBL3094	Homo sapiens	% Control	%	84.0
Not Active	23328920	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	87.0	CHEMBL3094	Homo sapiens	% Control	%	87.0
Not Active	23329499	CHEMBL4881206	PRAK(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	109.0	CHEMBL3094	Homo sapiens	% residual kinase activity	%	109.0
Not Active	23329866	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23330334	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	94.0	CHEMBL3094	Homo sapiens	% Control	%	94.0
Not Active	23331090	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	94.0	CHEMBL3094	Homo sapiens	% Control	%	94.0
Not Active	23331558	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23332145	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	91.7	CHEMBL3094	Homo sapiens	% Control	%	91.7
Not Active	23332611	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23333329	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23333968	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	88.0	CHEMBL3094	Homo sapiens	% Control	%	88.0
Not Active	23334436	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23334949	CHEMBL4881571	PRAK (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	36.0	CHEMBL3094	Homo sapiens	% inhibition	%	36.0
Not Active	23335415	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	81.0	CHEMBL3094	Homo sapiens	% Control	%	81.0
Not Active	23335883	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23336510	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	86.0	CHEMBL3094	Homo sapiens	% Control	%	86.0
Not Active	23336978	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	97.0	CHEMBL3094	Homo sapiens	% Control	%	97.0
Not Active	23337674	CHEMBL4882045	MAPKAPK5 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	98.5	CHEMBL3094	Homo sapiens	% Ctrl	%	98.5
Not Active	23338059	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	94.0	CHEMBL3094	Homo sapiens	% Control	%	94.0
Not Active	23338527	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	92.0	CHEMBL3094	Homo sapiens	% Control	%	92.0
Not Active	23339139	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	93.0	CHEMBL3094	Homo sapiens	% Control	%	93.0
Not Active	23339607	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	81.0	CHEMBL3094	Homo sapiens	% Control	%	81.0
Not Active	23340244	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	87.0	CHEMBL3094	Homo sapiens	% Control	%	87.0
Not Active	23340712	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23341369	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23341837	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	88.0	CHEMBL3094	Homo sapiens	% Control	%	88.0
Not Active	23342453	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	73.0	CHEMBL3094	Homo sapiens	% Control	%	73.0
Not Active	23342921	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23343551	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	92.0	CHEMBL3094	Homo sapiens	% Control	%	92.0
Not Active	23344019	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	89.0	CHEMBL3094	Homo sapiens	% Control	%	89.0
Not Active	23344657	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	87.0	CHEMBL3094	Homo sapiens	% Control	%	87.0
Not Active	23345230	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	88.0	CHEMBL3094	Homo sapiens	% Control	%	88.0
Not Active	23345698	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	96.0	CHEMBL3094	Homo sapiens	% Control	%	96.0
Not Active	23346275	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23346743	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	97.7	CHEMBL3094	Homo sapiens	% Control	%	97.7
Not Active	23347345	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	80.0	CHEMBL3094	Homo sapiens	% Control	%	80.0
Not Active	23347835	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23348414	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23348882	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	89.0	CHEMBL3094	Homo sapiens	% Control	%	89.0
Not Active	23349469	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	93.0	CHEMBL3094	Homo sapiens	% Control	%	93.0
Not Active	23350087	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23350555	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	91.0	CHEMBL3094	Homo sapiens	% Control	%	91.0
Not Active	23351160	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	94.0	CHEMBL3094	Homo sapiens	% Control	%	94.0
Not Active	23351628	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23352126	CHEMBL4882815	MAPKAPK5 (PRAK) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	14.21	CHEMBL3094	Homo sapiens	% Inhibition	%	14.2082
Not Active	23352652	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	93.0	CHEMBL3094	Homo sapiens	% Control	%	93.0
Not Active	23353120	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	73.0	CHEMBL3094	Homo sapiens	% Control	%	73.0
Not Active	23354002	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23354470	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23355202	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23355670	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23356306	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23356774	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	97.0	CHEMBL3094	Homo sapiens	% Control	%	97.0
Not Active	23357383	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	96.0	CHEMBL3094	Homo sapiens	% Control	%	96.0
Not Active	23358030	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23358498	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	76.0	CHEMBL3094	Homo sapiens	% Control	%	76.0
Not Active	23359084	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	93.8	CHEMBL3094	Homo sapiens	% Control	%	93.8
Not Active	23359682	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	84.0	CHEMBL3094	Homo sapiens	% Control	%	84.0
Not Active	23360150	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	93.0	CHEMBL3094	Homo sapiens	% Control	%	93.0
Not Active	23360735	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	95.0	CHEMBL3094	Homo sapiens	% Control	%	95.0
Not Active	23361203	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	92.0	CHEMBL3094	Homo sapiens	% Control	%	92.0
Not Active	23361776	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	68.0	CHEMBL3094	Homo sapiens	% Control	%	68.0
Not Active	23362312	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23362780	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23364422	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	82.0	CHEMBL3094	Homo sapiens	% Control	%	82.0
Not Active	23364890	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	81.0	CHEMBL3094	Homo sapiens	% Control	%	81.0
Not Active	23365629	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	99.0	CHEMBL3094	Homo sapiens	% Control	%	99.0
Not Active	23366172	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	95.0	CHEMBL3094	Homo sapiens	% Control	%	95.0
Not Active	23366762	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	93.0	CHEMBL3094	Homo sapiens	% Control	%	93.0
Not Active	23367230	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23367632	CHEMBL4883985	MAPKAPK5 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	97.0	CHEMBL3094	Homo sapiens	% Residual activity with Skepinone-L	%	97.0
Not Active	23368108	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	91.0	CHEMBL3094	Homo sapiens	% Control	%	91.0
Not Active	23368576	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	75.0	CHEMBL3094	Homo sapiens	% Control	%	75.0
Not Active	23369175	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	86.0	CHEMBL3094	Homo sapiens	% Control	%	86.0
Not Active	23369643	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	96.0	CHEMBL3094	Homo sapiens	% Control	%	96.0
Not Active	23370214	CHEMBL4884456	PRAK(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	87.0	CHEMBL3094	Homo sapiens	% residual kinase activity	%	87.0
Not Active	23370611	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23371079	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23371888	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23372356	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
	23372807	CHEMBL4884772	MAPKAPK5(MPK5LGN1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL3094	Homo sapiens	pIC50		6.0
	23373216	CHEMBL4885063	MAPKAPK5(MPK5LGN1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL3094	Homo sapiens	pIC50		6.0
	23373574	CHEMBL4885351	MAPKAPK5(MPK5LGN1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL3094	Homo sapiens	pIC50		6.0
Not Active	23375081	CHEMBL4886069	PRAK Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	-3.5	CHEMBL3094	Homo sapiens	% Inhibition	%	-3.5
Not Active	23375295	CHEMBL4886277	mitogen-activated protein kinase-activated protein kinase 5 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	7.0	CHEMBL3094	Homo sapiens	% inhibition	%	7.0
Not Active	23375783	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	78.0	CHEMBL3094	Homo sapiens	% Control	%	78.0
Not Active	23376251	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	92.0	CHEMBL3094	Homo sapiens	% Control	%	92.0
Not Active	23376828	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	92.0	CHEMBL3094	Homo sapiens	% Control	%	92.0
Not Active	23377296	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	73.0	CHEMBL3094	Homo sapiens	% Control	%	73.0
Not Active	23378156	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	82.0	CHEMBL3094	Homo sapiens	% Control	%	82.0
Not Active	23378624	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	86.0	CHEMBL3094	Homo sapiens	% Control	%	86.0
Not Active	23379791	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	56.0	CHEMBL3094	Homo sapiens	% Control	%	56.0
Not Active	23380259	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23380953	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	76.0	CHEMBL3094	Homo sapiens	% Control	%	76.0
Not Active	23381601	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	96.0	CHEMBL3094	Homo sapiens	% Control	%	96.0
Not Active	23382069	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23382693	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	76.0	CHEMBL3094	Homo sapiens	% Control	%	76.0
Not Active	23383161	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	94.0	CHEMBL3094	Homo sapiens	% Control	%	94.0
Not Active	23383880	CHEMBL4887499	MAPKAPK5 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	92.0	CHEMBL3094	Homo sapiens	% Ctrl	%	92.0
Not Active	23384065	CHEMBL4887663	PRAK DUNDEE kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	61.1	CHEMBL3094	Homo sapiens	% Ctrl	%	61.1
Not Active	23384436	CHEMBL4888031	PRAK(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	23.56	CHEMBL3094	Homo sapiens	% inhibition	%	23.56
Not Active	23385076	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
Not Active	23385543	CHEMBL4879800	KinomeScan assay: inhibition of MAPKAPK5	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL3094	Homo sapiens	% Control	%	100.0
